BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA. 1991;265:1287-1289. [PMID: 1995976 DOI: 10.1001/jama.1991.03460100089030] [Cited by in Crossref: 1255] [Cited by in F6Publishing: 812] [Article Influence: 40.5] [Reference Citation Analysis]
Number Citing Articles
1 Weston AP, Sharma P, Banerjee S, Mitreva D, Mathur S. Visible endoscopic and histologic changes in the cardia, before and after complete Barrett's esophagus ablation. Gastrointestinal Endoscopy 2005;61:515-21. [DOI: 10.1016/s0016-5107(05)00131-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
2 Wright TA. High-grade dysplasia in Barrett's oesophagus. Br J Surg 1997;84:760-6. [DOI: 10.1002/bjs.1800840606] [Cited by in Crossref: 28] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
3 Xia HH, Talley NJ. Helicobacter pylori infection, reflux esophagitis, and atrophic gastritis: an unexplored triangle. Am J Gastroenterol. 1998;93:394-400. [PMID: 9517647 DOI: 10.1111/j.1572-0241.1998.00394.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 1.7] [Reference Citation Analysis]
4 Ekström AM, Serafini M, Nyrén O, Hansson L, Ye W, Wolk A. Dietary antioxidant intake and the risk of cardia cancer and noncardia cancer of the intestinal and diffuse types: A population-based case-control study in Sweden. Int J Cancer 2000;87:133-40. [DOI: 10.1002/1097-0215(20000701)87:1<133::aid-ijc20>3.0.co;2-e] [Cited by in Crossref: 93] [Article Influence: 4.2] [Reference Citation Analysis]
5 Andrici J, Tio M, Cox MR, Eslick GD. Hiatal hernia and the risk of Barrett's esophagus. J Gastroenterol Hepatol. 2013;28:415-431. [PMID: 22694245 DOI: 10.1111/j.1440-1746.2012.07199.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 4.2] [Reference Citation Analysis]
6 Yagi K, Nakamura A, Sekine A. Accuracy of magnifying endoscopy with methylene blue in the diagnosis of specialized intestinal metaplasia and short-segment Barrett's esophagus in Japanese patients without Helicobacter pylori infection. Gastrointest Endosc 2003;58:189-95. [PMID: 12872084 DOI: 10.1067/mge.2003.342] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
7 Weinberg DS, Kadish SL. The diagnosis and management of gastroesophageal reflux disease. Med Clin North Am 1996;80:411-29. [PMID: 8614179 DOI: 10.1016/s0025-7125(05)70446-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
8 Weiss MM, Kuipers EJ, Hermsen MA, van Grieken NC, Offerhaus J, Baak JP, Meuwissen SG, Meijer GA. Barrett's adenocarcinomas resemble adenocarcinomas of the gastric cardia in terms of chromosomal copy number changes, but relate to squamous cell carcinomas of the distal oesophagus with respect to the presence of high-level amplifications. J Pathol 2003;199:157-65. [DOI: 10.1002/path.1260] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.3] [Reference Citation Analysis]
9 Yoo CH, Sohn BH, Han WK, Pae WK. Proximal gastrectomy reconstructed by jejunal pouch interposition for upper third gastric cancer: prospective randomized study. World J Surg. 2005;29:1592-1599. [PMID: 16311849 DOI: 10.1007/s00268-005-7793-1] [Cited by in Crossref: 54] [Cited by in F6Publishing: 42] [Article Influence: 3.4] [Reference Citation Analysis]
10 Cheung MC, Koniaris LG, Yang R, Zhuge Y, Mackinnon JA, Byrne MM, Franceschi D. Do all patients with carcinoma of the esophagus benefit from treatment at teaching facilities? J Surg Oncol 2010;102:18-26. [PMID: 20213687 DOI: 10.1002/jso.21509] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
11 Sihvo EI, Pentikäinen T, Luostarinen ME, Rämö OJ, Salo JA. Inoperable adenocarcinoma of the oesophagogastric junction: a comparative clinical study of laser coagulation versus self-expanding metallic stents with special reference to cost analysis. Eur J Surg Oncol 2002;28:711-5. [PMID: 12431467 DOI: 10.1053/ejso.2002.1315] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
12 Turcotte S, Duranceau A. Gastroesophageal reflux and cancer. Thorac Surg Clin 2005;15:341-52. [PMID: 16104125 DOI: 10.1016/j.thorsurg.2005.03.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
13 Levi F, Te V, Randimbison L, La Vecchia C. Re: Evaluating Gastric Cancer Misclassification: a Potential Explanation for the Rise in Cardia Cancer Incidence. JNCI Journal of the National Cancer Institute 1999;91:1585-6. [DOI: 10.1093/jnci/91.18.1585a] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
14 Shah AR, Elkhatib I, Krinsky ML. A novel method for esophageal stent placement: retroflexed endoscopic guidance from the stomach. Gastrointest Endosc 2015;81:474-8. [PMID: 25432529 DOI: 10.1016/j.gie.2014.09.042] [Reference Citation Analysis]
15 Maes S, Sharma P, Bisschops R. Review: Surveillance of patients with Barrett oesophagus. Best Pract Res Clin Gastroenterol. 2016;30:901-912. [PMID: 27938785 DOI: 10.1016/j.bpg.2016.09.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
16 Musana AK, Resnick JM, Torbey CF, Mukesh BN, Greenlee RT. Barrett's esophagus: incidence and prevalence estimates in a rural Mid-Western population. Am J Gastroenterol 2008;103:516-24. [PMID: 17970839 DOI: 10.1111/j.1572-0241.2007.01599.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
17 Dua KS, Kozarek R, Kim J, Evans J, Medda BK, Lang I, Hogan WJ, Shaker R. Self-expanding metal esophageal stent with anti-reflux mechanism. Gastrointest Endosc. 2001;53:603-613. [PMID: 11323586 DOI: 10.1067/mge.2001.114054] [Cited by in Crossref: 86] [Cited by in F6Publishing: 71] [Article Influence: 4.1] [Reference Citation Analysis]
18 Singh R, Yeap SP. Endoscopic imaging in Barrett's esophagus. Expert Rev Gastroenterol Hepatol 2015;9:475-85. [PMID: 25399554 DOI: 10.1586/17474124.2015.983080] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
19 Peng D, Sheta EA, Powell SM, Moskaluk CA, Washington K, Goldknopf IL, El-Rifai W. Alterations in Barrett's-related adenocarcinomas: a proteomic approach. Int J Cancer 2008;122:1303-10. [PMID: 18000824 DOI: 10.1002/ijc.23258] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
20 DeMeester SR. Adenocarcinoma of the esophagus and cardia: a review of the disease and its treatment. Ann Surg Oncol. 2006;13:12-30. [PMID: 16378161 DOI: 10.1245/aso.2005.12.025] [Cited by in Crossref: 152] [Cited by in F6Publishing: 56] [Article Influence: 9.5] [Reference Citation Analysis]
21 Blank S, Schmidt T, Heger P, Strowitzki MJ, Sisic L, Heger U, Nienhueser H, Haag GM, Bruckner T, Mihaljevic AL, Ott K, Büchler MW, Ulrich A. Surgical strategies in true adenocarcinoma of the esophagogastric junction (AEG II): thoracoabdominal or abdominal approach? Gastric Cancer 2018;21:303-14. [DOI: 10.1007/s10120-017-0746-1] [Cited by in Crossref: 35] [Cited by in F6Publishing: 25] [Article Influence: 7.0] [Reference Citation Analysis]
22 Torres C, Turner JR, Wang HH, Richards W, Sugarbaker D, Shahsafaei A, Odze RD. Pathologic prognostic factors in Barrett's-associated adenocarcinoma: A follow-up study of 96 patients. Cancer 1999;85:520-8. [DOI: 10.1002/(sici)1097-0142(19990201)85:3<520::aid-cncr2>3.0.co;2-l] [Cited by in Crossref: 36] [Article Influence: 1.6] [Reference Citation Analysis]
23 Shah MA, Ramanathan RK, Ilson DH, Levnor A, D’Adamo D, O’Reilly E, Tse A, Trocola R, Schwartz L, Capanu M. Multicenter phase II study of irinotecan, cisplatin, and bevacizumab in patients with metastatic gastric or gastroesophageal junction adenocarcinoma. J Clin Oncol. 2006;24:5201-5206. [PMID: 17114652 DOI: 10.1200/jco.2006.08.0887] [Cited by in Crossref: 292] [Cited by in F6Publishing: 142] [Article Influence: 18.3] [Reference Citation Analysis]
24 Cen P, Hofstetter WL, Correa AM, Wu TT, Lee JH, Ross WA, Davilla M, Swisher SG, Fukami N, Rashid A. Lymphovascular invasion as a tool to further subclassify T1b esophageal adenocarcinoma. Cancer. 2008;112:1020-1027. [PMID: 18205187 DOI: 10.1002/cncr.23265] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 2.8] [Reference Citation Analysis]
25 Tan W, Fulljames C, Stone N, Dix A, Shepherd N, Roberts D, Brown S, Krasner N, Barr H. Photodynamic therapy using 5-aminolaevulinic acid for oesophageal adenocarcinoma associated with Barrett’s metaplasia. Journal of Photochemistry and Photobiology B: Biology 1999;53:75-80. [DOI: 10.1016/s1011-1344(99)00129-3] [Cited by in Crossref: 40] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
26 Powell EL, Leoni LM, Canto MI, Forastiere AA, Iocobuzio-Donahue CA, Wang JS, Maitra A, Montgomery E. Concordant loss of MTAP and p16/CDKN2A expression in gastroesophageal carcinogenesis: evidence of homozygous deletion in esophageal noninvasive precursor lesions and therapeutic implications. Am J Surg Pathol 2005;29:1497-504. [PMID: 16224217 DOI: 10.1097/01.pas.0000170349.47680.e8] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 2.3] [Reference Citation Analysis]
27 Ellis KK, Fennerty MB. Gastric Malignancy. Gastrointestinal Endoscopy Clinics of North America 1996;6:545-63. [DOI: 10.1016/s1052-5157(18)30354-4] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
28 Wall CM, Charlett A, Caygill CP, Gatenby PA, Ramus JR, Winslet MC, Watson A. Are newly diagnosed columnar-lined oesophagus patients getting younger? Eur J Gastroenterol Hepatol. 2009;21:1127-1131. [PMID: 19295439 DOI: 10.1097/meg.0b013e328329c414] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
29 Balbuena L, Casson AG. Physical activity, obesity and risk for esophageal adenocarcinoma. Future Oncology 2009;5:1051-63. [DOI: 10.2217/fon.09.65] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
30 Naunheim KS, Petruska PJ, Roy TS, Andrus CH, Johnson FE, Schlueter JM, Baue AE. Preoperative chemotherapy and radiotherapy for esophageal carcinoma. The Journal of Thoracic and Cardiovascular Surgery 1992;103:887-95. [DOI: 10.1016/s0022-5223(19)34912-8] [Cited by in Crossref: 81] [Article Influence: 2.7] [Reference Citation Analysis]
31 Keswani RN, Chumsangsri A, Mustafi R, Delgado J, Cohen EE, Bissonnette M. Sorafenib inhibits MAPK-mediated proliferation in a Barrett’s esophageal adenocarcinoma cell line. Dis Esophagus. 2008;21:514-521. [PMID: 18840136 DOI: 10.1111/j.1442-2050.2007.00799.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
32 Ajani JA, Mansfield PF, Lynch PM, Pisters PW, Feig B, Dumas P, Evans DB, Raijman I, Hargraves K, Curley S, Ota DM. Enhanced Staging and All Chemotherapy Preoperatively in Patients with Potentially Resectable Gastric Carcinoma. JCO 1999;17:2403-2403. [DOI: 10.1200/jco.1999.17.8.2403] [Cited by in Crossref: 71] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
33 Trivers KF, Sabatino SA, Stewart SL. Trends in esophageal cancer incidence by histology, United States, 1998-2003. Int J Cancer. 2008;123:1422-1428. [PMID: 18546259 DOI: 10.1002/ijc.23691] [Cited by in Crossref: 132] [Cited by in F6Publishing: 121] [Article Influence: 9.4] [Reference Citation Analysis]
34 Yao JC, Ajani JA. Gastric cancer. Curr Opin Gastroenterol 2000;16:516-21. [PMID: 17031130 DOI: 10.1097/00001574-200011000-00009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
35 Ebert B, Nolte D, Sukowski U, Rinneberg H. Fluoreszenz-geführte Endoskopie von Hohlorganen. Phys Bl 1999;55:53-5. [DOI: 10.1002/phbl.19990550312] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
36 Landreneau RJ, Wiechmann RJ, Hazelrigg SR, Santucci TS, Boley TM, Magee MJ, Naunheim KS. Success of laparoscopic fundoplication for gastroesophageal reflux disease. Ann Thorac Surg 1998;66:1886-93. [PMID: 9930464 DOI: 10.1016/s0003-4975(98)01260-0] [Cited by in Crossref: 27] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
37 Wang W, Zheng C, Fang C, Li P, Xie J, Lin J, Zhan Y, Li W, Chen Y, Sun X, Xu D, Li Y, Huang C, Zhou Z. Time trends of clinicopathologic features and surgical treatment for gastric cancer: Results from 2 high-volume institutions in southern China. Surgery. 2015;158:1590-1597. [PMID: 26210225 DOI: 10.1016/j.surg.2015.04.038] [Cited by in Crossref: 13] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
38 Devesa SS, Fraumeni JF. The rising incidence of gastric cardia cancer. J Natl Cancer Inst. 1999;91:747-749. [PMID: 10328099 DOI: 10.1093/jnci/91.9.747] [Cited by in Crossref: 98] [Cited by in F6Publishing: 91] [Article Influence: 4.3] [Reference Citation Analysis]
39 Sampliner RE, Fennerty B, Garewal HS. Reversal of Barrett's esophagus with acid suppression and multipolar electrocoagulation: preliminary results. Gastrointestinal Endoscopy 1996;44:532-5. [DOI: 10.1016/s0016-5107(96)70004-4] [Cited by in Crossref: 135] [Cited by in F6Publishing: 23] [Article Influence: 5.2] [Reference Citation Analysis]
40 Ronkainen J, Aro P, Storskrubb T, Johansson SE, Lind T, Bolling-Sternevald E, Vieth M, Stolte M, Talley NJ, Agréus L. Prevalence of Barrett’s esophagus in the general population: an endoscopic study. Gastroenterology. 2005;129:1825-1831. [PMID: 16344051 DOI: 10.1053/j.gastro.2005.08.053] [Cited by in Crossref: 625] [Cited by in F6Publishing: 519] [Article Influence: 39.1] [Reference Citation Analysis]
41 Brown LM, Silverman DT, Pottern LM, Schoenberg JB, Greenberg RS, Swanson GM, Liff JM, Schwartz AG, Hayes RB, Blot WJ. Adenocarcinoma of the esophagus and esophagogastric junction in white men in the United States: alcohol, tobacco, and socioeconomic factors. Cancer Causes Control. 1994;5:333-340. [PMID: 8080945 DOI: 10.1007/bf01804984] [Cited by in Crossref: 135] [Cited by in F6Publishing: 39] [Article Influence: 4.8] [Reference Citation Analysis]
42 Bruno L, Nesi G, Montinaro F, Carassale G, Lassig R, Boddi V, Bechi P, Cortesini C. Clinicopathologic findings and results of surgical treatment in cardiac adenocarcinoma. J Surg Oncol 2000;74:33-5. [PMID: 10861606 DOI: 10.1002/1096-9098(200005)74:1<33::aid-jso8>3.0.co;2-r] [Cited by in Crossref: 24] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
43 Poneros JM. Diagnosis of Barrett's esophagus using optical coherence tomography. Gastrointest Endosc Clin N Am. 2004;14:573-88, x. [PMID: 15261203 DOI: 10.1016/j.giec.2004.03.002] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
44 Kearney DJ, Crump C, Maynard C, Boyko EJ. A case-control study of endoscopy and mortality from adenocarcinoma of the esophagus or gastric cardia in persons with GERD. Gastrointest Endosc 2003;57:823-9. [PMID: 12776027 DOI: 10.1016/s0016-5107(03)70015-7] [Cited by in Crossref: 26] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
45 Njei B, McCarty TR, Birk JW. Trends in esophageal cancer survival in United States adults from 1973 to 2009: A SEER database analysis. J Gastroenterol Hepatol. 2016;31:1141-1146. [PMID: 26749521 DOI: 10.1111/jgh.13289] [Cited by in Crossref: 125] [Cited by in F6Publishing: 114] [Article Influence: 25.0] [Reference Citation Analysis]
46 Vazquez-Sequeiros E, Levy MJ, Clain JE, Schwartz DA, Harewood GC, Salomao D, Wiersema MJ. Routine vs. selective EUS-guided FNA approach for preoperative nodal staging of esophageal carcinoma. Gastrointest Endosc. 2006;63:204-211. [PMID: 16427921 DOI: 10.1016/j.gie.2005.08.053] [Cited by in Crossref: 44] [Cited by in F6Publishing: 37] [Article Influence: 2.8] [Reference Citation Analysis]
47 Wayman J, Dresner SM, Raimes SA, Griffin SM. Transhiatal approach to total gastrectomy for adenocarcinoma of the gastric cardia. Br J Surg. 1999;86:536-540. [PMID: 10215832 DOI: 10.1046/j.1365-2168.1999.01043.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 1.7] [Reference Citation Analysis]
48 Schottenfeld D. The Etiology and Prevention of Aerodigestive Tract Cancers. In: Newell GR, Hong WK, editors. The Biology and Prevention of Aerodigestive Tract Cancers. Boston: Springer US; 1992. pp. 1-19. [DOI: 10.1007/978-1-4615-3468-6_1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
49 Justino PB, Carvalho HDA, Ferauche D, Ros R. Planejamento tridimensional para radioterapia de tumores de esôfago: comparação de técnicas de tratamento e análise de probabilidade de complicações. Radiol Bras 2003;36:157-62. [DOI: 10.1590/s0100-39842003000300007] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
50 Levine MS, Megibow AJ, Kochman ML. Carcinoma of the Stomach and Duodenum. Textbook of Gastrointestinal Radiology. Elsevier; 2008. pp. 619-43. [DOI: 10.1016/b978-1-4160-2332-6.50041-5] [Cited by in Crossref: 6] [Article Influence: 0.4] [Reference Citation Analysis]
51 Sharma P. Endoscopic recognition and screening of barrett's esophagus. Techniques in Gastrointestinal Endoscopy 2000;2:182-5. [DOI: 10.1053/tgie.2000.8940] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
52 Jolley SG. Current surgical considerations in gastroesophageal reflux disease in infancy and childhood. Surg Clin North Am 1992;72:1365-91. [PMID: 1440162 DOI: 10.1016/s0039-6109(16)45886-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
53 Janjigian YY, Kelsen DP. Genomic Dysregulation in gastric tumors: Genomic Dysregulation in Gastric Tumors. J Surg Oncol 2013;107:237-42. [DOI: 10.1002/jso.23263] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
54 Dave UR, Williams AD, Wilson JA, Amin Z, Gilderdale DJ, Larkman DJ, Thursz MR, Taylor-Robinson SD, deSouza NM. Esophageal cancer staging with endoscopic MR imaging: pilot study. Radiology 2004;230:281-6. [PMID: 14645876 DOI: 10.1148/radiol.2301021047] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 1.7] [Reference Citation Analysis]
55 Bonde P, Gao D, Chen L, Duncan M, Miyashita T, Montgomery E, Harmon JW, Wei C. Selective decrease in the DNA base excision repair pathway in squamous cell cancer of the esophagus. The Journal of Thoracic and Cardiovascular Surgery 2007;133:74-81.e3. [DOI: 10.1016/j.jtcvs.2006.06.050] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
56 Cooper GS. Endoscopic screening and surveillance for Barrett's esophagus: Can claims data determine its effectiveness? Gastrointestinal Endoscopy 2003;57:914-6. [DOI: 10.1016/s0016-5107(03)70029-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
57 Alikhan M, Rex D, Khan A, Rahmani E, Cummings O, Ulbright TM. Variable pathologic interpretation of columnar lined esophagus by general pathologists in community practice. Gastrointest Endosc. 1999;50:23-26. [PMID: 10385717 DOI: 10.1016/s0016-5107(99)70339-1] [Cited by in Crossref: 127] [Cited by in F6Publishing: 37] [Article Influence: 5.5] [Reference Citation Analysis]
58 Omae M, Fujisaki J, Horiuchi Y, Yoshizawa N, Matsuo Y, Kubota M, Suganuma T, Okada K, Ishiyama A, Hirasawa T, Yamamoto Y, Tsuchida T, Hoshino E, Igarashi M. Safety, efficacy, and long-term outcomes for endoscopic submucosal dissection of early esophagogastric junction cancer. Gastric Cancer 2013;16:147-54. [PMID: 22692465 DOI: 10.1007/s10120-012-0162-5] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
59 Stamp D. Glycine conjugated and free bile acids, aided by acid suppression, can easily enter the esophageal epithelium where they can activate oncogenes and eventually carcinogenesis. Med Hypotheses 2007;68:1428-9. [PMID: 17134842 DOI: 10.1016/j.mehy.2006.10.026] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
60 Farndon MA, Wayman J, Clague MB, Griffin SM. Cost-effectiveness in the management of patients with oesophageal cancer. Br J Surg 1998;85:1394-8. [PMID: 9782023 DOI: 10.1046/j.1365-2168.1998.00916.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 0.8] [Reference Citation Analysis]
61 Clark GW, Demeester TR. Biopsy of Upper Gastrointestinal Tract Lesions. Surgical Oncology Clinics of North America 1995;4:81-102. [DOI: 10.1016/s1055-3207(18)30469-1] [Cited by in Crossref: 5] [Article Influence: 0.2] [Reference Citation Analysis]
62 Safran H, Gaissert H, Akerman P, Hesketh PJ, Chen M, Moore T, Koness J, Graziano S, Wanebo HJ. Paclitaxel, Cisplatin, and Concurrent Radiation for Esophageal Cancer. Cancer Investigation 2001;19:1-7. [DOI: 10.1081/cnv-100000068] [Cited by in Crossref: 48] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
63 Meyer HJ, Jähne J, Pichlmayr R. Strategies in the surgical treatment of gastric carcinoma. Ann Oncol. 1994;5 Suppl 3:33-36. [PMID: 8204529 DOI: 10.1093/annonc/5.suppl_3.S33] [Cited by in Crossref: 18] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
64 Sikkema M, Kerkhof M, Steyerberg EW, Kusters JG, van Strien PM, Looman CW, van Dekken H, Siersema PD, Kuipers EJ. Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett’s esophagus: a case-control study. Am J Gastroenterol. 2009;104:2673-2680. [PMID: 19638963 DOI: 10.1038/ajg.2009.437] [Cited by in Crossref: 86] [Cited by in F6Publishing: 71] [Article Influence: 6.6] [Reference Citation Analysis]
65 Sharma P. Short segment Barrett esophagus and specialized columnar mucosa at the gastroesophageal junction. Mayo Clin Proc. 2001;76:331-334. [PMID: 11243283 DOI: 10.4065/76.3.331] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
66 Bonavina L, Incarbone R, Saino G, Clesi P, Peracchia A. Clinical outcome and survival after esophagectomy for carcinoma in elderly patients. Dis Esophagus. 2003;16:90-93. [PMID: 12823204 DOI: 10.1046/j.1442-2050.2003.00300.x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 36] [Article Influence: 2.4] [Reference Citation Analysis]
67 Regalado SP, Nambu Y, Iannettoni MD, Orringer MB, Beer DG. Abundant expression of the intestinal protein villin in Barrett's metaplasia and esophageal adenocarcinomas. Mol Carcinog 1998;22:182-9. [DOI: 10.1002/(sici)1098-2744(199807)22:3<182::aid-mc6>3.0.co;2-n] [Cited by in Crossref: 33] [Article Influence: 1.4] [Reference Citation Analysis]
68 Rice DC, Correa AM, Vaporciyan AA, Sodhi N, Smythe WR, Swisher SG, Walsh GL, Putnam JB, Komaki R, Ajani JA, Roth JA. Preoperative Chemoradiotherapy Prior to Esophagectomy in Elderly Patients is Not Associated With Increased Morbidity. The Annals of Thoracic Surgery 2005;79:391-7. [DOI: 10.1016/j.athoracsur.2004.08.045] [Cited by in Crossref: 52] [Cited by in F6Publishing: 38] [Article Influence: 3.1] [Reference Citation Analysis]
69 Fein M, Fuchs K, Demeester TR, Peters JH, Wittmann D, Weig M. Evaluation of the intestinal microflora in the rat model for esophageal adenocarcinoma. Diseases of the Esophagus 2000;13:39-43. [DOI: 10.1046/j.1442-2050.2000.00023.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
70 Van Blankenstein M. Barrett's esophagus: so what*. Diseases of the Esophagus 2002;15:1-4. [DOI: 10.1046/j.1442-2050.2002.00215.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
71 Perry C, Soomro I, Kaye P, Hardy E, Parsons SL, Ragunath K, Lobo DN, Martin SG, Madhusudan S. Analysis of lymphatic and blood vessel invasion biomarkers in T1 esophagogastric adenocarcinomas for improved patient prognostication: LVI in T1 esophagogastric adenocarcinoma. Dis Esophagus 2015;28:262-8. [DOI: 10.1111/dote.12190] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
72 Dietz J, Meurer L, Maffazzoni DR, Furtado AD, Prolla JC. Intestinal metaplasia in the distal esophagus and correlation with symptoms of gastroesophageal reflux disease. Dis Esophagus 2003;16:29-32. [PMID: 12581251 DOI: 10.1046/j.1442-2050.2003.00288.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
73 Spechler SJ. Esophageal Columnar Metaplasia (Barrett’s Esophagus). Gastrointestinal Endoscopy Clinics of North America 1997;7:1-18. [DOI: 10.1016/s1052-5157(18)30319-2] [Cited by in Crossref: 18] [Article Influence: 0.7] [Reference Citation Analysis]
74 Otani K, Kitayama J, Kaisaki S, Ishigami H, Hidemura A, Fujishiro M, Omata M, Nagawa H. Early gastric cancer shows different associations with adipose tissue volume depending on histological type. Gastric Cancer 2008;11:86-95. [DOI: 10.1007/s10120-008-0459-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
75 Stocks SC, Pratt N, Sales M, Johnston DA, Thompson AM, Carey FA, Kernohan NM. Chromosomal imbalances in gastric and esophageal adenocarcinoma: Specific comparative genomic hybridization-detected abnormalities segregate with junctional adenocarcinomas. Genes Chromosom Cancer 2001;32:50-8. [DOI: 10.1002/gcc.1166] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]
76 Gerson LB, Triadafilopoulos G. Screening for esophageal adenocarcinoma. The American Journal of Medicine 2002;113:499-505. [DOI: 10.1016/s0002-9343(02)01234-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
77 Post PN, Siersema PD, Van Dekken H. Rising incidence of clinically evident Barrett’s oesophagus in The Netherlands: a nation-wide registry of pathology reports. Scand J Gastroenterol. 2007;42:17-22. [PMID: 17190757 DOI: 10.1080/00365520600815654] [Cited by in Crossref: 50] [Cited by in F6Publishing: 152] [Article Influence: 3.3] [Reference Citation Analysis]
78 Terry P, Lagergren J, Ye W, Nyrén O, Wolk A. Antioxidants and cancers of the esophagus and gastric cardia. Int J Cancer 2000;87:750-4. [DOI: 10.1002/1097-0215(20000901)87:5<750::aid-ijc19>3.0.co;2-6] [Cited by in Crossref: 104] [Article Influence: 4.7] [Reference Citation Analysis]
79 Clark G, Roy M, Corcoran B, Carey P. Carcinoma of the oesophagus: The time for a multidiciplinary approach? Surgical Oncology 1996;5:149-64. [DOI: 10.1016/s0960-7404(96)80038-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
80 Chen H, Wang LD, Guo M, Gao SG, Guo HQ, Fan ZM, Li JL. Alterations of p53 and PCNA in cancer and adjacent tissues from concurrent carcinomas of the esophagus and gastric cardia in the same patient in Linzhou, a high incidence area for esophageal cancer in northern China. World J Gastroenterol 2003; 9(1): 16-21 [PMID: 12508343 DOI: 10.3748/wjg.v9.i1.16] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
81 Rothwell JF, Feehan E, Reid I, Walsh TN, Hennessy TPJ. Delay in treatment for oesophageal cancer. Br J Surg 1997;84:690-3. [DOI: 10.1002/bjs.1800840534] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
82 Gossner L, May A, Stolte M, Seitz G, Hahn EG, Ell C. KTP laser destruction of dysplasia and early cancer in columnar-lined Barrett’s esophagus. Gastrointest Endosc. 1999;49:8-12. [PMID: 9869716 DOI: 10.1016/s0016-5107(99)70438-4] [Cited by in Crossref: 121] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
83 Stockeld D, Backman L, Fagerberg J, Granström L. Esophageal cancer in Stockholm county 1978–1995. Acta Oncologica 2009;46:1075-84. [DOI: 10.1080/02841860701426807] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
84 Locke GR 3rd. Current medical management of gastroesophageal reflux disease. Thorac Surg Clin 2005;15:369-75. [PMID: 16104127 DOI: 10.1016/j.thorsurg.2005.04.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
85 Shao L, Lin J, Huang M, Ajani JA, Wu X. Predictors of esophageal cancer risk: assessment of susceptibility to DNA damage using comet assay. Genes Chromosomes Cancer 2005;44:415-22. [PMID: 16114035 DOI: 10.1002/gcc.20254] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
86 Pera M, Manterola C, Vidal O, Grande L. Epidemiology of esophageal adenocarcinoma. J Surg Oncol. 2005;92:151-159. [PMID: 16299786 DOI: 10.1002/jso.20357] [Cited by in Crossref: 216] [Cited by in F6Publishing: 189] [Article Influence: 12.7] [Reference Citation Analysis]
87 Li D, Bautista MC, Jiang SF, Daryani P, Brackett M, Armstrong MA, Hung YY, Postlethwaite D, Ladabaum U. Risks and Predictors of Gastric Adenocarcinoma in Patients with Gastric Intestinal Metaplasia and Dysplasia: A Population-Based Study. Am J Gastroenterol. 2016;111:1104-1113. [PMID: 27185078 DOI: 10.1038/ajg.2016.188] [Cited by in Crossref: 57] [Cited by in F6Publishing: 48] [Article Influence: 9.5] [Reference Citation Analysis]
88 Groisman GM, Amar M, Meir A. Expression of the intestinal marker Cdx2 in the columnar-lined esophagus with and without intestinal (Barrett’s) metaplasia. Mod Pathol. 2004;17:1282-1288. [PMID: 15167938 DOI: 10.1038/modpathol.3800182] [Cited by in Crossref: 88] [Cited by in F6Publishing: 70] [Article Influence: 5.2] [Reference Citation Analysis]
89 Reid BJ. Barrett's Esophagus and Esophageal Adenocarcinoma. Gastroenterology Clinics of North America 1991;20:817-34. [DOI: 10.1016/s0889-8553(21)00590-2] [Cited by in Crossref: 76] [Article Influence: 2.5] [Reference Citation Analysis]
90 de Manzoni G, Pedrazzani C, Pasini F, Di Leo A, Durante E, Castaldini G, Cordiano C. Results of surgical treatment of adenocarcinoma of the gastric cardia. Ann Thorac Surg. 2002;73:1035-1040. [PMID: 11996237 DOI: 10.1016/s0003-4975(01)03571-8] [Cited by in Crossref: 45] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
91 Jones DR, Davidson AG, Summers CL, Murray GF, Quinlan DC. Potential application of p53 as an intermediate biomarker in Barrett's esophagus. Ann Thorac Surg 1994;57:598-603. [PMID: 8147627 DOI: 10.1016/0003-4975(94)90551-7] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 1.4] [Reference Citation Analysis]
92 Liao Z, Liu H, Swisher SG, Wang L, Wu TT, Correa AM, Roth JA, Cox JD, Komaki R, Ajani JA, Wei Q. Polymorphism at the 3'-UTR of the thymidylate synthase gene: a potential predictor for outcomes in Caucasian patients with esophageal adenocarcinoma treated with preoperative chemoradiation. Int J Radiat Oncol Biol Phys 2006;64:700-8. [PMID: 16242255 DOI: 10.1016/j.ijrobp.2005.08.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
93 Alidina A, Gaffar A, Hussain F, Islam M, Vaziri I, Burney I, Valimohd A, Jafri W. Survival data and prognostic factors seen in Pakistani patients with esophageal cancer. Ann Oncol 2004;15:118-22. [PMID: 14679130 DOI: 10.1093/annonc/mdh014] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
94 Barr LL. Gastroesophageal reflux: Recognizing atypical presentations. Postgraduate Medicine 2017;99:231-7. [DOI: 10.1080/00325481.1996.11946110] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
95 Reynolds JC. Innovative endoscopic mapping technique of barrett’s mucosa. The American Journal of Medicine 2001;111:142-6. [DOI: 10.1016/s0002-9343(01)00865-8] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
96 Levine DS, Reid BJ. Endoscopic Diagnosis of Esophageal Neoplasms. Gastrointestinal Endoscopy Clinics of North America 1992;2:395-413. [DOI: 10.1016/s1052-5157(18)30622-6] [Cited by in Crossref: 10] [Article Influence: 0.3] [Reference Citation Analysis]
97 Kawano T, Ogiya K, Nakajima Y, Nishikage T, Nagai K. Prevalence of Barrett's esophagus in Japan. Esophagus 2006;3:155-64. [DOI: 10.1007/s10388-006-0095-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
98 Kruel CRP, Pinto LFR, Blanco TCM, Barja-fidalgo TC, Melo LL, Kruel CDP. Evaluation of the heme oxygenase-1 expression in esophagitis and esophageal cancer induced by different reflux experimental models and diethylnitrosamine. Acta Cir Bras 2010;25:304-10. [DOI: 10.1590/s0102-86502010000300015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
99 Kamath SD, Kalyan A, Benson AB 3rd. Pembrolizumab for the treatment of gastric cancer. Expert Rev Anticancer Ther 2018;18:1177-87. [PMID: 30280940 DOI: 10.1080/14737140.2018.1526084] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
100 Sasako M, Sano T, Yamamoto S, Sairenji M, Arai K, Kinoshita T, Nashimoto A, Hiratsuka M; Japan Clinical Oncology Group (JCOG9502). Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial. Lancet Oncol. 2006;7:644-651. [PMID: 16887481 DOI: 10.1016/s1470-2045(06)70766-5] [Cited by in Crossref: 265] [Cited by in F6Publishing: 94] [Article Influence: 16.6] [Reference Citation Analysis]
101 Russo A, Li P, Strong VE. Differences in the multimodal treatment of gastric cancer: East versus west. J Surg Oncol 2017;115:603-14. [PMID: 28181265 DOI: 10.1002/jso.24517] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 6.8] [Reference Citation Analysis]
102 Polkowski W, van Sandick JW, Offerhaus GJA, ten Kate FJW, Mulder J, Obertop H, van Lanschot JJB. Prognostic Value of Laurén Classification and c-erbB-2 Oncogene Overexpression in Adenocarcinoma of the Esophagus and Gastroesophageal Junction. Ann Surg Oncol 1999;6:290-7. [DOI: 10.1007/s10434-999-0290-2] [Cited by in Crossref: 87] [Cited by in F6Publishing: 74] [Article Influence: 3.8] [Reference Citation Analysis]
103 Canto MI, Setrakian S, Willis J, Chak A, Petras R, Powe NR, Sivak MV Jr. Methylene blue-directed biopsies improve detection of intestinal metaplasia and dysplasia in Barrett's esophagus. Gastrointest Endosc 2000;51:560-8. [PMID: 10805842 DOI: 10.1016/s0016-5107(00)70290-2] [Cited by in Crossref: 188] [Cited by in F6Publishing: 38] [Article Influence: 8.5] [Reference Citation Analysis]
104 Blackett KL, Siddhi SS, Cleary S, Steed H, Miller MH, Macfarlane S, Macfarlane GT, Dillon JF. Oesophageal bacterial biofilm changes in gastro-oesophageal reflux disease, Barrett's and oesophageal carcinoma: association or causality? Aliment Pharmacol Ther. 2013;37:1084-1092. [PMID: 23600758 DOI: 10.1111/apt.12317] [Cited by in Crossref: 102] [Cited by in F6Publishing: 97] [Article Influence: 11.3] [Reference Citation Analysis]
105 Munitiz V, Parrilla P, Ortiz A, Martinez-de-Haro LF, Yelamos J, Molina J. High risk of malignancy in familial Barrett’s esophagus: presentation of one family. J Clin Gastroenterol. 2008;42:806-809. [PMID: 18385604 DOI: 10.1097/mcg.0b013e3180329015] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
106 Cover TL, Berg DE, Blaser MJ, Mobley HL. H. pylori Pathogenesis. Principles of Bacterial Pathogenesis. Elsevier; 2001. pp. 509-58. [DOI: 10.1016/b978-012304220-0/50012-1] [Cited by in Crossref: 21] [Article Influence: 1.0] [Reference Citation Analysis]
107 Glickman JN, Wang H, Das KM, Goyal RK, Spechler SJ, Antonioli D, Odze RD. Phenotype of Barrett's esophagus and intestinal metaplasia of the distal esophagus and gastroesophageal junction: an immunohistochemical study of cytokeratins 7 and 20, Das-1 and 45 MI. Am J Surg Pathol. 2001;25:87-94. [PMID: 11145256 DOI: 10.1097/00000478-200101000-00010] [Cited by in Crossref: 99] [Cited by in F6Publishing: 93] [Article Influence: 4.7] [Reference Citation Analysis]
108 Mayer RJ. Overview: The Changing Nature of Esophageal Cancer. Chest 1993;103:404S-5S. [DOI: 10.1378/chest.103.4_supplement.404s] [Cited by in Crossref: 16] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
109 Heitmiller RF. Epidemiology, Diagnosis, and Staging of Esophageal Cancer. In: Ettinger DS, editor. Thoracic Oncology. Boston: Springer US; 2001. pp. 375-86. [DOI: 10.1007/978-1-4615-1589-0_14] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
110 Fennerty M. Barrett's-related esophageal cancer: Has the final hurdle been cleared, now paving the way for human chemoprevention trials? Gastroenterology 2002;122:1172-5. [DOI: 10.1053/gast.2002.32753] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
111 Constantinou M, Tsai JY, Safran H. Paclitaxel and concurrent radiation in upper gastrointestinal cancers. Cancer Invest. 2003;21:887-896. [PMID: 14735693 DOI: 10.1081/CNV-120025092] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
112 Menke V, van Zoest KP, Moons LM, Hansen B, Pot RG, Siersema PD, Kusters JG, Kuipers EJ. Nco I TNF-β gene polymorphism and TNF expression are associated with an increased risk of developing Barrett's esophagus and esophageal adenocarcinoma. Scandinavian Journal of Gastroenterology 2012;47:378-86. [DOI: 10.3109/00365521.2011.650192] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
113 Levi F, Randimbison L, Lucchini F, Te V, La Vecchia C. Epidemiology of adenocarcinoma and squamous cell carcinoma of the oesophagus: . European Journal of Cancer Prevention 2001;10:91-6. [DOI: 10.1097/00008469-200102000-00011] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.0] [Reference Citation Analysis]
114 Sato T, Kato Y, Matsuura M, Gagner M. Significance of Palisading Longitudinal Esophagus Vessels: Identification of the True Esophagogastric Junction Has Histopathological and Oncological Considerations. Dig Dis Sci 2010;55:3095-101. [DOI: 10.1007/s10620-010-1132-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
115 Schwartz GK, Wang H, Lampen N, Altorki N, Kelsen D, Albino AP. Defining the invasive phenotype of proximal gastric cancer cells. Cancer 1994;73:22-7. [DOI: 10.1002/1097-0142(19940101)73:1<22::aid-cncr2820730106>3.0.co;2-o] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
116 Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol 2006; 12(3): 354-362 [PMID: 16489633 DOI: 10.3748/wjg.v12.i3.354] [Cited by in CrossRef: 1071] [Cited by in F6Publishing: 975] [Article Influence: 66.9] [Reference Citation Analysis]
117 Askari A, Munster AB, Jambulingam P, Riaz A. Critical number of lymph node involvement in esophageal and gastric cancer and its impact on long-term survival-A single-center 8-year study. J Surg Oncol 2020;122:1364-72. [PMID: 32803769 DOI: 10.1002/jso.26145] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
118 Li LY, Tang JT, Jia LQ, Li PW. Mutations of p53 gene exons 4-8 in human esophageal cancer. World J Gastroenterol 2005; 11(19): 2998-3001 [PMID: 15902745 DOI: 10.3748/wjg.v11.i19.2998] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
119 Watt E, Whyte F. Research. The experience of dysphagia and its effect on the quality of life of patients with oesophageal cancer: Dysphagia and oesophageal cancer patients. European Journal of Cancer Care 2003;12:183-93. [DOI: 10.1046/j.1365-2354.2003.00376.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 2.0] [Reference Citation Analysis]
120 Cockburn MG, Wu AH, Bernstein L. Etiologic clues from the similarity of histology-specific trends in esophageal and lung cancers. Cancer Causes Control 2005;16:1065-74. [PMID: 16184472 DOI: 10.1007/s10552-005-5382-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
121 Greene CL, Worrell SG, Demeester TR. Rat Reflux Model of Esophageal Cancer and Its Implication in Human Disease. Annals of Surgery 2015;262:910-24. [DOI: 10.1097/sla.0000000000001207] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
122 Rugge M, Zaninotto G, Parente P, Zanatta L, Cavallin F, Germanà B, Macrì E, Galliani E, Iuzzolino P, Ferrara F, Marin R, Nisi E, Iaderosa G, Deboni M, Bellumat A, Valiante F, Florea G, Della Libera D, Benini M, Bortesi L, Meggio A, Zorzi MG, Depretis G, Miori G, Morelli L, Cataudella G, D'amore E, Franceschetti I, Bozzola L, Paternello E, Antonini C, Di Mario F, Dal Bò N, Furlanetto A, Norberto L, Polese L, Iommarini S, Farinati F, Battaglia G, Diamantis G, Realdon S, Guido E, Mastropaolo G, Canova D, Guerini A, Franceschi M, Zirillo M. Barrett's Esophagus and Adenocarcinoma Risk: The Experience of the North-Eastern Italian Registry (EBRA). Annals of Surgery 2012;256:788-95. [DOI: 10.1097/sla.0b013e3182737a7e] [Cited by in Crossref: 36] [Cited by in F6Publishing: 13] [Article Influence: 3.6] [Reference Citation Analysis]
123 Pickens A, Orringer MB. Geographical distribution and racial disparity in esophageal cancer. Ann Thorac Surg. 2003;76:S1367-S1369. [PMID: 14530066 DOI: 10.1016/s0003-4975(03)01202-5] [Cited by in Crossref: 105] [Cited by in F6Publishing: 46] [Article Influence: 5.5] [Reference Citation Analysis]
124 Wright TA. High-grade dysplasia in Barrett's oesophagus: HIGH-GRADE DYSPLASIA IN BARRETT'S OESOPHAGUS. Br J Surg 1997;84:760-6. [DOI: 10.1046/j.1365-2168.1997.02776.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
125 Eckardt VF, Kanzler G, Bernhard G. Life expectancy and cancer risk in patients with Barrett's esophagus: a prospective controlled investigation. Am J Med 2001;111:33-7. [PMID: 11448658 DOI: 10.1016/s0002-9343(01)00745-8] [Cited by in Crossref: 84] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
126 Hasegawa S, Yoshikawa T, Rino Y, Oshima T, Aoyama T, Hayashi T, Sato T, Yukawa N, Kameda Y, Sasaki T, Ono H, Tsuchida K, Cho H, Kunisaki C, Masuda M, Tsuburaya A. Priority of lymph node dissection for Siewert type II/III adenocarcinoma of the esophagogastric junction. Ann Surg Oncol. 2013;20:4252-4259. [PMID: 23943020 DOI: 10.1245/s10434-013-3036-0] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
127 Hajdu SI, Vadmal M, Tang P. A note from history: Landmarks in history of cancer, part 7. Cancer 2015;121:2480-513. [PMID: 25873516 DOI: 10.1002/cncr.29365] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
128 Weimann A, Zimmermann M, Gross M, Slevogt H, Rieger A, Morawietz L. CDX2 and LI-cadherin expression in esophageal mucosa: use of both markers can facilitate the histologic diagnosis of Barrett's esophagus and carcinoma. Int J Surg Pathol 2010;18:330-7. [PMID: 20444732 DOI: 10.1177/1066896910364228] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
129 Aldulaimi D, Jankowski J. Barrett’s esophagus: an overview of the molecular biology *. Diseases of the Esophagus 1999;12:177-80. [DOI: 10.1046/j.1442-2050.1999.00043.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.0] [Reference Citation Analysis]
130 Eisen GM, Dominitz JA, Faigel DO, Goldstein JL, Kalloo AN, Petersen BT, Raddawi HM, Ryan ME, Vargo JJ, Young HS, Fanelli RD, Hyman NH, Wheeler-harbaugh J. Ethnic issues in endoscopy. Gastrointestinal Endoscopy 2001;53:874-5. [DOI: 10.1016/s0016-5107(01)70310-0] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
131 Kubo A, Corley DA, Jensen CD, Kaur R. Dietary factors and the risks of oesophageal adenocarcinoma and Barrett's oesophagus. Nutr Res Rev. 2010;23:230-246. [PMID: 20624335 DOI: 10.1017/s0954422410000132] [Cited by in Crossref: 64] [Cited by in F6Publishing: 31] [Article Influence: 5.3] [Reference Citation Analysis]
132 Garai J, Uddo RB, Mohler MC, Pelligrino N, Scribner R, Sothern MS, Zabaleta J. At the Crossroad Between Obesity and Gastric Cancer. In: Verma M, editor. Cancer Epigenetics. New York: Springer; 2015. pp. 689-707. [DOI: 10.1007/978-1-4939-1804-1_36] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
133 Bonde P, Sui G, Dhara S, Wang J, Broor A, Kim IF, Wiley JE, Marti G, Duncan M, Jaffee E, Montgomery E, Maitra A, Harmon JW. Cytogenetic characterization and gene expression profiling in the rat reflux-induced esophageal tumor model. J Thorac Cardiovasc Surg 2007;133:763-9. [PMID: 17320581 DOI: 10.1016/j.jtcvs.2006.07.044] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.6] [Reference Citation Analysis]
134 Zhou Y, Zhang Z, Zhang Z, Wu J, Ren D, Yan X, Wang Q, Wang Y, Wang H, Zhang J, Zhu X, Yang Y, Luo C, Guo X, Tang C, Qiao L. A rising trend of gastric cardia cancer in Gansu Province of China. Cancer Lett. 2008;269:18-25. [PMID: 18501504 DOI: 10.1016/j.canlet.2008.04.013] [Cited by in Crossref: 51] [Cited by in F6Publishing: 44] [Article Influence: 3.6] [Reference Citation Analysis]
135 Law S, Wong J. Two-field dissection is enough for esophageal cancer. Dis Esophagus 2001;14:98-103. [PMID: 11553217 DOI: 10.1046/j.1442-2050.2001.00164.x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 55] [Article Influence: 2.6] [Reference Citation Analysis]
136 Casson AG, Manolopoulos B, Troster M, Kerkvliet N, O'malley F, Inculet R, Finley R, Roth JA. Clinical implications of p53 gene mutation in the progression of Barrett's epithelium to invasive esophageal cancer. The American Journal of Surgery 1994;167:52-7. [DOI: 10.1016/0002-9610(94)90053-1] [Cited by in Crossref: 50] [Cited by in F6Publishing: 48] [Article Influence: 1.8] [Reference Citation Analysis]
137 Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst. 2005;97:142-146. [PMID: 15657344 DOI: 10.1093/jnci/dji024] [Cited by in Crossref: 913] [Cited by in F6Publishing: 836] [Article Influence: 53.7] [Reference Citation Analysis]
138 Inoue M, Tajima K, Yamamura Y, Hamajima N, Hirose K, Kodera Y, Kito T, Tominaga S. Family history and subsite of gastric cancer: Data from a case-referent study in Japan. Int J Cancer 1998;76:801-5. [DOI: 10.1002/(sici)1097-0215(19980610)76:6<801::aid-ijc6>3.0.co;2-1] [Cited by in Crossref: 25] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
139 Cooper SC, Trudgill NJ. Subjects with prostate cancer are less likely to develop esophageal cancer: analysis of SEER 9 registries database. Cancer Causes Control. 2012;23:819-825. [PMID: 24251326 DOI: 10.1007/s10552-012-9950-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
140 Wu B, Min PQ, Yang K. Utility of multidetector CT in the diagnosis of gastric bare area invasion by proximal gastric carcinoma. Abdom Imaging. 2007;32:284-289. [PMID: 16967246 DOI: 10.1007/s00261-006-9058-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
141 Altorki NK, Girardi L, Skinner DB. En bloc esophagectomy improves survival for stage III esophageal cancer. J Thorac Cardiovasc Surg. 1997;114:948-955; discussion 955-956. [PMID: 9434690 DOI: 10.1016/s0022-5223(97)70009-6] [Cited by in Crossref: 115] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
142 Mayer RJ, Venook AP, Schilsky RL. Progress against GI cancer during the American Society of Clinical Oncology’s first 50 years. J Clin Oncol. 2014;32:1521-1530. [PMID: 24752046 DOI: 10.1200/jco.2014.55.4121] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
143 Rothwell JF, Feehan E, Reid I, Walsh TN, Hennessy TPJ. Delay in treatment for oesophageal cancer: DELAY IN TREATMENT FOR OESOPHAGEAL CANCER. Br J Surg 1997;84:690-3. [DOI: 10.1046/j.1365-2168.1997.02652.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
144 Parkin D, Bray F, Devesa S. Cancer burden in the year 2000. The global picture. European Journal of Cancer 2001;37:4-66. [DOI: 10.1016/s0959-8049(01)00267-2] [Cited by in Crossref: 1284] [Cited by in F6Publishing: 457] [Article Influence: 61.1] [Reference Citation Analysis]
145 Yao JC, Tseng JF, Worah S, Hess KR, Mansfield PF, Crane CH, Schnirer II, Reddy S, Chiang SS, Najam A, Yu C, Giacco GG, Xie K, Wu T, Feig BW, Pisters PW, Ajani JA. Clinicopathologic Behavior of Gastric Adenocarcinoma in Hispanic Patients: Analysis of a Single Institution's Experience Over 15 Years. JCO 2005;23:3094-103. [DOI: 10.1200/jco.2005.08.987] [Cited by in Crossref: 48] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
146 Shi J, Sun Q, Xu BY, Yu HP, Zhang YF, Zou XP, Huang L, Gold JS, Mashimo H, Yu CG, Huang Q. Changing trends in the proportions of small (≤ 2 cm) proximal and non-proximal gastric carcinomas treated at a high-volume tertiary medical center in China. J Dig Dis 2014;15:359-66. [PMID: 24720626 DOI: 10.1111/1751-2980.12151] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
147 Algan Ö, Coia LR, Keller SM, Engstrom PF, Weiner LM, Schultheiss TE, Hanks GE. Management of adenocarcinoma of the esophagus with chemoradiation alone or chemoradiation followed by esophagectomy: Results of sequential nonrandomized Phase II studies. International Journal of Radiation Oncology*Biology*Physics 1995;32:753-61. [DOI: 10.1016/0360-3016(94)00592-9] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 1.6] [Reference Citation Analysis]
148 Chang CY, Lee YC, Lee CT, Tu CH, Hwang JC, Chiang H, Tai CM, Chiang TH, Wu MS, Lin JT. The application of Prague C and M criteria in the diagnosis of Barrett's esophagus in an ethnic Chinese population. Am J Gastroenterol. 2009;104:13-20. [PMID: 19098843 DOI: 10.1038/ajg.2008.43] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 3.2] [Reference Citation Analysis]
149 Kim MA, Lee HS, Yang HK, Kim WH. Clinicopa-thologic and protein expression differences between cardia carcinoma and noncardia carcinoma of the stomach. Cancer. 2005;103:1439-1446. [PMID: 15726543 DOI: 10.1002/cncr.20966] [Cited by in Crossref: 46] [Cited by in F6Publishing: 53] [Article Influence: 2.7] [Reference Citation Analysis]
150 Moriyama N, Amano Y, Mishima Y, Okita K, Takahashi Y, Yuki T, Ishimura N, Ishihara S, Kinoshita Y. What is the clinical significance of stromal angiogenesis in Barrett’s esophagus? J Gastroenterol Hepatol. 2008;23 Suppl 2:S210-S215. [PMID: 19120900 DOI: 10.1111/j.1440-1746.2008.05440.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
151 Claydon PE, Ackroyd R. 5-Aminolaevulinic acid-induced photodynamic therapy and photodetection in Barrett’s esophagus. Diseases of the Esophagus 2004;17:205-12. [DOI: 10.1111/j.1442-2050.2004.00409.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
152 Casson AG, Zheng Z, Chiasson D, MacDonald K, Riddell DC, Guernsey JR, Guernsey DL, McLaughlin J. Associations between genetic polymorphisms of Phase I and II metabolizing enzymes, p53 and susceptibility to esophageal adenocarcinoma. Cancer Detect Prev. 2003;27:139-146. [PMID: 12670526 DOI: 10.1016/s0361-090x(03)00033-3] [Cited by in Crossref: 49] [Cited by in F6Publishing: 23] [Article Influence: 2.7] [Reference Citation Analysis]
153 Soest EMV, Dieleman JP, Kuipers EJ. The effect of anticholinergic agents on gastro-oesophageal reflux and related disorders. Expert Opinion on Drug Safety 2008;7:173-80. [DOI: 10.1517/14740338.7.2.173] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
154 Montgomery E, Goldblum JR, Greenson JK, Haber MM, Lamps LW, Lauwers GY, Lazenby AJ, Lewin DN, Robert ME, Washington K. Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: a follow-up study based on 138 cases from a diagnostic variability study. Hum Pathol. 2001;32:379-388. [PMID: 11331954 DOI: 10.1053/hupa.2001.23511] [Cited by in Crossref: 208] [Cited by in F6Publishing: 193] [Article Influence: 9.9] [Reference Citation Analysis]
155 Schwartz GK. c-sis and oncogene expression: a fundamental approach toward understanding esophageal cancer. Cancer Invest 1994;12:266-7. [PMID: 8131104 DOI: 10.3109/07357909409024885] [Reference Citation Analysis]
156 Dickman R, Levi Z, Vilkin A, Zvidi I, Niv Y. Predictors of specialized intestinal metaplasia in patients with an incidental irregular Z line. European Journal of Gastroenterology & Hepatology 2010;22:135-8. [DOI: 10.1097/meg.0b013e3283318f69] [Cited by in Crossref: 13] [Cited by in F6Publishing: 1] [Article Influence: 1.1] [Reference Citation Analysis]
157 Yagi K, Nakamura A, Sekine A. Cytokeratin immunoreactivity patterns in short-segment Barrett's esophagus in Japanese patients. J Gastroenterol Hepatol 2005;20:929-34. [PMID: 15946143 DOI: 10.1111/j.1440-1746.2005.03845.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
158 Van Cutsem E. The treatment of advanced gastric cancer: new findings on the activity of the taxanes. Oncologist. 2004;9 Suppl 2:9-15. [PMID: 15161986 DOI: 10.1634/theoncologist.9-suppl_2-9] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 1.9] [Reference Citation Analysis]
159 Sandler AB, Kindler HL, Einhorn LH, Mitchell E, Masters G, Kraut M, Nicol S, Raghavan D. Phase II trial of gemcitabine in patients with previously untreated metastatic cancer of the esophagus or gastroesophageal junction. Ann Oncol 2000;11:1161-4. [PMID: 11061612 DOI: 10.1023/a:1008369718242] [Cited by in Crossref: 21] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
160 Martín-de-Argila C, Boixeda D, Redondo C, Alvarez I, Gisbert JP, García Plaza A, Cantón R. Relation between histologic subtypes and location of gastric cancer and Helicobacter pylori. Scand J Gastroenterol. 1997;32:303-307. [PMID: 9140150 DOI: 10.3109/00365529709007676] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 1.0] [Reference Citation Analysis]
161 Orr WC. Therapeutic options in the treatment of nighttime gastroesophageal reflux. Digestion 2005;72:229-38. [PMID: 16319458 DOI: 10.1159/000089957] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
162 Guggenheim DE, Shah MA. Gastric cancer epidemiology and risk factors. J Surg Oncol. 2013;107:230-236. [PMID: 23129495 DOI: 10.1002/jso.23262] [Cited by in Crossref: 245] [Cited by in F6Publishing: 229] [Article Influence: 24.5] [Reference Citation Analysis]
163 Allameh A, Rasmi Y, Nasseri-Moghaddam S, Tavangar SM, Sharifi R, Sadreddini M. Immunohistochemical analysis of selected molecular markers in esophagus precancerous, adenocarcinoma and squamous cell carcinoma in Iranian subjects. Cancer Epidemiol 2009;33:79-84. [PMID: 19679052 DOI: 10.1016/j.canep.2009.05.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
164 Bosetti C, Malvezzi M, Chatenoud L, Negri E, Levi F, La Vecchia C. Trends in cancer mortality in the Americas, 1970-2000. Ann Oncol. 2005;16:489-511. [PMID: 15668262 DOI: 10.1093/annonc/mdi086] [Cited by in Crossref: 104] [Cited by in F6Publishing: 60] [Article Influence: 6.1] [Reference Citation Analysis]
165 Oberg S, DeMeester TR, Peters JH, Hagen JA, Nigro JJ, DeMeester SR, Theisen J, Campos GM, Crookes PF. The extent of Barrett’s esophagus depends on the status of the lower esophageal sphincter and the degree of esophageal acid exposure. J Thorac Cardiovasc Surg. 1999;117:572-580. [PMID: 10047662 DOI: 10.1016/s0022-5223(99)70337-5] [Cited by in Crossref: 110] [Cited by in F6Publishing: 26] [Article Influence: 4.8] [Reference Citation Analysis]
166 Chandrasoma P, Wickramasinghe K, Ma Y, DeMeester T. Adenocarcinomas of the distal esophagus and "gastric cardia" are predominantly esophageal carcinomas. Am J Surg Pathol. 2007;31:569-575. [PMID: 17414104 DOI: 10.1097/01.pas.0000213394.34451.d2] [Cited by in Crossref: 71] [Cited by in F6Publishing: 51] [Article Influence: 4.7] [Reference Citation Analysis]
167 Lerut T, Coosemans W, Raemdonck DV, Dillemans B, De Leyn P, Marnette J, Geboes K, Demeester TR. Surgical treatment of Barrett's carcinoma. The Journal of Thoracic and Cardiovascular Surgery 1994;107:1059-66. [DOI: 10.1016/s0022-5223(94)70381-7] [Cited by in Crossref: 68] [Article Influence: 2.4] [Reference Citation Analysis]
168 Dua KS. Antireflux stents in tumors of the cardia. The American Journal of Medicine 2001;111:190-6. [DOI: 10.1016/s0002-9343(01)00854-3] [Cited by in Crossref: 7] [Article Influence: 0.3] [Reference Citation Analysis]
169 Si J, Fu X, Behar J, Wands J, Beer DG, Souza RF, Spechler SJ, Lambeth D, Cao W. NADPH oxidase NOX5-S mediates acid-induced cyclooxygenase-2 expression via activation of NF-kappaB in Barrett’s esophageal adenocarcinoma cells. J Biol Chem. 2007;282:16244-16255. [PMID: 17403674 DOI: 10.1074/jbc.m700297200] [Cited by in Crossref: 54] [Cited by in F6Publishing: 33] [Article Influence: 3.6] [Reference Citation Analysis]
170 Kirkwood KS, Khitin LM, Barwick KW. Gastric Cancer. Surgical Oncology Clinics of North America 1997;6:495-514. [DOI: 10.1016/s1055-3207(18)30314-4] [Cited by in Crossref: 7] [Article Influence: 0.3] [Reference Citation Analysis]
171 Okabayashi T, Gotoda T, Kondo H, Inui T, Ono H, Saito D, Yoshida S, Sasako M, Shimoda T. Early carcinoma of the gastric cardia in Japan: Is it different from that in the West? Cancer 2000;89:2555-9. [DOI: 10.1002/1097-0142(20001215)89:12<2555::aid-cncr6>3.0.co;2-r] [Cited by in Crossref: 70] [Article Influence: 3.2] [Reference Citation Analysis]
172 Subasinghe D, Acott N, Kumarasinghe MP. A survival guide to HER2 testing in gastric/gastroesophageal junction carcinoma. Gastrointest Endosc 2019;90:44-54. [PMID: 30928424 DOI: 10.1016/j.gie.2019.03.022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
173 De Ceglie A, Filiberti R, Blanchi S, Fontana V, Fisher DA, Grossi E, Lacchin T, De Matthaeis M, Ignomirelli O, Cappiello R, Casa DD, Foti M, Laterza F, Rosati R, Annese V, Iaquinto G, Conio M. History of cancer in first degree relatives of Barrett's esophagus patients: A case-control study. Clinics and Research in Hepatology and Gastroenterology 2011;35:831-8. [DOI: 10.1016/j.clinre.2011.07.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
174 Gunderson LL, Tepper JE, Calvo FA, Callister MD. Gastric/GE Junction Cancer. Clinical Radiation Oncology. Elsevier; 2012. pp. 903-33. [DOI: 10.1016/b978-1-4377-1637-5.00045-6] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
175 El-rifai W, Powell SM. Molecular and biologic basis of upper gastrointestinal malignancy. Surgical Oncology Clinics of North America 2002;11:273-91. [DOI: 10.1016/s1055-3207(02)00004-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
176 Stamp D. Bile acids and esophageal cancer the elusive "pulsatile acid or bile acid-induced" proliferation. Med Hypotheses 2010;75:338-40. [PMID: 20427131 DOI: 10.1016/j.mehy.2010.03.034] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
177 Coriat R, Perkins G, Brezault C. Incidence et physiopathologie de l’endobrachyœsophage. La Presse Médicale 2011;40:496-501. [DOI: 10.1016/j.lpm.2011.02.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
178 Yao JC, Mansfield PF, Pisters PW, Feig BW, Janjan NA, Crane C, Ajani JA. Combined-modality therapy for gastric cancer. Semin Surg Oncol. 2003;21:223-227. [PMID: 14648779 DOI: 10.1002/ssu.10040] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
179 Hurlstone D. Barrett's esophagus: A role for high-resolution magnification chromoendoscopy? Journal of Gastroenterology and Hepatology 2002;17:633-5. [DOI: 10.1046/j.1440-1746.2002.02766.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
180 Walker MJ. A review of carcinoma of the stomach at a tertiary care referral hospital. The American Journal of Surgery 1996;172:75-8. [DOI: 10.1016/s0002-9610(97)89550-5] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
181 Levine DS, Haggitt RC, Blount PL, Rabinovitch PS, Rusch VW, Reid BJ. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. Gastroenterology 1993;105:40-50. [PMID: 8514061 DOI: 10.1016/0016-5085(93)90008-z] [Cited by in Crossref: 420] [Cited by in F6Publishing: 119] [Article Influence: 14.5] [Reference Citation Analysis]
182 Scotiniotis IA, Kochman ML, Lewis JD, Furth EE, Rosato EF, Ginsberg GG. Accuracy of EUS in the evaluation of Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma. Gastrointest Endosc. 2001;54:689-696. [PMID: 11726843 DOI: 10.1067/mge.2001.119216] [Cited by in Crossref: 99] [Cited by in F6Publishing: 74] [Article Influence: 5.0] [Reference Citation Analysis]
183 Collard JM. High-grade dysplasia in Barrett's esophagus. The case for esophagectomy. Chest Surg Clin N Am. 2002;12:77-92. [PMID: 738222 DOI: 10.1016/s1052-3359(03)00067-x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
184 Sharma P. Current status of ablative therapies in esophageal disorders. Curr Gastroenterol Rep 2001;3:219-24. [DOI: 10.1007/s11894-001-0025-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
185 Doecke J, Zhao ZZ, Pandeya N, Sadeghi S, Stark M, Green AC, Hayward NK, Webb PM, Whiteman DC. Polymorphisms in MGMT and DNA repair genes and the risk of esophageal adenocarcinoma. Int J Cancer. 2008;123:174-180. [PMID: 18386788 DOI: 10.1002/ijc.23410] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 3.9] [Reference Citation Analysis]
186 Gulmann C, Counihan I, Grace A, Patchett S, Leen E, Leader M, Kay E. Cytokeratin 7/20 and mucin expression patterns in oesophageal, cardia and distal gastric adenocarcinomas: Cytokeratin and mucin immunoprofiles in gastric and oesophageal carcinomas. Histopathology 2003;43:453-61. [DOI: 10.1046/j.1365-2559.2003.01724.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
187 Ji L, Wang T, Tian L, Gao M. The early diagnostic value of C-reactive protein for anastomotic leakage post radical gastrectomy for esophagogastric junction carcinoma: A retrospective study of 97 patients. International Journal of Surgery 2016;27:182-6. [DOI: 10.1016/j.ijsu.2016.02.021] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
188 Kutup A, Yekebas EF, Izbicki JR. Current diagnosis and future impact of micrometastases for therapeutic strategies in adenocarcinoma of the esophagus, gastric cardia, and upper gastric third. Recent Results Cancer Res 2010;182:115-25. [PMID: 20676876 DOI: 10.1007/978-3-540-70579-6_10] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
189 Chen X, Mikhail SS, Ding YW, Yang Gy, Bondoc F, Yang CS. Effects of vitamin E and selenium supplementation on esophageal adenocarcinogenesis in a surgical model with rats. Carcinogenesis. 2000;21:1531-1536. [PMID: 10910955 DOI: 10.1093/carcin/21.8.1531] [Cited by in Crossref: 47] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
190 van Dekken H, Vissers K, Tilanus HW, Kuo WL, Tanke HJ, Rosenberg C, Ijszenga M, Szuhai K. Genomic array and expression analysis of frequent high-level amplifications in adenocarcinomas of the gastro-esophageal junction. Cancer Genet Cytogenet. 2006;166:157-162. [PMID: 16631473 DOI: 10.1016/j.cancergencyto.2005.11.002] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
191 Duggan A. Management of dyspepsia at the beginning of the twenty-first century. Intern Med J 2003;33:604-9. [PMID: 14656236 DOI: 10.1111/j.1445-5994.2003.00495.x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
192 González CA, Agudo A, Montes J, Riboli E, Sanz JM. Tobacco and alcohol intake in relation to adenocarcinoma of the gastric cardia in Spain. Cancer Causes Control 1994;5:88-9. [DOI: 10.1007/bf01830731] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
193 Bosset JF, Lorchel F, Mantion G. Neoadjuvant treatment of early stage squamous cell carcinoma of the esophagus*. Diseases of the Esophagus 2002;15:117-20. [DOI: 10.1046/j.1442-2050.2002.00213.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
194 Reddy RP, Levy MJ, Wiersema MJ. Endoscopic ultrasound for luminal malignancies. Gastrointest Endosc Clin N Am 2005;15:399-429, vii. [PMID: 15990049 DOI: 10.1016/j.giec.2005.03.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
195 Qi X, Sivak MV, Rollins AM. Optical Coherence Tomography for Gastrointestinal Endoscopy. In: Drexler W, Fujimoto JG, editors. Optical Coherence Tomography. Berlin: Springer Berlin Heidelberg; 2008. pp. 1047-81. [DOI: 10.1007/978-3-540-77550-8_33] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
196 Hasegawa S, Yoshikawa T. Adenocarcinoma of the esophagogastric junction: incidence, characteristics, and treatment strategies. Gastric Cancer 2010;13:63-73. [DOI: 10.1007/s10120-010-0555-2] [Cited by in Crossref: 76] [Cited by in F6Publishing: 78] [Article Influence: 6.3] [Reference Citation Analysis]
197 Reid BJ, Blount PL, Rubin CE, Levine DS, Haggitt RC, Rabinovitch PS. Flow-cytometric and histological progression to malignancy in Barrett's esophagus: Prospective endoscopic surveillance of a cohort. Gastroenterology 1992;102:1212-9. [DOI: 10.1016/0016-5085(92)90758-q] [Cited by in Crossref: 318] [Article Influence: 10.6] [Reference Citation Analysis]
198 Brenner B, Shah MA, Karpeh MS, Gonen M, Brennan MF, Coit DG, Klimstra DS, Tang LH, Kelsen DP. A phase II trial of neoadjuvant cisplatin-fluorouracil followed by postoperative intraperitoneal floxuridine-leucovorin in patients with locally advanced gastric cancer. Ann Oncol. 2006;17:1404-1411. [PMID: 16788003 DOI: 10.1093/annonc/mdl133] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 2.4] [Reference Citation Analysis]
199 Sano T, Sasako M, Yamamoto S, Nashimoto A, Kurita A, Hiratsuka M, Tsujinaka T, Kinoshita T, Arai K, Yamamura Y, Okajima K. Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy--Japan Clinical Oncology Group study 9501. J Clin Oncol. 2004;22:2767-2773. [PMID: 15199090 DOI: 10.1200/jco.2004.10.184] [Cited by in Crossref: 464] [Cited by in F6Publishing: 205] [Article Influence: 25.8] [Reference Citation Analysis]
200 Hermansson M, DeMeester SR. Management of stage 1 esophageal cancer. Surg Clin North Am. 2012;92:1155-1167. [PMID: 23026275 DOI: 10.1016/j.suc.2012.07.014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
201 Faulx AL, Vela S, Das A, Cooper G, Sivak MV, Isenberg G, Chak A. The changing landscape of practice patterns regarding unsedated endoscopy and propofol use: a national Web survey. Gastrointest Endosc. 2005;62:9-15. [PMID: 15990813 DOI: 10.1016/s0016-5107(05)00518-3] [Cited by in Crossref: 93] [Cited by in F6Publishing: 39] [Article Influence: 5.5] [Reference Citation Analysis]
202 Hongo M. Review article: Barrett’s oesophagus and carcinoma in Japan. Aliment Pharmacol Ther. 2004;20 Suppl 8:50-54. [PMID: 15575874 DOI: 10.1111/j.1365-2036.2004.02230.x] [Cited by in Crossref: 60] [Cited by in F6Publishing: 52] [Article Influence: 3.5] [Reference Citation Analysis]
203 Wijetunge S, Ma Y, DeMeester S, Hagen J, DeMeester T, Chandrasoma P. Association of adenocarcinomas of the distal esophagus, “gastroesophageal junction,” and “gastric cardia” with gastric pathology. Am J Surg Pathol. 2010;34:1521-1527. [PMID: 20871225 DOI: 10.1097/pas.0b013e3181eff133] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
204 Gatenby PA, Ramus JR, Caygill CP, Charlett A, Winslet MC, Watson A. Treatment modality and risk of development of dysplasia and adenocarcinoma in columnar-lined esophagus. Dis Esophagus. 2009;22:133-142. [PMID: 19018855 DOI: 10.1111/j.1442-2050.2008.00886.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
205 Wu PC, Posner MC. The role of surgery in the management of oesophageal cancer. Lancet Oncol. 2003;4:481-488. [PMID: 12901962 DOI: 10.1016/s1470-2045(03)01167-7] [Cited by in Crossref: 172] [Cited by in F6Publishing: 61] [Article Influence: 9.1] [Reference Citation Analysis]
206 Bozzetti F, Bignami P, Bertario L, Fissi S, Eboli M. Surgical treatment of gastric cancer invading the oesophagus. Eur J Surg Oncol. 2000;26:810-814. [PMID: 11087650 DOI: 10.1053/ejso.2000.1009] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
207 Orth K, Rück A, Stanescu A, Beger H. Intraluminal treatment of inoperable oesophageal tumours by intralesional photodynamic therapy with methylene blue. The Lancet 1995;345:519-20. [DOI: 10.1016/s0140-6736(95)90617-7] [Cited by in Crossref: 54] [Article Influence: 2.0] [Reference Citation Analysis]
208 Zhang J, Su XQ, Wu XJ, Liu YH, Wang H, Zong XN, Wang Y, Ji JF. Effect of body mass index on adenocarcinoma of gastric cardia. World J Gastroenterol 2003; 9(12): 2658-2661 [PMID: 14669307 DOI: 10.3748/wjg.v9.i12.2658] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
209 Ji BT, Chow WH, Yang G, McLaughlin JK, Zheng W, Shu XO, Jin F, Gao RN, Gao YT, Fraumeni JF Jr. Dietary habits and stomach cancer in Shanghai, China. Int J Cancer 1998;76:659-64. [PMID: 9610722 DOI: 10.1002/(sici)1097-0215(19980529)76:5<659::aid-ijc8>3.0.co;2-p] [Cited by in Crossref: 95] [Cited by in F6Publishing: 36] [Article Influence: 4.0] [Reference Citation Analysis]
210 Ng C, Husband J, Macvicar A, Ross P, Cunningham D. Correlation of CT with histopathological findings in patients with gastric and gastro-oesophageal carcinomas following neoadjuvant chemotherapy. Clinical Radiology 1998;53:422-7. [DOI: 10.1016/s0009-9260(98)80270-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
211 Piso P, Werner U, Lang H, Mirena P, Klempnauer J. Proximal versus distal gastric carcinoma--what are the differences? Ann Surg Oncol 2000;7:520-5. [PMID: 10947021 DOI: 10.1007/s10434-000-0520-0] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 1.9] [Reference Citation Analysis]
212 Spechler SJ. Barrett's oesophagus: diagnosis and management. Best Practice & Research Clinical Gastroenterology 2000;14:857-79. [DOI: 10.1053/bega.2000.0129] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
213 Patti MG, Owen D. Prognostic Factors in Esophageal Cancer. Surgical Oncology Clinics of North America 1997;6:515-31. [DOI: 10.1016/s1055-3207(18)30315-6] [Cited by in Crossref: 9] [Article Influence: 0.4] [Reference Citation Analysis]
214 Li Y, Wo JM, Ray MB, Jones W, Su RR, Ellis S, Martin RCG. Cyclooxygenase-2 and epithelial growth factor receptor up-regulation during progression of Barrett’s esophagus to adenocarcinoma. World J Gastroenterol 2006; 12(6): 928-934 [PMID: 16521222 DOI: 10.3748/wjg.v12.i6.928] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 23] [Article Influence: 1.3] [Reference Citation Analysis]
215 Hagen JA, Demeester TR. Esophageal adenocarcinoma. The Annals of Thoracic Surgery 2001;72:1430-2. [DOI: 10.1016/s0003-4975(01)02845-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
216 Stevens PD, Lightdale CJ, Green PH, Siegel LM, Garcia-carrasquillo RJ, Rotterdam H. Combined magnification endoscopy with chromoendoscopy for the evaluation of Barrett's esophagus. Gastrointestinal Endoscopy 1994;40:747-9. [DOI: 10.1016/s0016-5107(94)70121-0] [Cited by in Crossref: 80] [Article Influence: 2.9] [Reference Citation Analysis]
217 Demeester SR. Endoscopic Mucosal Resection and Vagal-Sparing Esophagectomy for High-Grade Dysplasia and Adenocarcinoma of the Esophagus. Seminars in Thoracic and Cardiovascular Surgery 2005;17:320-5. [DOI: 10.1053/j.semtcvs.2005.09.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
218 Rubenstein JH, Chen JW. Epidemiology of gastroesophageal reflux disease. Gastroenterol Clin North Am. 2014;43:1-14. [PMID: 24503355 DOI: 10.1016/j.gtc.2013.11.006] [Cited by in Crossref: 62] [Cited by in F6Publishing: 50] [Article Influence: 6.9] [Reference Citation Analysis]
219 Amano Y, Ishihara S, Kushiyama Y, Yuki T, Takahashi Y, Chinuki D, Miyake T, Miyaoka Y, Rumi MA, Ishimura N, Adachi K, Kinoshita Y. Barrett's oesophagus with predominant intestinal metaplasia correlates with superficial cyclo-oxygenase-2 expression, increased proliferation and reduced apoptosis: changes that are partially reversed by non-steroidal anti-inflammatory drugs usage. Aliment Pharmacol Ther 2004;20:793-802. [PMID: 15379840 DOI: 10.1111/j.1365-2036.2004.02195.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
220 Roukos DH. Current status and future perspectives in gastric cancer management. Cancer Treat Rev. 2000;26:243-255. [PMID: 10913380 DOI: 10.1053/ctrv.2000.0164] [Cited by in Crossref: 128] [Cited by in F6Publishing: 133] [Article Influence: 5.8] [Reference Citation Analysis]
221 Celik S, Almalı N, Aras A, Yılmaz Ö, Kızıltan R. Intraoperatively Testing the Anastomotic Integrity of Esophagojejunostomy Using Methylene Blue. Scand J Surg 2017;106:62-7. [DOI: 10.1177/1457496916630652] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
222 Levi F, Randimbison L, La Vecchia C. Esophageal and gastric carcinoma in Vaud, Switzerland, 1976-1994. Int J Cancer 1998;75:160-1. [DOI: 10.1002/(sici)1097-0215(19980105)75:1<160::aid-ijc25>3.0.co;2-j] [Cited by in Crossref: 17] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
223 Ajani J. Therapy of carcinoma of the oesophagus: Either attempt it not or succeed. European Journal of Cancer 1995;31:790-3. [DOI: 10.1016/0959-8049(94)e0124-m] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
224 Ellis FH Jr, Loda M. p27 and Barrett's esophagus: a review*. Dis Esophagus 2004;17:113-7. [PMID: 15230722 DOI: 10.1111/j.1442-2050.2004.00402.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
225 Montgomery E, Mamelak AJ, Gibson M, Maitra A, Sheikh S, Amr SS, Yang S, Brock M, Forastiere A, Zhang S, Murphy KM, Berg KD. Overexpression of Claudin Proteins in Esophageal Adenocarcinoma and Its Precursor Lesions. Applied Immunohistochemistry & Molecular Morphology 2006;14:24-30. [DOI: 10.1097/01.pai.0000151933.04800.1c] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 2.1] [Reference Citation Analysis]
226 Mohamed A, El-Rayes B, Khuri FR, Saba NF. Targeted therapies in metastatic esophageal cancer: advances over the past decade. Crit Rev Oncol Hematol. 2014;91:186-196. [PMID: 24582516 DOI: 10.1016/j.critrevonc.2014.01.010] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
227 Alexandrou A, Davis PA, Law S, Murthy S, Whooley BP, Wong J. Squamous cell carcinoma and adenocarcinoma of the lower third of the esophagus and gastric cardia: similarities and differences. Diseases of the Esophagus 2002;15:290-5. [DOI: 10.1046/j.1442-2050.2002.00272.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.2] [Reference Citation Analysis]
228 Ilson DH, Sirott M, Saltz L, Heelan R, Huang Y, Keresztes R, Kelsen DP. A phase II trial of interferon alpha-2A, 5-fluorouracil, and cisplatin in patients with advanced esophageal carcinoma. Cancer 1995;75:2197-202. [DOI: 10.1002/1097-0142(19950501)75:9<2197::aid-cncr2820750902>3.0.co;2-s] [Cited by in Crossref: 21] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
229 Cooper GS, Mourad WA, Koroukian SM. Diagnosis and treatment of gastroesophageal reflux disease in Ohio Medicaid patients: practice patterns and temporal trends: DIAGNOSIS AND TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE. Pharmacoepidem Drug Safe 2004;13:21-7. [DOI: 10.1002/pds.818] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
230 Markar SR, Mackenzie H, Lagergren P, Hanna GB, Lagergren J. Surgical Proficiency Gain and Survival After Esophagectomy for Cancer. J Clin Oncol. 2016;34:1528-1536. [PMID: 26951311 DOI: 10.1200/jco.2015.65.2875] [Cited by in Crossref: 55] [Cited by in F6Publishing: 18] [Article Influence: 9.2] [Reference Citation Analysis]
231 Tercioti-Junior V, Lopes LR, Coelho-Neto Jde S, Carvalheira JB, Andreollo NA. Esophagogastric junction adenocarcinoma: multivariate analyses of surgical morbi-mortality and adjuvant therapy. Arq Bras Cir Dig 2012;25:229-34. [PMID: 23411920 DOI: 10.1590/s0102-67202012000400004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
232 Gulmann C, Grace A, Leader M, Butler D, Patchett S, Kay E. Adenomatous polyposis coli gene, beta-catenin, and E-cadherin expression in proximal and distal gastric cancers and precursor lesions: an immunohistochemical study using tissue microarrays. Appl Immunohistochem Mol Morphol. 2003;11:230-237. [PMID: 12966349 DOI: 10.1097/00129039-200309000-00005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
233 Malfertheiner P, O'Connor HJ, Genta RM, Unge P, Axon AT. Symposium: Helicobacter pylori and clinical risks--focus on gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2002;16 Suppl 3:1-10. [PMID: 12000312 DOI: 10.1046/j.1365-2036.16.s3.1.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
234 Mooney MM. Neoadjuvant and adjuvant chemotherapy for esophageal adenocarcinoma. J Surg Oncol 2005;92:230-8. [PMID: 16299790 DOI: 10.1002/jso.20364] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
235 Luketich JD, Schauer PR, Meltzer CC, Landreneau RJ, Urso GK, Townsend DW, Ferson PF, Keenan RJ, Belani CP. Role of positron emission tomography in staging esophageal cancer. Ann Thorac Surg 1997;64:765-9. [PMID: 9307471 DOI: 10.1016/s0003-4975(97)00624-3] [Cited by in Crossref: 146] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
236 Abdel-Latif MM, Duggan S, Reynolds JV, Kelleher D. Inflammation and esophageal carcinogenesis. Curr Opin Pharmacol. 2009;9:396-404. [PMID: 19596608 DOI: 10.1016/j.coph.2009.06.010] [Cited by in Crossref: 71] [Cited by in F6Publishing: 64] [Article Influence: 5.5] [Reference Citation Analysis]
237 Clark GW, Peters JH, Ireland AP, Ehsan A, Hagen JA, Kiyabu MT, Bremner CG, DeMeester TR. Nodal metastasis and sites of recurrence after en bloc esophagectomy for adenocarcinoma. Ann Thorac Surg 1994;58:646-53; discussion 653-4. [PMID: 7944684 DOI: 10.1016/0003-4975(94)90722-6] [Cited by in Crossref: 121] [Cited by in F6Publishing: 100] [Article Influence: 4.3] [Reference Citation Analysis]
238 Mao Y, Hu J, Semenciw R, White K. Active and passive smoking and the risk of stomach cancer, by subsite, in Canada: . European Journal of Cancer Prevention 2002;11:27-38. [DOI: 10.1097/00008469-200202000-00005] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.2] [Reference Citation Analysis]
239 Lerut T, Coosemans W, Decker G, De Leyn P, Nafteux P, Van Raemdonck D. Cancer of the esophagus and gastro-esophageal junction: potentially curative therapies. Surgical Oncology 2001;10:113-22. [DOI: 10.1016/s0960-7404(01)00027-5] [Cited by in Crossref: 39] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
240 Jin D, Yang F, Chen Z, Yang S, Xing D. Biomechanical and morphological multi-parameter photoacoustic endoscope for identification of early esophageal disease. Appl Phys Lett 2017;111:103703. [DOI: 10.1063/1.5001272] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
241 Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R;  Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101:1900-20; quiz 1943. [PMID: 16928254 DOI: 10.1111/j.1572-0241.2006.00630.x] [Cited by in Crossref: 2128] [Cited by in F6Publishing: 1700] [Article Influence: 133.0] [Reference Citation Analysis]
242 Zhang J, Chen XL, Wang KM, Guo XD, Zuo AL, Gong J. Relationship of gastric Helicobacter pylori infection to Barrett’s esophagus and gastro-esophageal reflux disease in Chinese. World J Gastroenterol 2004; 10(5): 672-675 [PMID: 14991936 DOI: 10.3748/wjg.v10.i5.672] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]
243 Rusch VW, Levine DS, Haggitt R, Reid BJ. The management of high grade dysplasia and early cancer in Barrett's esophagus. A multidisciplinary problem. Cancer 1994;74:1225-9. [PMID: 8055442 DOI: 10.1002/1097-0142(19940815)74:4<1225::aid-cncr2820740408>3.0.co;2-q] [Cited by in Crossref: 64] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
244 Moskaluk CA, Hu J, Perlman EJ. Comparative genomic hybridization of esophageal and gastroesophageal adenocarcinomas shows consensus areas of DNA gain and loss. Genes Chromosom Cancer 1998;22:305-11. [DOI: 10.1002/(sici)1098-2264(199808)22:4<305::aid-gcc6>3.0.co;2-z] [Cited by in Crossref: 58] [Article Influence: 2.4] [Reference Citation Analysis]
245 Teng S, Karl R. Surgical Approaches to Esophageal Cancer: The optimal surgical treatment approach for esophageal cancer remains controversial. Cancer Control 1999;6:36-42. [DOI: 10.1177/107327489900600103] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
246 Lieberman MD, Shriver CD, Bleckner S, Burt M. Carcinoma of the esophagus: Prognostic significance of histologic type. The Journal of Thoracic and Cardiovascular Surgery 1995;109:130-9. [DOI: 10.1016/s0022-5223(95)70428-0] [Cited by in Crossref: 75] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
247 Alexandre L, Broughton T, Loke Y, Beales IL. Meta-analysis: risk of esophageal adenocarcinoma with medications which relax the lower esophageal sphincter. Dis Esophagus. 2012;25:535-544. [PMID: 22129441 DOI: 10.1111/j.1442-2050.2011.01285.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
248 Carta R, Tortora G, Thoné J, Lenaerts B, Valdastri P, Menciassi A, Dario P, Puers R. Wireless powering for a self-propelled and steerable endoscopic capsule for stomach inspection. Biosens Bioelectron. 2009;25:845-851. [PMID: 19775883 DOI: 10.1016/j.bios.2009.08.049] [Cited by in Crossref: 107] [Cited by in F6Publishing: 42] [Article Influence: 8.2] [Reference Citation Analysis]
249 Lang H, Piso P, Stukenborg C, Raab R, Jähne J. Management and results of proximal anastomotic leaks in a series of 1114 total gastrectomies for gastric carcinoma. Eur J Surg Oncol. 2000;26:168-171. [PMID: 10744938 DOI: 10.1053/ejso.1999.0764] [Cited by in Crossref: 142] [Cited by in F6Publishing: 108] [Article Influence: 6.5] [Reference Citation Analysis]
250 Strong VE, Song KY, Park CH, Jacks LM, Gonen M, Shah M, Coit DG, Brennan MF. Comparison of gastric cancer survival following R0 resection in the United States and Korea using an internationally validated nomogram. Ann Surg 2010;251:640-6. [PMID: 20224369 DOI: 10.1097/SLA.0b013e3181d3d29b] [Cited by in Crossref: 227] [Cited by in F6Publishing: 129] [Article Influence: 18.9] [Reference Citation Analysis]
251 Fléjou JF, Muzeau F, Potet F, Lepelletier F, Fékété F, Hénin D. Overexpression of the p53 tumor suppressor gene product in esophageal and gastric carcinomas. Pathol Res Pract. 1994;190:1141-1148. [PMID: 7540752 DOI: 10.1016/s0344-0338(11)80440-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
252 Naunheim KS, Petruska PJ, Roy TS, Schlueter JM, Kim H, Baue AE. Multimodality therapy for adenocarcinoma of the esophagus. Ann Thorac Surg. 1995;59:1085-1090; discussion 1085-1090. [PMID: 7733702 DOI: 10.1016/0003-4975(95)00119-6] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 1.2] [Reference Citation Analysis]
253 Fu X, Beer DG, Behar J, Wands J, Lambeth D, Cao W. cAMP-response element-binding protein mediates acid-induced NADPH oxidase NOX5-S expression in Barrett esophageal adenocarcinoma cells. J Biol Chem 2006;281:20368-82. [PMID: 16707484 DOI: 10.1074/jbc.M603353200] [Cited by in Crossref: 97] [Cited by in F6Publishing: 60] [Article Influence: 6.1] [Reference Citation Analysis]
254 Hill MJ. The changing spectrum of gastroesophageal cancer: . European Journal of Cancer Prevention 2002;11:203-4. [DOI: 10.1097/00008469-200206000-00001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
255 Conio M, Filiberti R, Blanchi S, Giacosa A. Carditis, intestinal metaplasia and adenocarcinoma of oesophagogastric junction. Eur J Cancer Prev 2001;10:483-7. [PMID: 11916346 DOI: 10.1097/00008469-200112000-00002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
256 Tamagawa Y, Ishimura N, Uno G, Yuki T, Kazumori H, Ishihara S, Amano Y, Kinoshita Y. Notch signaling pathway and Cdx2 expression in the development of Barrett's esophagus. Lab Invest. 2012;92:896-909. [PMID: 22449796 DOI: 10.1038/labinvest.2012.56] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 2.9] [Reference Citation Analysis]
257 Gretschel S, Schlag PM. Current Status of Sentinel Lymph Node Biopsy in Adenocarcinoma of the Distal Esophagus, Gastric Cardia, and Proximal Stomach. In: Schneider PM, editor. Adenocarcinoma of the Esophagogastric Junction. Berlin: Springer Berlin Heidelberg; 2010. pp. 107-14. [DOI: 10.1007/978-3-540-70579-6_9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
258 Ouatu-Lascar R, Fitzgerald RC, Triadafilopoulos G. Differentiation and proliferation in Barrett’s esophagus and the effects of acid suppression. Gastroenterology. 1999;117:327-335. [PMID: 10419913 DOI: 10.1053/gast.1999.0029900327] [Cited by in Crossref: 270] [Cited by in F6Publishing: 233] [Article Influence: 11.7] [Reference Citation Analysis]
259 Parada KS, Peng R, Erickson RA, Hawes R, Sahai AV, Ziogas A, Chang KJ. A resource utilization projection study of EUS. Gastrointest Endosc 2002;55:328-34. [PMID: 11868004 DOI: 10.1067/mge.2002.118948] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
260 Hejna M, Kornek GV, Schratter-sehn AU, Zach M, Schoder M, Raderer M, Rosen H, Schiessel R, Scheithauer W. Effective radiochemotherapy with cisplatin and etoposide for the management of patients with locally inoperable and metastatic esophageal carcinoma. Cancer 1996;78:1646-50. [DOI: 10.1002/(sici)1097-0142(19961015)78:8<1646::aid-cncr2>3.0.co;2-c] [Cited by in Crossref: 7] [Article Influence: 0.3] [Reference Citation Analysis]
261 Schlansky B, Sonnenberg A. Epidemiology of noncardia gastric adenocarcinoma in the United States. Am J Gastroenterol. 2011;106:1978-1985. [PMID: 22008896 DOI: 10.1038/ajg.2011.213] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 4.2] [Reference Citation Analysis]
262 Ganesh S, Sier CF, Heerding MM, van Krieken JH, Griffioen G, Welvaart K, van de Velde CJ, Verheijen JH, Lamers CB, Verspaget HW. Prognostic value of the plasminogen activation system in patients with gastric carcinoma. Cancer 1996;77:1035-43. [PMID: 8635120 DOI: 10.1002/(sici)1097-0142(19960315)77:6<1035::aid-cncr5>3.0.co;2-g] [Cited by in Crossref: 29] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
263 Haigh CR, Attwood SE, Thompson DG, Jankowski JA, Kirton CM, Pritchard D, Varro A, Dimaline R. Gastrin induces proliferation in Barrett's metaplasia through activation of the CCK2 receptor. Gastroenterology 2003;124:615-25. [DOI: 10.1053/gast.2003.50091] [Cited by in Crossref: 106] [Cited by in F6Publishing: 100] [Article Influence: 5.6] [Reference Citation Analysis]
264 Cameron AJ. The History of Barrett Esophagus. Mayo Clinic Proceedings 2001;76:94-6. [DOI: 10.4065/76.1.94] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
265 Lerut T, Coosemans W, De Leyn P, Van Raemdonck D, Nafteux P, Moons J. Optimizing Treatment of Carcinoma of the Esophagus and Gastroesophageal Junction. Surgical Oncology Clinics of North America 2001;10:863-84. [DOI: 10.1016/s1055-3207(18)30037-1] [Cited by in Crossref: 17] [Article Influence: 0.8] [Reference Citation Analysis]
266 Hirdes MM, Vleggaar FP, Laasch HU, Siersema PD. Technical feasibility and safety of a new, implantable reflux control system to prevent gastroesophageal reflux in patients with stents placed through the lower esophageal sphincter (with video). Gastrointest Endosc 2012;75:174-8. [PMID: 22196815 DOI: 10.1016/j.gie.2011.08.037] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
267 Stahl M, Vanhoefer U, Stuschke M, Walz M, Müller C, Wilke H. Pre-operative sequential chemo- and radiochemotherapy in locally advanced carcinomas of the lower oesophagus and gastro-oesophageal junction. European Journal of Cancer 1998;34:668-73. [DOI: 10.1016/s0959-8049(97)10109-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
268 Gao SG, Wang LD, Fan ZM, Li JL, He X, Guo RF, Xie DL, He XW, Gao SS, Guo HQ, Wang JK, Feng XS, Ma BG. Histochemical studies on intestinal metaplasia adjacent to gastric cardia adenocarcinoma in subjects at high-incidence area in Henan, north China. World J Gastroenterol 2005; 11(30): 4634-4637 [PMID: 16094701 DOI: 10.3748/wjg.v11.i30.4634] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
269 Cunningham JD, Schwartz GK, Karpeh M, Blundell M, Kelson DP, Jhanwar SC, Albino AP. Loss of heterozygosity and homozygous deletion of the tpr locus in human gastric cancer. Am J Surg 1997;173:521-2. [PMID: 9207167 DOI: 10.1016/s0002-9610(97)00011-1] [Reference Citation Analysis]
270 Siewert J, Fink U, Sendler A, Becker K, Böttcher K, Feldmann H, Höfler H, Mueller J, Molls M, Nekarda H, Roder J, Stein H. Gastric cancer. Current Problems in Surgery 1997;34:835-939. [DOI: 10.1016/s0011-3840(97)80006-8] [Cited by in Crossref: 37] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
271 Iijima K, Henry E, Moriya A, Wirz A, Kelman AW, McColl KE. Dietary nitrate generates potentially mutagenic concentrations of nitric oxide at the gastroesophageal junction. Gastroenterology. 2002;122:1248-1257. [PMID: 11984511 DOI: 10.1053/gast.2002.32963] [Cited by in Crossref: 112] [Cited by in F6Publishing: 100] [Article Influence: 5.6] [Reference Citation Analysis]
272 Michelet P, D'journo X, Roch A, Papazian L, Ragni J, Thomas P, Auffray J. Perioperative Risk Factors for Anastomotic Leakage After Esophagectomy. Chest 2005;128:3461-6. [DOI: 10.1378/chest.128.5.3461] [Cited by in Crossref: 89] [Cited by in F6Publishing: 60] [Article Influence: 5.2] [Reference Citation Analysis]
273 Devesa SS, Blot WJ, Fraumeni JF. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998;83:2049-53. [DOI: 10.1002/(sici)1097-0142(19981115)83:10<2049::aid-cncr1>3.0.co;2-2] [Cited by in Crossref: 1358] [Cited by in F6Publishing: 2] [Article Influence: 56.6] [Reference Citation Analysis]
274 Ekström AM, Held M, Hansson LE, Engstrand L, Nyrén O. Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection. Gastroenterology. 2001;121:784-791. [PMID: 11606491 DOI: 10.1053/gast.2001.27999] [Cited by in Crossref: 264] [Cited by in F6Publishing: 247] [Article Influence: 12.6] [Reference Citation Analysis]
275 Yang K, Lu ZH, Zhang WH, Liu K, Chen XZ, Chen XL, Guo DJ, Zhou ZG, Hu JK. Comparisons Between Different Procedures of No. 10 Lymphadenectomy for Gastric Cancer Patients With Total Gastrectomy. Medicine (Baltimore) 2015;94:e1305. [PMID: 26287413 DOI: 10.1097/MD.0000000000001305] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
276 Green R, Northway MG, Buena NB, Musa MM, Lambourne A. Gastric carcinoma in the Sultanate of Oman: Incidence and distribution. Ann Saudi Med 1996;16:291-5. [PMID: 17372447 DOI: 10.5144/0256-4947.1996.291] [Reference Citation Analysis]
277 Esquivias P, Morandeira A, Escartín A, Cebrián C, Santander S, Esteva F, García-González MA, Ortego J, Lanas A, Piazuelo E. Indomethacin but not a selective cyclooxygenase-2 inhibitor inhibits esophageal adenocarcinogenesis in rats. World J Gastroenterol 2012; 18(35): 4866-4874 [PMID: 23002358 DOI: 10.3748/wjg.v18.i35.4866] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
278 E. I. T. Sihvo, J. T. Salminen, O.. The Epidemiology of Oesophageal Adenocarcinoma: Has the Cancer of Gastric Cardia an Influence on the Rising Incidence of Oesophageal Adenocarcinoma? Scandinavian Journal of Gastroenterology 2009;35:1082-6. [DOI: 10.1080/003655200451216] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
279 Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer. 1998;83:2049-2053. [PMID: 9827707 DOI: 10.1002/(SICI)1097-0142(19981115)83:10%3C2049::AID-CNCR1%3E3.0.CO;2-2] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
280 Freedman J, Lagergren J, Bergström R, Näslund E, Nyrén O. Cholecystectomy, peptic ulcer disease and the risk of adenocarcinoma of the oesophagus and gastric cardia. Br J Surg. 2000;87:1087-1093. [PMID: 10931056 DOI: 10.1046/j.1365-2168.2000.01459.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.5] [Reference Citation Analysis]
281 Mayne ST, Navarro SA. Diet, obesity and reflux in the etiology of adenocarcinomas of the esophagus and gastric cardia in humans. J Nutr. 2002;132:3467S-3470S. [PMID: 12421872 DOI: 10.1093/jn/132.11.3467s] [Cited by in Crossref: 105] [Cited by in F6Publishing: 32] [Article Influence: 5.3] [Reference Citation Analysis]
282 Rigberg DA, Kim FS, Sebastian JL, Kazanjian KK, McFadden DW. Hypophosphorylated retinoblastoma protein is associated with G2 arrest in esophageal squamous cell carcinoma. J Surg Res. 1999;84:101-105. [PMID: 10334897 DOI: 10.1006/jsre.1999.5617] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
283 Hsu CP, Wu CC, Chen CY, Hsu NY, Jiun-Yi-Hsia, Wang PY. Clinical experience in radical lymphadenectomy for adenocarcinoma of the gastric cardia. J Thorac Cardiovasc Surg 1997;114:544-51. [PMID: 9338639 DOI: 10.1016/S0022-5223(97)70042-4] [Cited by in Crossref: 25] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
284 Cooper SC, Croft S, Day R, Thomson CS, Trudgill NJ. The risk of oesophageal cancer is not affected by a diagnosis of breast cancer. Eur J Cancer Prev 2010;19:182-5. [PMID: 20145541 DOI: 10.1097/CEJ.0b013e3283372137] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
285 Abdel-latif MMM, O’riordan JM, Ravi N, Kelleher D, Reynolds JV. Activated nuclear factor-kappa B and cytokine profiles in the esophagus parallel tumor regression following neoadjuvant chemoradiotherapy. Diseases of the Esophagus 2005;18:246-52. [DOI: 10.1111/j.1442-2050.2005.00497.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 1.6] [Reference Citation Analysis]
286 Mamede M, El Fakhri G, Abreu-e-Lima P, Gandler W, Nosé V, Gerbaudo VH. Pre-operative estimation of esophageal tumor metabolic length in FDG-PET images with surgical pathology confirmation. Ann Nucl Med. 2007;21:553-562. [PMID: 18092131 DOI: 10.1007/s12149-007-0040-0] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 2.9] [Reference Citation Analysis]
287 Samalin E, Afchain P, Thézenas S, Abbas F, Romano O, Guimbaud R, Bécouarn Y, Desseigne F, Edeline J, Mitry E, Bouché O, Adenis A, Aparicio T, Dorval E, Kramar A, Ychou M. Efficacy of irinotecan in combination with 5-fluorouracil (FOLFIRI) for metastatic gastric or gastroesophageal junction adenocarcinomas (MGA) treatment. Clin Res Hepatol Gastroenterol 2011;35:48-54. [PMID: 21634054 DOI: 10.1016/j.gcb.2010.06.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
288 Wu JC, Sung JJ, Chan FK, Ching JY, Ng AC, Go MY, Wong SK, Ng EK, Chung SC. Helicobacter pylori infection is associated with milder gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2000;14:427-432. [PMID: 10759622 DOI: 10.1046/j.1365-2036.2000.00714.x] [Cited by in Crossref: 64] [Cited by in F6Publishing: 62] [Article Influence: 2.9] [Reference Citation Analysis]
289 Thompson CL, Khiani V, Chak A, Berger NA, Li L. Carbohydrate consumption and esophageal cancer:an ecological assessment. Am J Gastroenterol 2008;103:555-61. [PMID: 17986316 DOI: 10.1111/j.1572-0241.2007.01613.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
290 Wickramasinghe KS, Chandrasoma PT, Chandraratna PA. Detection of Barrett's epithelium by acoustic microscopy. Ultrasound Med Biol 2002;28:203-7. [PMID: 11937283 DOI: 10.1016/s0301-5629(01)00492-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
291 Wolfsen HC. Carpe luz--seize the light: endoprevention of esophageal adenocarcinoma when using photodynamic therapy with porfimer sodium. Gastrointest Endosc 2005;62:499-503. [PMID: 16185960 DOI: 10.1016/j.gie.2005.07.017] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
292 Cowley A, Bath-Hextall F, Cooper J. Interventions for healthcare professionals, organizations and patients to enhance quality of life for people diagnosed with palliative esophagogastric cancer: a systematic review. JBI Database System Rev Implement Rep 2017;15:840-52. [PMID: 28267035 DOI: 10.11124/JBISRIR-2016-003108] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
293 Wenner J, Johnsson F, Johansson J, Öberg S. Acid Reflux Immediately Above the Squamocolumnar Junction and in the Distal Esophagus: Simultaneous pH Monitoring Using the Wireless Capsule pH System. The American Journal of Gastroenterology 2006;101:1734-41. [DOI: 10.1111/j.1572-0241.2006.00653.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
294 Gudlaugsdottir S, van Blankenstein M, Dees J, Wilson JH. A majority of patients with Barrett's oesophagus are unlikely to benefit from endoscopic cancer surveillance. Eur J Gastroenterol Hepatol 2001;13:639-45. [PMID: 11434588 DOI: 10.1097/00042737-200106000-00005] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.0] [Reference Citation Analysis]
295 Forman D. Review article: oesophago-gastric adenocarcinoma -- an epidemiological perspective. Aliment Pharmacol Ther. 2004;20 Suppl 5:55-60; discussion 61-62. [PMID: 15456465 DOI: 10.1111/j.1365-2036.2004.02133.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 1.6] [Reference Citation Analysis]
296 Vogt K, Fenlon D, Rhodes S, Malthaner R, Malthaner R. Preoperative chemotherapy for resectable thoracic esophageal cancer. Cochrane Database of Systematic Reviews. Chichester: John Wiley & Sons, Ltd; 1996. [DOI: 10.1002/14651858.cd001556.pub2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 17] [Article Influence: 0.7] [Reference Citation Analysis]
297 Wenz F, Mamon H. Perioperative radiotherapy for cancer of the esophagus. Semin Surg Oncol 2001;20:33-9. [DOI: 10.1002/ssu.1014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
298 Cameron AJ. Barrett's esophagus and adenocarcinoma: from the family to the gene. Gastroenterology 1992;102:1421-4. [PMID: 1551552 DOI: 10.1016/0016-5085(92)90789-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 0.5] [Reference Citation Analysis]
299 Cady B. Contemporary approaches to gastric carcinoma. Cancer Treat Res 1997;90:239-52. [PMID: 9367087 DOI: 10.1007/978-1-4615-6165-1_13] [Reference Citation Analysis]
300 Januszewicz W, Kaminski MF, Wieszczy P, Wronska E, Bielasik A, Wojciechowska U, Didkowska J, Orlowska J, Regula J. Adenocarcinoma risk in patients registered with Polish Barrett's Oesophagus Registry. Dis Esophagus 2017;30:1-6. [PMID: 27377059 DOI: 10.1111/dote.12483] [Reference Citation Analysis]
301 Schuchert MJ, Luketich JD, Landreneau RJ. Management of esophageal cancer. Curr Probl Surg 2010;47:845-946. [PMID: 20937424 DOI: 10.1067/j.cpsurg.2010.07.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
302 Dixon JL, Copeland LA, Zeber JE, MacCarthy AA, Reznik SI, Smythe WR, Rascoe PA. Association between diabetes and esophageal cancer, independent of obesity, in the United States Veterans Affairs population. Dis Esophagus 2016;29:747-51. [PMID: 26455587 DOI: 10.1111/dote.12402] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
303 Akiyama J, Marcus SN, Triadafilopoulos G. Effective Intra-Esophageal Acid Control Is Associated with Improved Radiofrequency Ablation Outcomes in Barrett’s Esophagus. Dig Dis Sci 2012;57:2625-32. [DOI: 10.1007/s10620-012-2313-2] [Cited by in Crossref: 30] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
304 Créhange G, Bosset M, Fabrice L, Buffet-miny J, Dumas JL, Mercier M, Puyraveau M, Maingon P, Bosset JF. Tumor Volume as Outcome Determinant in Patients Treated With Chemoradiation for Locally Advanced Esophageal Cancer. American Journal of Clinical Oncology 2006;29:583-7. [DOI: 10.1097/01.coc.0000242346.25229.48] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 1.3] [Reference Citation Analysis]
305 Huang Q, Zhang LH. The histopathologic spectrum of carcinomas involving the gastroesophageal junction in the Chinese. Int J Surg Pathol. 2007;15:38-52. [PMID: 17172496 DOI: 10.1177/1066896906295998] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
306 Morales TG, Bhattacharyya A, Camargo E, Johnson C, Sampliner RE. Methylene blue staining for intestinal metaplasia of the gastric cardia with follow-up for dysplasia. Gastrointest Endosc 1998;48:26-31. [PMID: 9684660 DOI: 10.1016/s0016-5107(98)70124-5] [Cited by in Crossref: 37] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
307 Zheng T, Mayne ST, Holford TR, Boyle P, Liu W, Chen Y, Mador M, Flannery J. Time trend and age-period-cohort effects on incidence of esophageal cancer in Connecticut, 1935?89. Cancer Causes Control 1992;3:481-92. [DOI: 10.1007/bf00051361] [Cited by in Crossref: 28] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
308 Thomas CR Jr, Berkey BA, Minsky BD, Gaspar LE, Herskovic A, Rich TA, Gunderson LL. Recursive partitioning analysis of pretreatment variables of 416 patients with locoregional esophageal cancer treated with definitive concomitant chemoradiotherapy on Intergroup and Radiation Therapy Oncology Group trials. Int J Radiat Oncol Biol Phys. 2004;58:1405-1410. [PMID: 15050316 DOI: 10.1016/j.ijrobp.2003.09.022] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
309 Lepage C, Rachet B, Jooste V, Faivre J, Coleman MP. Continuing Rapid Increase in Esophageal Adenocarcinoma in England and Wales. The American Journal of Gastroenterology 2008;103:2694-9. [DOI: 10.1111/j.1572-0241.2008.02191.x] [Cited by in Crossref: 173] [Cited by in F6Publishing: 268] [Article Influence: 12.4] [Reference Citation Analysis]
310 Taghavi N, Nasrollahzadeh D, Merat S, Yazdanbod A, Hormazdi M, Sotoudeh M, Semnani S, Eslami F, Marjani HA, Fahimi S, Khademi H, Malekzadeh R. Epidemiology of upper gastrointestinal cancers in Iran: A sub site analysis of 761 cases. World J Gastroenterol 2007; 13(40): 5367-5370 [PMID: 17879408 DOI: 10.3748/wjg.v13.i40.5367] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
311 Siewert JR, B�ttcher K, Stein HJ, Roder JD, Busch R. Problem of proximal third gastric carcinoma. World J Surg 1995;19:523-31. [DOI: 10.1007/bf00294713] [Cited by in Crossref: 68] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
312 Pera M, Trastek VF, Carpenter HA, Fernandez PL, Cardesa A, Mohr U, Pairolero PC. Influence of pancreatic and biliary reflux on the development of esophageal carcinoma. The Annals of Thoracic Surgery 1993;55:1386-93. [DOI: 10.1016/0003-4975(93)91077-z] [Cited by in Crossref: 81] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
313 McColl KE. Review article: Helicobacter pylori and gastro-oesophageal reflux disease--the European perspective. Aliment Pharmacol Ther. 2004;20 Suppl 8:36-39. [PMID: 15575871 DOI: 10.1111/j.1365-2036.2004.02227.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
314 Mueller JD, Stein HJ, Oyang T, Natsugoe S, Feith M, Werner M, Rüdiger Siewert J. Frequency and clinical impact of lymph node micrometastasis and tumor cell microinvolvement in patients with adenocarcinoma of the esophagogastric junction: Lymph Node Esophagogastric Junction. Cancer 2000;89:1874-82. [DOI: 10.1002/1097-0142(20001101)89:9<1874::aid-cncr2>3.0.co;2-m] [Cited by in Crossref: 9] [Article Influence: 0.4] [Reference Citation Analysis]
315 Tercioti-junior V, Lopes LR, Coelho-neto JDS. Adenocarcinoma versus carcinoma epidermóide: análise de 306 pacientes em hospital universitário. ABCD, arq bras cir dig 2011;24:272-6. [DOI: 10.1590/s0102-67202011000400005] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
316 Apfel T, Lopez R, Sanaka MR, Thota PN. Risk of progression of Barrett's esophagus in patients with cirrhosis. World J Gastroenterol 2017; 23(18): 3287-3294 [PMID: 28566888 DOI: 10.3748/wjg.v23.i18.3287] [Reference Citation Analysis]
317 Sharma P. Review article: prevalence of Barrett's oesophagus and metaplasia at the gastro-oesophageal junction. Aliment Pharmacol Ther 2004;20 Suppl 5:48-54; discussion 61-2. [PMID: 15456464 DOI: 10.1111/j.1365-2036.2004.02138.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
318 Hongo M, Nagasaki Y, Shoji T. Epidemiology of esophageal cancer: Orient to Occident. Effects of chronology, geography and ethnicity. J Gastroenterol Hepatol. 2009;24:729-735. [PMID: 19646015 DOI: 10.1111/j.1440-1746.2009.05824.x] [Cited by in Crossref: 224] [Cited by in F6Publishing: 214] [Article Influence: 17.2] [Reference Citation Analysis]
319 Ye W, Held M, Lagergren J, Engstrand L, Blot WJ, McLaughlin JK, Nyrén O. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. J Natl Cancer Inst. 2004;96:388-396. [PMID: 14996860 DOI: 10.1093/jnci/djh057] [Cited by in Crossref: 238] [Cited by in F6Publishing: 230] [Article Influence: 13.2] [Reference Citation Analysis]
320 Nakamura M, Iwahashi M, Nakamori M, Naka T, Ojima T, Iida T, Katsuda M, Tsuji T, Hayata K, Mastumura S, Yamaue H. Lower Mediastinal Lymph Node Metastasis is an Independent Survival Factor of Siewert Type II and III Adenocarcinomas in the Gastroesophageal Junction. The American Surgeon 2012;78:567-73. [DOI: 10.1177/000313481207800539] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
321 Haag S, Nandurkar S, Talley NJ. Regression of Barrett's esophagus: the role of acid suppression, surgery, and ablative methods. Gastrointestinal Endoscopy 1999;50:229-40. [DOI: 10.1016/s0016-5107(99)70230-0] [Cited by in Crossref: 35] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
322 Lagorce C, Paraf F, Vidaud D, Couvelard A, Wendum D, Martin A, Fléjou JF. Cyclooxygenase-2 is expressed frequently and early in Barrett's oesophagus and associated adenocarcinoma. Histopathology. 2003;42:457-465. [PMID: 12713622 DOI: 10.1046/j.1365-2559.2003.01627.x] [Cited by in Crossref: 60] [Cited by in F6Publishing: 63] [Article Influence: 3.2] [Reference Citation Analysis]
323 Cao JQ, Wang GH, Yang WJ, Dai GF, Zhang HF, Xie L, Yu MY, Ye XF. Clinical and pathological characteristics of adenocarcinoma of the esophagogastric junction in Hui and Han patients from Ningxia Hui Autonomous Region: Analysis of 1524 cases. Shijie Huaren Xiaohua Zazhi 2015; 23(12): 1949-1955 [DOI: 10.11569/wcjd.v23.i12.1949] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
324 Grade AJ, Shah IA, Medlin SM, Ramirez FC. The efficacy and safety of argon plasma coagulation therapy in Barrett's esophagus. Gastrointest Endosc. 1999;50:18-22. [PMID: 10385716 DOI: 10.1016/s0016-5107(99)70338-x] [Cited by in Crossref: 71] [Cited by in F6Publishing: 13] [Article Influence: 3.1] [Reference Citation Analysis]
325 Keeney S, Bauer TL. Epidemiology of adenocarcinoma of the esophagogastric junction. Surg Oncol Clin N Am. 2006;15:687-696. [PMID: 17030267 DOI: 10.1016/j.soc.2006.07.014] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
326 Chan WL, Lam KO, Lee VHF, Davidson M, So TH, Li JS, Chau I, Kwong DLW. Gastric Cancer - From Aetiology to Management: Differences Between the East and the West. Clin Oncol (R Coll Radiol). 2019;31:570-577. [PMID: 31178345 DOI: 10.1016/j.clon.2019.05.012] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
327 Jiang Y, Kimchi ET, Montero AJ, Staveley-O’Carroll KF, Ajani JA. Upper gastrointestinal tumors: current status and future perspectives. Expert Rev Anticancer Ther. 2008;8:975-991. [PMID: 18533807 DOI: 10.1586/14737140.8.6.975] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
328 Reid BJ, Sanchez CA, Blount PL, Levine DS. Barrett's esophagus: cell cycle abnormalities in advancing stages of neoplastic progression. Gastroenterology 1993;105:119-29. [PMID: 8514029 DOI: 10.1016/0016-5085(93)90017-7] [Cited by in Crossref: 127] [Cited by in F6Publishing: 113] [Article Influence: 4.4] [Reference Citation Analysis]
329 Levi Z, Kark JD, Shamiss A, Derazne E, Tzur D, Keinan-boker L, Liphshitz I, Niv Y, Furman M, Afek A. Body mass index and socioeconomic status measured in adolescence, country of origin, and the incidence of gastroesophageal adenocarcinoma in a cohort of 1 million men: Adolescent Obesity and Cancer. Cancer 2013;119:4086-93. [DOI: 10.1002/cncr.28241] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 3.9] [Reference Citation Analysis]
330 Falk GW. Barrett’s esophagus. Gastroenterology. 2002;122:1569-1591. [PMID: 12016424 DOI: 10.1053/gast.2002.33427] [Cited by in Crossref: 251] [Cited by in F6Publishing: 232] [Article Influence: 12.6] [Reference Citation Analysis]
331 Nandurkar S, Talley NJ. Epidemiology and natural history of reflux disease. Baillieres Best Pract Res Clin Gastroenterol. 2000;14:743-757. [PMID: 11003807 DOI: 10.1053/bega.2000.0122] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 2.0] [Reference Citation Analysis]
332 Hansson LE, Sparén P, Nyrén O. Increasing incidence of both major histological types of esophageal carcinomas among men in Sweden. Int J Cancer. 1993;54:402-407. [PMID: 8509215 DOI: 10.1002/ijc.2910540309] [Cited by in Crossref: 104] [Cited by in F6Publishing: 107] [Article Influence: 3.6] [Reference Citation Analysis]
333 Wu GD, Beer DG, Moore JH, Orringer MB, Appelman HD, Traber PG. Sucrase-isomaltase gene expression in Barrett's esophagus and adenocarcinoma. Gastroenterology 1993;105:837-44. [PMID: 8359653 DOI: 10.1016/0016-5085(93)90902-o] [Cited by in Crossref: 35] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
334 Zaninotto G, Minnei F, Guirroli E, Ceolin M, Battaglia G, Bellumat A, Betetto G, Bozzola L, Cassaro M, Cataudella G, Dal Bò N, Farinati F, Florea G, Furlanetto A, Galliani E, Germanà B, Guerini A, Macrì E, Marcon V, Mastropaolo G, Meggio A, Miori G, Morelli L, Murer B, Norberto L, Togni R, Valiante F, Rugge M. The Veneto Region's Barrett's Oesophagus Registry: Aims, methods, preliminary results. Digestive and Liver Disease 2007;39:18-25. [DOI: 10.1016/j.dld.2006.09.021] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
335 Hölscher AH, Bollschweiler E, Schneider PM, Siewert JR. Prognosis of early esophageal cancer. Comparison between adeno-and squamous cell carcinoma. Cancer 1995;76:178-86. [DOI: 10.1002/1097-0142(19950715)76:2<178::aid-cncr2820760204>3.0.co;2-d] [Cited by in Crossref: 130] [Cited by in F6Publishing: 31] [Article Influence: 4.8] [Reference Citation Analysis]
336 van den Boogert J, van Staveren HJ, de Bruin RW, Eikelaar JH, Siersema PD, van Hillegersberg R. Photodynamic therapy for esophageal lesions: selectivity depends on wavelength, power, and light dose. The Annals of Thoracic Surgery 1999;68:1763-9. [DOI: 10.1016/s0003-4975(99)01003-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
337 Li Y, Martin RCG. Reflux injury of esophageal mucosa: experimental studies in animal models of esophagitis, Barrett’s esophagus and esophageal adenocarcinoma. Diseases of the Esophagus 2007;20:372-8. [DOI: 10.1111/j.1442-2050.2007.00713.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 2.5] [Reference Citation Analysis]
338 Zheng T, Mayne ST, Holford TR, Boyle P, Liu W, Chen Y, Mador M, Flannery J. The time trend and age—period—cohort effects on incidence of adenocarcinoma of the stomach in connecticut from 1955–1989. Cancer 1993;72:330-40. [DOI: 10.1002/1097-0142(19930715)72:2<330::aid-cncr2820720205>3.0.co;2-l] [Cited by in Crossref: 54] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
339 Falk GW, Rice TW, Goldblum JR, Richter JE. Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia. Gastrointest Endosc. 1999;49:170-176. [PMID: 9925694 DOI: 10.1016/s0016-5107(99)70482-7] [Cited by in Crossref: 201] [Cited by in F6Publishing: 65] [Article Influence: 8.7] [Reference Citation Analysis]
340 Ofman JJ. The relation between gastroesophageal reflux disease and esophageal and head and neck cancers: a critical appraisal of epidemiologic literature. The American Journal of Medicine 2001;111:124-9. [DOI: 10.1016/s0002-9343(01)00857-9] [Cited by in Crossref: 15] [Article Influence: 0.7] [Reference Citation Analysis]
341 Chaves P, Crespo M, Ribeiro C, Laranjeira C, Pereira AD, Suspiro A, Cardoso P, Leitão CN, Soares J. Chromosomal analysis of Barrett's cells: demonstration of instability and detection of the metaplastic lineage involved. Mod Pathol 2007;20:788-96. [PMID: 17529926 DOI: 10.1038/modpathol.3800787] [Cited by in Crossref: 53] [Cited by in F6Publishing: 41] [Article Influence: 3.5] [Reference Citation Analysis]
342 Pérez-Pérez GI, Bhat N, Gaensbauer J, Fraser A, Taylor DN, Kuipers EJ, Zhang L, You WC, Blaser MJ. Country-specific constancy by age in cagA+ proportion of Helicobacter pylori infections. Int J Cancer 1997;72:453-6. [PMID: 9247289 DOI: 10.1002/(sici)1097-0215(19970729)72:3<453::aid-ijc13>3.0.co;2-d] [Cited by in Crossref: 53] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
343 Suleiman UL, Harrison M, Britton A, McPherson K, Bates T. H2-receptor antagonists may increase the risk of cardio-oesophageal adenocarcinoma: a case-control study. Eur J Cancer Prev. 2000;9:185-191. [PMID: 10954258 DOI: 10.1097/00008469-200006000-00007] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
344 Chak A, Faulx A, Eng C, Grady W, Kinnard M, Ochs-Balcom H, Falk G. Gastroesophageal reflux symptoms in patients with adenocarcinoma of the esophagus or cardia. Cancer. 2006;107:2160-2166. [PMID: 17019737 DOI: 10.1002/cncr.22245] [Cited by in Crossref: 57] [Cited by in F6Publishing: 50] [Article Influence: 3.6] [Reference Citation Analysis]
345 Isenberg G, Sivak MV, Chak A, Wong RC, Willis JE, Wolf B, Rowland DY, Das A, Rollins A. Accuracy of endoscopic optical coherence tomography in the detection of dysplasia in Barrett’s esophagus: a prospective, double-blinded study. Gastrointest Endosc. 2005;62:825-831. [PMID: 16301020 DOI: 10.1016/j.gie.2005.07.048] [Cited by in Crossref: 141] [Cited by in F6Publishing: 126] [Article Influence: 8.8] [Reference Citation Analysis]
346 Spechler SJ. La fréquence du cancer œsophagien chez les patients porteurs d’un endobrachyœsophage. Acta Endosc 1992;22:541-4. [DOI: 10.1007/bf02965117] [Cited by in Crossref: 16] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
347 Heidl G, Langhans P, Krieg V, Mellin W, Schilke R, B�nte H. Comparative studies of cardia carcinoma and infracardial gastric carcinoma. J Cancer Res Clin Oncol 1993;120:91-4. [DOI: 10.1007/bf01200730] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
348 Guelrud M, Ehrlich EE. Endoscopic classification of Barrett's esophagus. Gastrointestinal Endoscopy 2004;59:58-65. [DOI: 10.1016/s0016-5107(03)02508-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
349 Falk GW, Richter JE. Why is esophageal adenocarcinoma increasing in incidence? Abdom Imaging 1998;23:539-42. [DOI: 10.1007/s002619900396] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
350 Marshall REK, Anggiansah A, Owen WJ. Bile in the oesophagus: Clinical relevance and ambulatory detection: BILE IN THE OESOPHAGUS. Br J Surg 1997;84:21-8. [DOI: 10.1046/j.1365-2168.1997.02648.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
351 Ji J, Hemminki K. Socio-economic and occupational risk factors for gastric cancer: a cohort study in Sweden. Eur J Cancer Prev 2006;15:391-7. [PMID: 16912567 DOI: 10.1097/00008469-200610000-00003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
352 Gourtsoyiannis N, Grammatikakis J, Prassopoulos P. Role of conventional radiology in the diagnosis and staging of gastrointestinal tract neoplasms. Semin Surg Oncol. 2001;20:91-108. [PMID: 11398203 DOI: 10.1002/ssu.1023] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
353 Sasazuki S, Sasaki S, Tsugane S;  Japan Public Health Center Study Group. Cigarette smoking, alcohol consumption and subsequent gastric cancer risk by subsite and histologic type. Int J Cancer. 2002;101:560-566. [PMID: 12237898 DOI: 10.1002/ijc.10649] [Cited by in Crossref: 107] [Cited by in F6Publishing: 93] [Article Influence: 5.4] [Reference Citation Analysis]
354 Cathcart MC, O'Byrne KJ, Reynolds JV, O'Sullivan J, Pidgeon GP. COX-derived prostanoid pathways in gastrointestinal cancer development and progression: novel targets for prevention and intervention. Biochim Biophys Acta. 2012;1825:49-63. [PMID: 22015819 DOI: 10.1016/j.bbcan.2011.09.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 27] [Article Influence: 0.9] [Reference Citation Analysis]
355 Hong MK, Laskin WB, Herman BE, Johnston MH, Vargo JJ, Steinberg SM, Allegra CJ, Johnston PG. Expansion of the Ki-67 proliferative compartment correlates with degree of dysplasia in Barrett's esophagus. Cancer 1995;75:423-9. [PMID: 7812911 DOI: 10.1002/1097-0142(19950115)75:2<423::aid-cncr2820750202>3.0.co;2-5] [Cited by in Crossref: 117] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
356 Hong SJ, Kim TJ, Nam KB, Lee IS, Yang HC, Cho S, Kim K, Jheon S, Lee KW. New TNM staging system for esophageal cancer: what chest radiologists need to know. Radiographics 2014;34:1722-40. [PMID: 25310426 DOI: 10.1148/rg.346130079] [Cited by in Crossref: 48] [Cited by in F6Publishing: 32] [Article Influence: 6.9] [Reference Citation Analysis]
357 Fennerty MB. Endoscopic diagnosis and surveillance of Barrett's esophagus. Gastrointest Endosc Clin N Am. 2003;13:257-267. [PMID: 12916658 DOI: 10.1016/s1052-5157(03)00010-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
358 Meluch AA, Greco FA, Gray JR, Thomas M, Sutton VM, Davis JL, Kalman LA, Shaffer DW, Yost K, Rinaldi DA, Hainsworth JD. Preoperative Therapy with Concurrent Paclitaxel/Carboplatin/Infusional 5-FU and Radiation Therapy in Locoregional Esophageal Cancer: Final Results of a Minnie Pearl Cancer Research Network Phase II Trial. The Cancer Journal 2003;9:251-60. [DOI: 10.1097/00130404-200307000-00007] [Cited by in Crossref: 79] [Cited by in F6Publishing: 78] [Article Influence: 4.2] [Reference Citation Analysis]
359 Niu WX, Qin XY, Liu H, Wang CP. Clinicopathological analysis of patients with gastric cancer in 1200 cases. World J Gastroenterol 2001; 7(2): 281-284 [PMID: 11819775 DOI: 10.3748/wjg.v7.i2.281] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 29] [Article Influence: 1.3] [Reference Citation Analysis]
360 Breyer HP, Silva De Barros SG, Maguilnik I, Edelweiss MI. Does methylene blue detect intestinal metaplasia in Barrett’s esophagus? Gastrointest Endosc. 2003;57:505-509. [PMID: 12665760 DOI: 10.1067/mge.2003.137] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 1.7] [Reference Citation Analysis]
361 Meyer HJ, J�hne J, Wilke H. Perspectives of surgery and multimodality treatment in gastric carcinoma. J Cancer Res Clin Oncol 1993;119:384-94. [DOI: 10.1007/bf01218419] [Cited by in Crossref: 16] [Article Influence: 0.6] [Reference Citation Analysis]
362 Fletcher J, Wirz A, Young J, Vallance R, McColl KE. Unbuffered highly acidic gastric juice exists at the gastroesophageal junction after a meal. Gastroenterology. 2001;121:775-783. [PMID: 11606490 DOI: 10.1053/gast.2001.27997] [Cited by in Crossref: 215] [Cited by in F6Publishing: 185] [Article Influence: 10.2] [Reference Citation Analysis]
363 Lindblad M, Rodríguez LA, Lagergren J. Body mass, tobacco and alcohol and risk of esophageal, gastric cardia, and gastric non-cardia adenocarcinoma among men and women in a nested case-control study. Cancer Causes Control. 2005;16:285-294. [PMID: 15947880 DOI: 10.1007/s10552-004-3485-7] [Cited by in Crossref: 198] [Cited by in F6Publishing: 167] [Article Influence: 11.6] [Reference Citation Analysis]
364 Casson AG, Kerkvliet N, O'malley F. Prognostic value of p53 protein in esophageal adenocarcinoma. J Surg Oncol 1995;60:5-11. [DOI: 10.1002/jso.2930600103] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 0.7] [Reference Citation Analysis]
365 Iijima K, Shimosegawa T. Involvement of luminal nitric oxide in the pathogenesis of the gastroesophageal reflux disease spectrum: Nitric oxide and esophagus. J Gastroenterol Hepatol 2014;29:898-905. [DOI: 10.1111/jgh.12548] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
366 Smythe A, Troy GP, Ackroyd R, Bird NC. Proton pump inhibitor influence on reflux in Barrettʼs oesophagus: . European Journal of Gastroenterology & Hepatology 2008;20:881-7. [DOI: 10.1097/meg.0b013e3282f9b221] [Cited by in Crossref: 5] [Article Influence: 0.4] [Reference Citation Analysis]
367 Cheng KK, Day NE. Nutrition and esophageal cancer. Cancer Causes Control 1996;7:33-40. [DOI: 10.1007/bf00115636] [Cited by in Crossref: 58] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
368 Murphy SJ, Anderson LA, Ferguson HR, Johnston BT, Watson PR, McGuigan J, Comber H, Reynolds JV, Murray LJ, Cantwell MM. Dietary antioxidant and mineral intake in humans is associated with reduced risk of esophageal adenocarcinoma but not reflux esophagitis or Barrett’s esophagus. J Nutr. 2010;140:1757-1763. [PMID: 20702746 DOI: 10.3945/jn.110.124362] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 3.5] [Reference Citation Analysis]
369 Park JC, Lee YC, Kim JH, Kim YJ, Lee SK, Shin SK, Hyung WJ, Noh SH, Kim CB. Clinicopathological features and prognostic factors of proximal gastric carcinoma in a population with high Helicobacter pylori prevalence: a single-center, large-volume study in Korea. Ann Surg Oncol. 2010;17:829-837. [PMID: 19882188 DOI: 10.1245/s10434-009-0785-x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
370 Delaney BC. Review article: prevalence and epidemiology of gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2004;20 Suppl 8:2-4. [PMID: 15575863 DOI: 10.1111/j.1365-2036.2004.02219.x] [Cited by in Crossref: 52] [Cited by in F6Publishing: 45] [Article Influence: 3.1] [Reference Citation Analysis]
371 Vial M, Grande L, Pera M. Epidemiology of adenocarcinoma of the esophagus, gastric cardia, and upper gastric third. Recent Results Cancer Res. 2010;182:1-17. [PMID: 20676867 DOI: 10.1007/978-3-540-70579-6_1] [Cited by in Crossref: 42] [Cited by in F6Publishing: 52] [Article Influence: 3.5] [Reference Citation Analysis]
372 Hansson LE, Sparén P, Nyrén O. Increasing incidence of carcinoma of the gastric cardia in Sweden from 1970 to 1985. Br J Surg. 1993;80:374-377. [PMID: 8472157 DOI: 10.1002/bjs.1800800338] [Cited by in Crossref: 97] [Cited by in F6Publishing: 94] [Article Influence: 3.3] [Reference Citation Analysis]
373 Iijima K, Shimosegawa T. Gastric carditis: Is it a histological response to high concentrations of luminal nitric oxide? World J Gastroenterol 2006; 12(36): 5767-5771 [PMID: 17007040 DOI: 10.3748/wjg.v12.i36.5767] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
374 Catalano V, Labianca R, Beretta GD, Gatta G, de Braud F, Van Cutsem E. Gastric cancer. Critical Reviews in Oncology/Hematology 2009;71:127-64. [DOI: 10.1016/j.critrevonc.2009.01.004] [Cited by in Crossref: 266] [Cited by in F6Publishing: 262] [Article Influence: 20.5] [Reference Citation Analysis]
375 Derakhshan MH, Arnold M, Brewster DH, Going JJ, Mitchell DR, Forman D, Mccoll KEL. Worldwide Inverse Association between Gastric Cancer and Esophageal Adenocarcinoma Suggesting a Common Environmental Factor Exerting Opposing Effects. American Journal of Gastroenterology 2016;111:228-39. [DOI: 10.1038/ajg.2015.405] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
376 Gerbaudo VH, Killoran JH, Kim CK, Hornick JL, Nowak JA, Enzinger PC, Mamon HJ. Pilot study of serial FLT and FDG-PET/CT imaging to monitor response to neoadjuvant chemoradiotherapy of esophageal adenocarcinoma: correlation with histopathologic response. Ann Nucl Med 2018;32:165-74. [PMID: 29332233 DOI: 10.1007/s12149-018-1229-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
377 Weinstein WM. Precursor Lesions for Cancer of the Cardia. Gastrointestinal Endoscopy Clinics of North America 1997;7:19-28. [DOI: 10.1016/s1052-5157(18)30320-9] [Cited by in Crossref: 9] [Article Influence: 0.4] [Reference Citation Analysis]
378 Kendall C, Stone N, Shepherd N, Geboes K, Warren B, Bennett R, Barr H. Raman spectroscopy, a potential tool for the objective identification and classification of neoplasia in Barrett's oesophagus. J Pathol 2003;200:602-9. [DOI: 10.1002/path.1376] [Cited by in Crossref: 177] [Cited by in F6Publishing: 160] [Article Influence: 9.3] [Reference Citation Analysis]
379 Wang XJ, Yuan SL, Li CP, Iida N, Oda H, Aiso S, Ishikawa T. Infrequent p53 gene mutation and expression of the cardia adenocarcinomas from a high-incidence area of Southwest China. World J Gastroenterol 2000; 6(5): 750-753 [PMID: 11819688 DOI: 10.3748/wjg.v6.i5.750] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
380 Barr H, Kendall C, Stone N. Photodynamic therapy for esophageal cancer: a useful and realistic option. Technol Cancer Res Treat 2003;2:65-76. [PMID: 12625755 DOI: 10.1177/153303460300200108] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
381 Sharma P, Jaffe PE, Bhattacharyya A, Sampliner RE. Laser and multipolar electrocoagulation ablation of early Barrett’s adenocarcinoma: long-term follow-up. Gastrointest Endosc. 1999;49:442-446. [PMID: 10202056 DOI: 10.1016/s0016-5107(99)70040-4] [Cited by in Crossref: 55] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
382 Martin S, Chen JZ, Rashid Dar A, Yartsev S. Dosimetric comparison of helical tomotherapy, RapidArc, and a novel IMRT & Arc technique for esophageal carcinoma. Radiother Oncol 2011;101:431-7. [PMID: 21962823 DOI: 10.1016/j.radonc.2011.08.030] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 4.1] [Reference Citation Analysis]
383 Fennerty MB, Sampliner RE, Garewal HS. Barrett's oesophagus-cancer risk, biology and therapeutic management. Alimentary Pharmacology & Therapeutics 1993;7:339-45. [DOI: 10.1111/j.1365-2036.1993.tb00107.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 1.4] [Reference Citation Analysis]
384 Talley NJ. Review article: gastro-oesophageal reflux disease -- how wide is its span? Aliment Pharmacol Ther. 2004;20 Suppl 5:27-37; discussion 38-9. [PMID: 15456461 DOI: 10.1111/j.1365-2036.2004.02134.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
385 Saltz L, Kelsen D. Combined-modality therapy in the treatment of local-regional esophageal cancer. Annals of Oncology 1992;3:793-9. [DOI: 10.1093/oxfordjournals.annonc.a058098] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.2] [Reference Citation Analysis]
386 Rudi J, Müller M, von Herbay A, Zuna I, Raedsch R, Stremmel W, Räth U. Lack of association of Helicobacter pylori seroprevalence and gastric cancer in a population with low gastric cancer incidence. Scand J Gastroenterol. 1995;30:958-963. [PMID: 8545615 DOI: 10.3109/00365529509096338] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 1.0] [Reference Citation Analysis]
387 Rigberg DA, Blinman TA, Kim FS, Cole MA, McFadden DW. Antisense blockade of p21/WAF1 decreases radiation-induced G2 arrest in esophageal squamous cell carcinoma. J Surg Res 1999;81:6-10. [PMID: 9889049 DOI: 10.1006/jsre.1998.5483] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
388 Wolf C, Seldenrijk CA, Timmer R, Breumelhof R, Smout AJ. Epidemiological, clinical, and histological characteristics of intestinal metaplasia at the oesophagogastric junction compared to short segments of columnar-lined oesophagus. Eur J Gastroenterol Hepatol 2001;13:113-20. [PMID: 11246609 DOI: 10.1097/00042737-200102000-00005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
389 Mountford CE, Doran S, Lean CL, Russell P. Proton MRS Can Determine the Pathology of Human Cancers with a High Level of Accuracy. Chem Rev 2004;104:3677-704. [DOI: 10.1021/cr030410g] [Cited by in Crossref: 52] [Cited by in F6Publishing: 46] [Article Influence: 2.9] [Reference Citation Analysis]
390 Sihvo EI, Salminen JT, Rantanen TK, Rämö OJ, Ahotupa M, Färkkilä M, Auvinen MI, Salo JA. Oxidative stress has a role in malignant transformation in Barrett's oesophagus. Int J Cancer. 2002;102:551-555. [PMID: 12447994 DOI: 10.1002/ijc.10755] [Cited by in Crossref: 68] [Cited by in F6Publishing: 68] [Article Influence: 3.4] [Reference Citation Analysis]
391 Powell AGMT, Hughes DL, Brown J, Larsen M, Witherspoon J, Lewis WG. Esophageal cancer's 100 most influential manuscripts: a bibliometric analysis. Diseases of the Esophagus 2017;30:1-8. [DOI: 10.1093/dote/dow039] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
392 Archer V, Mulholland P, Stocken D, Darnton S, Ferry D. Combined Results from Three Phase II Trials of Neoadjuvant Chemotherapy in Operable Adenocarcinoma of the Oesophagus. Clinical Oncology 2001;13:164-9. [DOI: 10.1053/clon.2001.9246] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
393 Ye W, Chow W, Lagergren J, Yin L, Nyrén O. Risk of adenocarcinomas of the esophagus and gastric cardia in patients with gastroesophageal reflux diseases and after antireflux surgery. Gastroenterology 2001;121:1286-93. [DOI: 10.1053/gast.2001.29569] [Cited by in Crossref: 176] [Cited by in F6Publishing: 158] [Article Influence: 8.4] [Reference Citation Analysis]
394 Grotenhuis BA, van Lanschot JJ, Dinjens WN, Wijnhoven BP. The pathogenesis of Barrett’s metaplasia and the progression to esophageal adenocarcinoma. Recent Results Cancer Res. 2010;182:39-63. [PMID: 20676870 DOI: 10.1007/978-3-540-70579-6_4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
395 Reynolds JV, Ravi N, Hollywood D, Kennedy MJ, Rowley S, Ryan A, Hughes N, Carey M, Byrne P. Neoadjuvant chemoradiation may increase the risk of respiratory complications and sepsis after transthoracic esophagectomy. The Journal of Thoracic and Cardiovascular Surgery 2006;132:549-55. [DOI: 10.1016/j.jtcvs.2006.05.015] [Cited by in Crossref: 80] [Cited by in F6Publishing: 73] [Article Influence: 5.0] [Reference Citation Analysis]
396 Haruta S, Shinohara H, Hosogi H, Ohkura Y, Kobayashi N, Mizuno A, Okamura R, Ueno M, Sakai Y, Udagawa H. Proximal gastrectomy with exclusion of no. 3b lesser curvature lymph node dissection could be indicated for patients with advanced upper-third gastric cancer. Gastric Cancer 2017;20:528-35. [DOI: 10.1007/s10120-016-0624-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
397 Junfeng Z, Yingxue H, Peiwu Y. Systematic review of risk factors for metastasis to para-aortic lymph nodes in gastric cancer. Surg Oncol. 2013;22:210-216. [PMID: 24269310 DOI: 10.1016/j.suronc.2013.10.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
398 Hölscher AH, Bollschweiler E, Schneider PM, Siewert JR. Early adenocarcinoma in Barrett's oesophagus. Br J Surg. 1997;84:1470-1473. [PMID: 9361616 DOI: 10.1002/bjs.1800841035] [Cited by in Crossref: 119] [Cited by in F6Publishing: 74] [Article Influence: 4.8] [Reference Citation Analysis]
399 Matsuzaki J, Suzuki H, Tsugawa H, Watanabe M, Hossain S, Arai E, Saito Y, Sekine S, Akaike T, Kanai Y. Bile acids increase levels of microRNAs 221 and 222, leading to degradation of CDX2 during esophageal carcinogenesis. Gastroenterology. 2013;145:1300-1311. [PMID: 23933602 DOI: 10.1053/j.gastro.2013.08.008] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 4.4] [Reference Citation Analysis]
400 de Jonge PJ, van Blankenstein M, Looman CW, Casparie MK, Meijer GA, Kuipers EJ. Risk of colorectal cancer in patients with Barrett's esophagus: A Dutch population-based study. Am J Gastroenterol 2010;105:77-83. [PMID: 19724268 DOI: 10.1038/ajg.2009.503] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
401 Fareed KR, Kaye P, Soomro IN, Ilyas M, Martin S, Parsons SL, Madhusudan S. Biomarkers of response to therapy in oesophago-gastric cancer. Gut. 2009;58:127-143. [PMID: 19091831 DOI: 10.1111/j.1365-2559.2009.03404.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 2.2] [Reference Citation Analysis]
402 Li Y, Wo JM, Cai L, Zhou Z, Rosenbaum D, Mendez C, Ray MB, Jones WF, Kang YJ. Association of Metallothionein Expression and Lack of Apoptosis with Progression of Carcinogenesis in Barrett's Esophagus. Exp Biol Med (Maywood) 2003;228:286-92. [DOI: 10.1177/153537020322800307] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
403 Wang RH. From reflux esophagitis to Barrett’s esophagus and esophageal adenocarcinoma. World J Gastroenterol 2015; 21(17): 5210-5219 [PMID: 25954094 DOI: 10.3748/wjg.v21.i17.5210] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
404 Amano Y, Kushiyama Y, Yuki T, Takahashi Y, Moriyama I, Fukuhara H, Ishimura N, Furuta K, Ishihara S, Adachi K. Prevalence of and risk factors for Barrett’s esophagus with intestinal predominant mucin phenotype. Scand J Gastroenterol. 2006;41:873-879. [PMID: 16803684 DOI: 10.1080/00365520500535485] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 2.1] [Reference Citation Analysis]
405 Fein M, Peters JH, Baril N, McGarvey M, Chandrasoma P, Shibata D, Laird PW, Skinner KA. Loss of function of Trp53, but not Apc, leads to the development of esophageal adenocarcinoma in mice with jejunoesophageal reflux. J Surg Res 1999;83:48-55. [PMID: 10210642 DOI: 10.1006/jsre.1998.5559] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
406 Kroep J, Pinedo H, Giaccone G, Van Bochove A, Peters G, Van Groeningen C. Phase II study of cisplatin preceding gemcitabine in patients with advanced oesophageal cancer. Annals of Oncology 2004;15:230-5. [DOI: 10.1093/annonc/mdh063] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
407 Ajani JA, Komaki R, Putnam JB, Walsh G, Nesbitt J, Pisters PW, Lynch PM, Vaporciyan A, Smythe R, Lahoti S, Raijman I, Swisher S, Martin FD, Roth JA. A three-step strategy of induction chemotherapy then chemoradiation followed by surgery in patients with potentially resectable carcinoma of the esophagus or gastroesophageal junction. Cancer 2001;92:279-86. [PMID: 11466680 DOI: 10.1002/1097-0142(20010715)92:2<279::aid-cncr1320>3.0.co;2-2] [Cited by in Crossref: 91] [Cited by in F6Publishing: 23] [Article Influence: 4.3] [Reference Citation Analysis]
408 Oniscu GC, Paterson-Brown S. Trends in oesophago-gastric surgery in Scotland. Surgeon 2003;1:51-7. [PMID: 15568427 DOI: 10.1016/s1479-666x(03)80011-2] [Reference Citation Analysis]
409 Daly JM, Karnell LH, Menck HR. National Cancer Data Base report on esophageal carcinoma. Cancer 1996;78:1820-8. [PMID: 8859198 DOI: 10.1002/(sici)1097-0142(19961015)78:8<1820::aid-cncr25>3.0.co;2-z] [Cited by in Crossref: 216] [Cited by in F6Publishing: 64] [Article Influence: 8.3] [Reference Citation Analysis]
410 Levine MS, Herman JB, Furth EE. Barrett's esophagus and esophageal adenocarcinoma: the scope of the problem. Abdom Imaging 1995;20:291-8. [DOI: 10.1007/bf00203356] [Cited by in Crossref: 9] [Article Influence: 0.3] [Reference Citation Analysis]
411 Caygill CP, Zaninotto G, Rugge M. Barrett's Registries in Europe: report of an International Workshop. European Journal of Cancer Prevention 2008;17:426-9. [DOI: 10.1097/cej.0b013e3282f75f79] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
412 Sihvo EI, Ruohtula T, Auvinen MI, Koivistoinen A, Harjula AL, Salo JA. Simultaneous progression of oxidative stress and angiogenesis in malignant transformation of Barrett esophagus. J Thorac Cardiovasc Surg 2003;126:1952-7. [PMID: 14688711 DOI: 10.1016/j.jtcvs.2003.08.014] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 1.8] [Reference Citation Analysis]
413 Goldblum JR. Gastric Cardia: Controversial Topics: . Pathology Case Reviews 2002;7:12-8. [DOI: 10.1097/00132583-200201000-00003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
414 Genta RM, Huberman RM, Graham DY. The gastric cardia in Helicobacter pylori infection. Hum Pathol. 1994;25:915-919. [PMID: 8088767 DOI: 10.1016/0046-8177(94)90011-6] [Cited by in Crossref: 111] [Cited by in F6Publishing: 111] [Article Influence: 4.0] [Reference Citation Analysis]
415 Walker MM, Talley NJ. Review article: bacteria and pathogenesis of disease in the upper gastrointestinal tract--beyond the era of Helicobacter pylori. Aliment Pharmacol Ther. 2014;39:767-779. [PMID: 24612362 DOI: 10.1111/apt.12666] [Cited by in Crossref: 65] [Cited by in F6Publishing: 56] [Article Influence: 8.1] [Reference Citation Analysis]
416 Vizcaino AP, Moreno V, Lambert R, Parkin DM. Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973-1995. Int J Cancer. 2002;99:860-868. [PMID: 12115489 DOI: 10.1002/ijc.10427] [Cited by in Crossref: 287] [Cited by in F6Publishing: 269] [Article Influence: 14.4] [Reference Citation Analysis]
417 Nakamura T, Nekarda H, Hoelscher AH, Bollschweiler E, Harbeck N, Becker K, Siewert JR, Harbec N [corrected to Harbeck N]. Prognostic value of DNA ploidy and c-erbB-2 oncoprotein overexpression in adenocarcinoma of Barrett's esophagus. Cancer 1994;73:1785-94. [PMID: 7907940 DOI: 10.1002/1097-0142(19940401)73:7<1785::aid-cncr2820730703>3.0.co;2-0] [Cited by in Crossref: 85] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
418 Malfertheiner P, Hallerbäck B. Clinical manifestations and complications of gastroesophageal reflux disease (GERD). Int J Clin Pract. 2005;59:346-355. [PMID: 15857335 DOI: 10.1111/j.1742-1241.2005.00370.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 45] [Article Influence: 3.4] [Reference Citation Analysis]
419 Kim R, Rose S, Shar AO, Weiner M, Reynolds JC. Extent of Barrett's metaplasia: a prospective study of the serial change in area of Barrett's measured by quantitative endoscopic imaging. Gastrointestinal Endoscopy 1997;45:456-62. [DOI: 10.1016/s0016-5107(97)70173-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
420 Rigberg DA, Kim FS, Blinman TA, Cole MA, Lane JS, So J, Mcfadden DW. p21 Expression Is Increased by Irradiation in Esophageal Squamous Cell Carcinoma. Journal of Surgical Research 1998;76:137-42. [DOI: 10.1006/jsre.1998.5308] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
421 Macdonald WC, Owen DA. Gastric carcinoma after surgical treatment of peptic ulcer: An analysis of morphologic features and a comparison with cancer in the nonoperated stomach. Cancer 2001;91:1732-8. [DOI: 10.1002/1097-0142(20010501)91:9<1732::aid-cncr1191>3.0.co;2-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
422 Sano T. Adjuvant and neoadjuvant therapy of gastric cancer: A comparison of three pivotal studies. Curr Oncol Rep 2008;10:191-8. [DOI: 10.1007/s11912-008-0030-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
423 Brenes F, Correa P. Pathology of Gastric Cancer. Surgical Oncology Clinics of North America 1993;2:347-70. [DOI: 10.1016/s1055-3207(18)30561-1] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
424 Kumanyika S. Racial and Ethnic Issues in Diet and Cancer Epidemiology. In: Jacobs MM, editor. Diet and Cancer. Boston: Springer US; 1994. pp. 59-70. [DOI: 10.1007/978-1-4899-0939-8_4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
425 Lloyd GR, Almond LM, Stone N, Shepherd N, Sanders S, Hutchings J, Barr H, Kendall C. Utilising non-consensus pathology measurements to improve the diagnosis of oesophageal cancer using a Raman spectroscopic probe. Analyst 2014;139:381-8. [DOI: 10.1039/c3an01163a] [Cited by in Crossref: 16] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
426 Tanaka N, Horiuchi A, Yokoyama T, Kawa S, Kiyosawa K. Pancreatic exocrine insufficiency: a rare cause of nonalcoholic steatohepatitis. Am J Gastroenterol 2008;103:245-6. [PMID: 18184133 DOI: 10.1111/j.1572-0241.2007.01562_7.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
427 Lehrbach DM, Cecconello I, Ribeiro U Jr, Capelozzi VL, Ab'saber AM, Alves VA. Adenocarcinoma of the esophagogastric junction: relationship between clinicopathological data and p53, cyclin D1 and Bcl-2 immunoexpressions. Arq Gastroenterol. 2009;46:315-320. [PMID: 20232013 DOI: 10.1590/S0004-28032009000400013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
428 Miller JA, Rege RV, Ko CY, Livingston EH. Health care access and poverty do not explain the higher esophageal cancer mortality in African Americans. Am J Surg 2004;188:22-6. [PMID: 15219480 DOI: 10.1016/j.amjsurg.2003.12.055] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
429 Inoue M, Tajima K, Hirose K, Kuroishi T, Gao CM, Kitoh T. Life-style and subsite of gastric cancer--joint effect of smoking and drinking habits. Int J Cancer. 1994;56:494-499. [PMID: 8112885 DOI: 10.1002/ijc.2910560407] [Cited by in Crossref: 97] [Cited by in F6Publishing: 87] [Article Influence: 3.5] [Reference Citation Analysis]
430 Gao S, Brown J, Wang H, Feng X. The role of glycogen synthase kinase 3-β in immunity and cell cycle: implications in esophageal cancer. Arch Immunol Ther Exp (Warsz) 2014;62:131-44. [PMID: 24276788 DOI: 10.1007/s00005-013-0263-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
431 Cen P, Correa AM, Le JH, Maru D, Anandasabapathy S, Liao Z, Hofstetter WL, Swisher SG, Komaki R, Ross WA, Vaporciyan A, Ajani JA. Adenocarcinoma of the lower esophagus with Barrett's esophagus or without Barrett's esophagus: differences in patients' survival after preoperative chemoradiation. Diseases of the Esophagus 2009;22:32-41. [DOI: 10.1111/j.1442-2050.2008.00881.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
432 Sawyers JL. Gastric carcinoma. Current Problems in Surgery 1995;32:101-78. [DOI: 10.1016/s0011-3840(05)80009-7] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
433 Dickman R, Green C, Chey WD, Jones MP, Eisen GM, Ramirez F, Briseno M, Garewal HS, Fass R. Clinical predictors of Barrett's esophagus length. Gastrointestinal Endoscopy 2005;62:675-81. [DOI: 10.1016/j.gie.2005.05.019] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
434 Rajabi B, Corral JC, Hakim N, Mulla ZD. Descriptive epidemiology of gastric adenocarcinoma in the State of Texas by ethnicity: Hispanic versus White non-Hispanic. Gastric Cancer 2012;15:405-13. [DOI: 10.1007/s10120-011-0127-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
435 Shim JH, Song KY, Jeon HM, Park CH, Jacks LM, Gonen M, Shah MA, Brennan MF, Coit DG, Strong VE. Is gastric cancer different in Korea and the United States? Ann Surg Oncol. 2014;21:2332-2339. [PMID: 24599411 DOI: 10.1245/s10434-014-3608-7] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 4.6] [Reference Citation Analysis]
436 Créhange G, Maingon P, Bosset JF. [Radiochemotherapy for oesophageal cancer: a locoregional failure history]. Cancer Radiother 2008;12:640-8. [PMID: 18845466 DOI: 10.1016/j.canrad.2008.09.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
437 Edgren G, Adami HO, Weiderpass E, Nyrén O. A global assessment of the oesophageal adenocarcinoma epidemic. Gut. 2013;62:1406-1414. [PMID: 22917659 DOI: 10.1136/gutjnl-2012-302412] [Cited by in Crossref: 206] [Cited by in F6Publishing: 192] [Article Influence: 20.6] [Reference Citation Analysis]
438 La Vecchia C, Negri E, Lagiou P, Trichopoulos D. Oesophageal adenocarcinoma: A paradigm of mechanical carcinogenesis? Int J Cancer 2002;102:269-70. [DOI: 10.1002/ijc.10697] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.2] [Reference Citation Analysis]
439 O'Reilly S, Forastiere AA. Is surgery necessary with multimodality treatment of oesophageal cancer. Ann Oncol 1995;6:519-21. [PMID: 8573528 DOI: 10.1093/oxfordjournals.annonc.a059237] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 0.7] [Reference Citation Analysis]
440 Armstrong D. Should patients with Barrett's oesophagus be kept under surveillance? The case for. Best Pract Res Clin Gastroenterol 2008;22:721-39. [PMID: 18656826 DOI: 10.1016/j.bpg.2008.03.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
441 Coia LR, Minsky BD, Berkey BA, John MJ, Haller D, Landry J, Pisansky TM, Willett CG, Hoffman JP, Owen JB, Hanks GE. Outcome of Patients Receiving Radiation for Cancer of the Esophagus: Results of the 1992-1994 Patterns of Care Study. JCO 2000;18:455-455. [DOI: 10.1200/jco.2000.18.3.455] [Cited by in Crossref: 117] [Cited by in F6Publishing: 30] [Article Influence: 5.3] [Reference Citation Analysis]
442 Guenther T, Hackelsberger A, Kuester D, Malfertheiner P, Roessner A. Reflux esophagitis or Helicobacter infection? - diagnostic value of the inflammatory pattern in metaplastic mucosa at the squamocolumnar junction. Pathol Res Pract 2007;203:831-7. [PMID: 17993370 DOI: 10.1016/j.prp.2007.09.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
443 Flood WA, Forastiere AA. Esophageal cancer. Cancer Treat Res. 1998;98:1-40. [PMID: 10326663 DOI: 10.1007/978-1-4615-4977-2_1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
444 Bollschweiler E, Wolfgarten E, Gutschow C, Hölscher AH. Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer 2001;92:549-55. [PMID: 11505399 DOI: 10.1002/1097-0142(20010801)92:3<549::aid-cncr1354>3.0.co;2-l] [Cited by in Crossref: 303] [Cited by in F6Publishing: 126] [Article Influence: 14.4] [Reference Citation Analysis]
445 Calais G. [Concomitant chemoradiotherapy of cancer of the esophagus]. Cancer Radiother 1998;2:689-95. [PMID: 9922774 DOI: 10.1016/s1278-3218(99)80009-2] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
446 Iwagami H, Ishihara R, Aoyama K, Fukuda H, Shimamoto Y, Kono M, Nakahira H, Matsuura N, Shichijo S, Kanesaka T, Kanzaki H, Ishii T, Nakatani Y, Tada T. Artificial intelligence for the detection of esophageal and esophagogastric junctional adenocarcinoma. J Gastroenterol Hepatol. 2021;36:131-136. [PMID: 32511793 DOI: 10.1111/jgh.15136] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
447 Markar SR, Arhi C, Leusink A, Vidal-diez A, Karthikesalingam A, Darzi A, Lagergren J, Hanna GB. The Influence of Antireflux Surgery on Esophageal Cancer Risk in England: National Population-based Cohort Study. Annals of Surgery 2018;268:861-7. [DOI: 10.1097/sla.0000000000002890] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
448 Crookes PF, Incarbone R, Peters JH, Engle S, Bremner CG, Demeester TR. A selective therapeutic approach to gastric cancer in a large public hospital. The American Journal of Surgery 1995;170:602-5. [DOI: 10.1016/s0002-9610(99)80024-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
449 Fass R, Sampliner RE. Barrett??s Oesophagus: Optimal Strategies for Prevention and Treatment. Drugs 2003;63:555-64. [DOI: 10.2165/00003495-200363060-00003] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
450 Dickman R, Kim JL, Camargo L, Green SB, Sampliner RE, Garewal HS, Fass R. Correlation of gastroesophageal reflux disease symptoms characteristics with long-segment Barrett’s esophagus. Dis Esophagus. 2006;19:360-365. [PMID: 16984533 DOI: 10.1111/j.1442-2050.2006.00606.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
451 Schmassmann A, Oldendorf M, Gebbers J. Changing incidence of gastric and oesophageal cancer subtypes in central Switzerland between 1982 and 2007. Eur J Epidemiol 2009;24:603-9. [DOI: 10.1007/s10654-009-9379-y] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
452 Perelman LT. Optical diagnostic technology based on light scattering spectroscopy for early cancer detection. Expert Rev Med Devices 2006;3:787-803. [PMID: 17280544 DOI: 10.1586/17434440.3.6.787] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
453 Swisher SG, Pisters PWT, Komaki R, Lahoti S, Ajani JA. Gastroesophageal junction adenocarcinoma. Curr Treat Options in Oncol 2000;1:387-98. [DOI: 10.1007/s11864-000-0066-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
454 Wr�blewski S, Berenson M, Kope?kov� P, Kope?ek J. Biorecognition of HPMA copolymer-lectin conjugates as an indicator of differentiation of cell-surface glycoproteins in development, maturation, and diseases of human and rodent gastrointestinal tissues. J Biomed Mater Res 2000;51:329-42. [DOI: 10.1002/1097-4636(20000905)51:3<329::aid-jbm6>3.0.co;2-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
455 Faybush EM, Sampliner RE. Randomized trials in the treatment of Barrett's esophagus. Dis Esophagus 2005;18:291-7. [PMID: 16197527 DOI: 10.1111/j.1442-2050.2005.00503.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
456 Shimada K, Ajani JA. Adjuvant therapy for gastric carcinoma patients in the past 15 years: A review of Western and Oriental trials. Cancer 1999;86:1657-68. [DOI: 10.1002/(sici)1097-0142(19991101)86:9<1657::aid-cncr6>3.0.co;2-j] [Cited by in Crossref: 37] [Article Influence: 1.6] [Reference Citation Analysis]
457 Kara MA, Smits ME, Rosmolen WD, Bultje AC, Ten Kate FJ, Fockens P, Tytgat GN, Bergman JJ. A randomized crossover study comparing light-induced fluorescence endoscopy with standard videoendoscopy for the detection of early neoplasia in Barrett’s esophagus. Gastrointest Endosc. 2005;61:671-678. [PMID: 15855970 DOI: 10.1016/s0016-5107(04)02777-4] [Cited by in Crossref: 80] [Cited by in F6Publishing: 20] [Article Influence: 4.7] [Reference Citation Analysis]
458 Peters FP, Kara MA, Rosmolen WD, Aalders MC, Ten Kate FJ, Bultje BC, Krishnadath KK, Fockens P, van Lanschot JJ, van Deventer SJ. Endoscopic treatment of high-grade dysplasia and early stage cancer in Barrett’s esophagus. Gastrointest Endosc. 2005;61:506-514. [PMID: 15812401 DOI: 10.1016/s0016-5107(05)00063-5] [Cited by in Crossref: 124] [Cited by in F6Publishing: 36] [Article Influence: 7.3] [Reference Citation Analysis]
459 Heath EI, Burtness BA, Heitmiller RF, Salem R, Kleinberg L, Knisely JP, Yang SC, Talamini MA, Kaufman HS, Canto MI, Topazian M, Wu TT, Olukayode K, Forastiere AA. Phase II evaluation of preoperative chemoradiation and postoperative adjuvant chemotherapy for squamous cell and adenocarcinoma of the esophagus. J Clin Oncol 2000;18:868-76. [PMID: 10673530 DOI: 10.1200/JCO.2000.18.4.868] [Cited by in Crossref: 109] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
460 Forastiere AA, Heitmiller RF, Kleinberg L. Multimodality Therapy for Esophageal Cancer. Chest 1997;112:195S-200S. [DOI: 10.1378/chest.112.4_supplement.195s] [Cited by in Crossref: 30] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
461 Ramos-Suzarte M, Lorenzo-Luaces P, Lazo NG, Perez ML, Soriano JL, Gonzalez CE, Hernadez IM, Albuerne YÁ, Moreno BP, Alvarez ES, Callejo IP, Alert J, Martell JA, Gonzalez YS, Gonzalez YS, Astudillo de la Vega H, Ruiz-Garcia EB, Ramos TC. Treatment of malignant, non-resectable, epithelial origin esophageal tumours with the humanized anti-epidermal growth factor antibody nimotuzumab combined with radiation therapy and chemotherapy. Cancer Biol Ther 2012;13:600-5. [PMID: 22555809 DOI: 10.4161/cbt.19849] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 4.0] [Reference Citation Analysis]
462 Gisbert JP, María Pajares J. Prevalencia de la infección por Helicobacter pylori en la enfermedad por reflujo gastroesofágico y en el esófago de Barrett: revisión sistemática y metaanálisis. Medicina Clínica 2002;119:217-23. [DOI: 10.1016/s0025-7753(02)73368-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
463 Yousef F, Cardwell C, Cantwell MM, Galway K, Johnston BT, Murray L. The incidence of esophageal cancer and high-grade dysplasia in Barrett’s esophagus: a systematic review and meta-analysis. Am J Epidemiol. 2008;168:237-249. [PMID: 18550563 DOI: 10.1093/aje/kwn121] [Cited by in Crossref: 273] [Cited by in F6Publishing: 232] [Article Influence: 19.5] [Reference Citation Analysis]
464 Buskens CJ, Westerterp M, Lagarde SM, Bergman JJ, ten Kate FJ, van Lanschot JJ. Prediction of appropriateness of local endoscopic treatment for high-grade dysplasia and early adenocarcinoma by EUS and histopathologic features. Gastrointest Endosc. 2004;60:703-710. [PMID: 15557945 DOI: 10.1016/s0016-5107(04)02017-6] [Cited by in Crossref: 176] [Cited by in F6Publishing: 57] [Article Influence: 10.4] [Reference Citation Analysis]
465 Kakar S, Burgart LJ. Adenocarcinoma of the Esophagus and Gastric Cardia: Two Diseases or One?: . Pathology Case Reviews 2002;7:43-7. [DOI: 10.1097/00132583-200201000-00007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
466 Moore JH, Lesser EJ, Erdody DH, Natale RB, Orringer MB, Beer DG. Intestinal differentiation and p53 gene alterations in Barrett’s esophagus and esophageal adenocarcinoma. Int J Cancer. 1994;56:487-493. [PMID: 7906678 DOI: 10.1002/ijc.2910560406] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 1.5] [Reference Citation Analysis]
467 Yang K, Cho M, Roh CK, Seo WJ, Choi S, Son T, Kim H, Hyung WJ. Robotic spleen-preserving splenic hilar lymph node dissection during total gastrectomy for gastric cancer. Surg Endosc 2019;33:2357-63. [DOI: 10.1007/s00464-019-06772-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
468 Schraub S, Bourgeois P, Mercier M. Cancer incidence registration and trends in the department of Doubs, France. European Journal of Cancer 1992;28:1759-60. [DOI: 10.1016/0959-8049(92)90085-g] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
469 Kubba A, Macintyre I. Gastric cancer distal to the cardia—prevention or cure? Surgical Oncology 1997;6:111-24. [DOI: 10.1016/s0960-7404(97)00011-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
470 Marzo M, Alonso P, Bonfill X, Fernández M, Fernández J, Martínez G, Mearín F, Mascort J, Piqué J, Ponce J, Sáez M. Guía de práctica clínica sobre el manejo del paciente con enfermedad por reflujo gastroesofágico (ERGE). Gastroenterología y Hepatología 2002;25:85-110. [DOI: 10.1016/s0210-5705(02)70245-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
471 Corley DA, Kerlikowske K, Verma R, Buffler P. Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis. Gastroenterology. 2003;124:47-56. [PMID: 12512029 DOI: 10.1053/gast.2003.50008] [Cited by in Crossref: 354] [Cited by in F6Publishing: 321] [Article Influence: 18.6] [Reference Citation Analysis]
472 Stark SP, Romberg MS, Pierce GE, Hermreck AS, Jewell WR, Moran JF, Cherian G, Delcore R, Thomas JH. Transhiatal versus transthoracic esophagectomy for adenocarcinoma of the distal esophagus and cardia. The American Journal of Surgery 1996;172:478-82. [DOI: 10.1016/s0002-9610(96)00224-3] [Cited by in Crossref: 63] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
473 Noguchi Y, Yoshikawa T, Tsuburaya A, Motohashi H, Karpeh MS, Brennan MF. Is gastric carcinoma different between Japan and the United States? Cancer. 2000;89:2237-2246. [PMID: 11147594 DOI: 10.1002/1097-0142(20001201)89:11%3C2237::AID-CNCR12%3E3.0.CO;2-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
474 Ahn HS, Lee HJ, Yoo MW, Jeong SH, Park DJ, Kim HH, Kim WH, Lee KU, Yang HK. Changes in clinicopathological features and survival after gastrectomy for gastric cancer over a 20-year period. Br J Surg. 2011;98:255-260. [PMID: 21082693 DOI: 10.1002/bjs.7310] [Cited by in Crossref: 115] [Cited by in F6Publishing: 109] [Article Influence: 10.5] [Reference Citation Analysis]
475 Nicolini G, Ghosh-laskar S, Shrivastava SK, Banerjee S, Chaudhary S, Agarwal JP, Munshi A, Clivio A, Fogliata A, Mancosu P, Vanetti E, Cozzi L. Volumetric Modulation Arc Radiotherapy With Flattening Filter-Free Beams Compared With Static Gantry IMRT and 3D Conformal Radiotherapy for Advanced Esophageal Cancer: A Feasibility Study. International Journal of Radiation Oncology*Biology*Physics 2012;84:553-60. [DOI: 10.1016/j.ijrobp.2011.12.041] [Cited by in Crossref: 71] [Cited by in F6Publishing: 62] [Article Influence: 7.1] [Reference Citation Analysis]
476 Kamangar F, Dores GM, Anderson WF. Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World. JCO 2006;24:2137-50. [DOI: 10.1200/jco.2005.05.2308] [Cited by in Crossref: 2385] [Cited by in F6Publishing: 1251] [Article Influence: 149.1] [Reference Citation Analysis]
477 Li Y, Woodall C, Wo JM, Zheng H, Ng CK, Ray MB, Martin RC. The use of dynamic positron emission tomography imaging for evaluating the carcinogenic progression of intestinal metaplasia to esophageal adenocarcinoma. Cancer Invest 2008;26:278-85. [PMID: 18317969 DOI: 10.1080/07357900701708401] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
478 Gray JR, Coldman AJ, Macdonald WC. Cigarette and alcohol use in patients with adenocarcinoma of the gastric cardia or lower esophagus. Cancer 1992;69:2227-31. [DOI: 10.1002/1097-0142(19920501)69:9<2227::aid-cncr2820690903>3.0.co;2-q] [Cited by in Crossref: 52] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
479 Yajima K, Kanda T, Kosugi SI, Kano Y, Ishikawa T, Ichikawa H, Hanyu T, Wakai T. Intrathoracic esophagojejunostomy using OrVil™ for gastric adenocarcinoma involving the esophagus. World J Gastrointest Surg 2014; 6(12): 235-240 [PMID: 25548608 DOI: 10.4240/wjgs.v6.i12.235] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
480 J. Van Den Boogert, R. Van Hilleger. Barrett's Oesophagus: Pathophysiology, Diagnosis, and Management. Scandinavian Journal of Gastroenterology 2009;33:449-53. [DOI: 10.1080/00365529850171981] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
481 Hatta W, Tong D, Lee YY, Ichihara S, Uedo N, Gotoda T. Different time trend and management of esophagogastric junction adenocarcinoma in three Asian countries. Dig Endosc 2017;29 Suppl 2:18-25. [PMID: 28425657 DOI: 10.1111/den.12808] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 5.8] [Reference Citation Analysis]
482 Lepage C, Drouillard A, Jouve JL, Faivre J. Epidemiology and risk factors for oesophageal adenocarcinoma. Dig Liver Dis. 2013;45:625-629. [PMID: 23453359 DOI: 10.1016/j.dld.2012.12.020] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 4.3] [Reference Citation Analysis]
483 Triadafilopoulos G. Proton pump inhibitors in Barrett's esophagus: Pluripotent but controversial. Eur Surg 2008;40:58-65. [DOI: 10.1007/s10353-008-0394-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
484 Yang K, Bang HJ, Almadani ME, Dy-Abalajon DM, Kim YN, Roh KH, Lim SH, Son T, Kim HI, Noh SH, Hyung WJ. Laparoscopic Proximal Gastrectomy with Double-Tract Reconstruction by Intracorporeal Anastomosis with Linear Staplers. J Am Coll Surg. 2016;222:e39-e45. [PMID: 26968319 DOI: 10.1016/j.jamcollsurg.2016.01.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
485 Wang LD, Zheng S, Zheng ZY, Casson AG. Primary adenocarcinomas of lower esophagus, esophagogastric junction and gastric cardia: in special reference to China. World J Gastroenterol 2003; 9(6): 1156-1164 [PMID: 12800215 DOI: 10.3748/wjg.v9.i6.1156] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 38] [Article Influence: 1.9] [Reference Citation Analysis]
486 Fein M, Fuchs K, Ritter MP, Freys SM, Heimbucher J, Staab C, Thiede A. Application of the new classification for cancer of the cardia. Surgery 1998;124:707-14. [DOI: 10.1067/msy.1998.91363] [Cited by in Crossref: 41] [Cited by in F6Publishing: 31] [Article Influence: 1.7] [Reference Citation Analysis]
487 Kang KJ, Lee JH. Characteristics of Gastric Cancer in Korea - with an Emphasis on the Increase of the Early Gastric Cancer (EGC). J Korean Med Assoc 2010;53:283. [DOI: 10.5124/jkma.2010.53.4.283] [Cited by in Crossref: 20] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
488 Lagergren J, Bergström R, Lindgren A, Nyrén O. The role of tobacco, snuff and alcohol use in the aetiology of cancer of the oesophagus and gastric cardia. Int J Cancer 2000;85:340-6. [DOI: 10.1002/(sici)1097-0215(20000201)85:3<340::aid-ijc8>3.0.co;2-n] [Cited by in Crossref: 196] [Article Influence: 8.9] [Reference Citation Analysis]
489 Keld R, Thian M, Hau C, Sajid J, Kumar N, Ang Y. Polymorphisms of MTHFR and susceptibility to oesophageal adenocarcinoma in a Caucasian United Kingdom population. World J Gastroenterol 2014; 20(34): 12212-12216 [PMID: 25232254 DOI: 10.3748/wjg.v20.i34.12212] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
490 Ashfaq A, Kidwell JT, McGhan LJ, Dueck AC, Pockaj BA, Gray RJ, Bagaria SP, Wasif N. Validation of a gastric cancer nomogram using a cancer registry. J Surg Oncol 2015;112:377-80. [PMID: 26271201 DOI: 10.1002/jso.23999] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
491 Barr H. Barrett’s Esophagus: Treatment with 5-Aminolevulinic Acid Photodynamic Therapy. Gastrointestinal Endoscopy Clinics of North America 2000;10:421-37. [DOI: 10.1016/s1052-5157(18)30114-4] [Cited by in Crossref: 25] [Article Influence: 1.1] [Reference Citation Analysis]
492 Goldschmid S, Nord HJ. Endoscopic Diagnosis and Treatment of Esophageal Cancer. Gastrointestinal Endoscopy Clinics of North America 1994;4:827-50. [DOI: 10.1016/s1052-5157(18)30483-5] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
493 Singh S, Bansal A, Puli S, Wani S, Mathur S, Rastogi A, Sharma P. Effect of Proton Pump Inhibitor Therapy on Inflammatory Changes in the Gastric Cardia (Carditis). Dig Dis Sci 2007;52:2178-82. [DOI: 10.1007/s10620-006-9688-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
494 Lee LS, Poneros JM. New frontiers in endoscopic imaging. Gastrointest Endosc Clin N Am 2005;15:631-51, xi. [PMID: 15990060 DOI: 10.1016/j.giec.2005.04.006] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
495 Li Y, Cui G, Farmer R, Jacob K, Pandit H, Li X, Martin RCG 2nd. Exposure to bile acids alters the intracellular location and function of MnSOD in Barrett's esophagus. J Surg Res 2018;229:156-63. [PMID: 29936984 DOI: 10.1016/j.jss.2018.03.055] [Reference Citation Analysis]
496 Iannettoni MD, Lee SS, Bonnell MR, Sell TL, Whyte RI, Orringer MB, Beer DG. Detection of Barrett's adenocarcinoma of the gastric cardia with sucrase isomaltase and p53. Ann Thorac Surg. 1996;62:1460-1465; discussion 1460-1465. [PMID: 8893584 DOI: 10.1016/0003-4975(96)00749-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
497 Horii T, Koike T, Abe Y, Kikuchi R, Unakami H, Iijima K, Imatani A, Ohara S, Shimosegawa T. Two distinct types of cancer of different origin may be mixed in gastroesophageal junction adenocarcinomas in Japan: evidence from direct evaluation of gastric acid secretion. Scand J Gastroenterol. 2011;46:710-719. [PMID: 21446884 DOI: 10.3109/00365521.2011.565069] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
498 van den Boogert J, Houtsmuller AB, de Rooij FW, de Bruin RW, Siersema PD, van Hillegersberg R. Kinetics, localization, and mechanism of 5-aminolevulinic acid-induced porphyrin accumulation in normal and Barrett's-like rat esophagus. Lasers Surg Med 1999;24:3-13. [DOI: 10.1002/(sici)1096-9101(1999)24:1<3::aid-lsm3>3.0.co;2-n] [Cited by in Crossref: 24] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
499 D'Amico TA. Molecular biologic staging of esophageal cancer. Thorac Surg Clin 2006;16:317-27. [PMID: 17240819 DOI: 10.1016/j.thorsurg.2006.09.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
500 Nakagawa M, Kojima K, Inokuchi M, Kobayashi K, Tanioka T, Okuno K, Gokita K. Feasibility of laparoscopic total gastrectomy in overweight patients: Implications of less impact of overweight on laparoscopic versus open approach. World J Clin Cases 2018; 6(16): 1094-1100 [PMID: 30613667 DOI: 10.12998/wjcc.v6.i16.1094] [Reference Citation Analysis]
501 Wijnhoven BP, Pignatelli M, Dinjens WN, Tilanus HW. Reduced p120ctn expression correlates with poor survival in patients with adenocarcinoma of the gastroesophageal junction. J Surg Oncol 2005;92:116-23. [PMID: 16231374 DOI: 10.1002/jso.20344] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 2.2] [Reference Citation Analysis]
502 Maziak DE, Johnston MR, Casson AG. Adenocarcinoma of the neo-esophagus after collis gastroplasty. The Annals of Thoracic Surgery 1995;60:1795-7. [DOI: 10.1016/0003-4975(95)00588-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
503 Wobst A, Audisio RA, Colleoni M, Geraghty JG. Oesophageal cancer treatment: studies, strategies and facts. Ann Oncol. 1998;9:951-962. [PMID: 9818067 DOI: 10.1023/A:1008273110272] [Cited by in Crossref: 48] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]
504 Freedman J, Ye W, Näslund E, Lagergren J. Association between cholecystectomy and adenocarcinoma of the esophagus. Gastroenterology. 2001;121:548-553. [PMID: 11522738 DOI: 10.1053/gast.2001.27217] [Cited by in Crossref: 33] [Cited by in F6Publishing: 39] [Article Influence: 1.6] [Reference Citation Analysis]
505 Kwong KF. Molecular Biologic Assessment of Barrett's Esophagus. Thoracic Surgery Clinics 2006;16:311-5. [DOI: 10.1016/j.thorsurg.2006.08.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
506 Mason R. Palliation of oesophageal cancer. Surgical Oncology 2001;10:123-6. [DOI: 10.1016/s0960-7404(01)00026-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
507 A. K. Kubba, N. Krasner. The Emerging Role of Photodynamic Therapy in the Management of Barrett's Oesophagus. Scandinavian Journal of Gastroenterology 2009;33:1121-9. [DOI: 10.1080/00365529850172449] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
508 Coia LR. Chemoradiation: A superior alternative for the primary management of esophageal carcinoma. Seminars in Radiation Oncology 1994;4:157-64. [DOI: 10.1016/s1053-4296(05)80063-3] [Cited by in Crossref: 17] [Article Influence: 0.6] [Reference Citation Analysis]
509 Gudlaugsdottir S, Verschuren W, Dees J, Stijnen T, Wilson J. Hypertension is frequently present in patients with reflux esophagitis or Barrett’s esophagus but not in those with non-ulcer dyspepsia. European Journal of Internal Medicine 2002;13:369-75. [DOI: 10.1016/s0953-6205(02)00090-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
510 Fox JR, Kuwada SK. Today's approach to esophageal cancer. What is the role of the primary care physician? Postgrad Med 2000;107:109-14. [PMID: 10844946 DOI: 10.3810/pgm.2000.5.1.1061] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
511 Willis J, Cooper GS, Isenberg G, Sivak MV, Levitan N, Clayman J, Chak A. Correlation of EUS measurement with pathologic assessment of neoadjuvant therapy response in esophageal carcinoma. Gastrointest Endosc. 2002;55:655-661. [PMID: 11979246 DOI: 10.1067/mge.2002.123273] [Cited by in Crossref: 70] [Cited by in F6Publishing: 59] [Article Influence: 3.5] [Reference Citation Analysis]
512 Lightdale CJ. Photodynamic therapy: A new light on Barrett's esophagus. Gastrointestinal Endoscopy 1995;42:96-8. [DOI: 10.1016/s0016-5107(95)70256-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
513 Hasegawa S, Yoshikawa T, Aoyama T, Hayashi T, Yamada T, Tsuchida K, Cho H, Oshima T, Yukawa N, Rino Y. Esophagus or stomach? The seventh TNM classification for Siewert type II/III junctional adenocarcinoma. Ann Surg Oncol. 2013;20:773-779. [PMID: 23224137 DOI: 10.1245/s10434-012-2780-x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
514 Buck JL, Pantongrag-brown L. Tumors of the esophagus. Seminars in Roentgenology 1994;29:351-63. [DOI: 10.1016/s0037-198x(05)80049-5] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
515 Locke GR, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ. Risk factors associated with symptoms of gastroesophageal reflux. Am J Med. 1999;106:642-649. [PMID: 10378622 DOI: 10.1016/s0002-9343(99)00121-7] [Cited by in Crossref: 338] [Cited by in F6Publishing: 109] [Article Influence: 14.7] [Reference Citation Analysis]
516 Demeester TR. Esophageal carcinoma: Current controversies. Semin Surg Oncol 1997;13:217-33. [DOI: 10.1002/(sici)1098-2388(199707/08)13:4<217::aid-ssu2>3.0.co;2-8] [Cited by in Crossref: 42] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
517 Kasakura Y, Phan A, Ajani J. Adjuvant therapy for resected gastric carcinoma. Surg Oncol Clin N Am. 2002;11:431-444, xii-xiii. [PMID: 12424861 DOI: 10.1016/s1055-3207(02)00009-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
518 Gao Y, Mclaughlin JK, Blot WJ, Ji B, Benichou J, Dai Q, Fraumeni JF. Risk factors for esophageal cancer in Shanghai, China. I. Role of cigarette smoking and alcohol drinking. Int J Cancer 1994;58:192-6. [DOI: 10.1002/ijc.2910580208] [Cited by in Crossref: 122] [Cited by in F6Publishing: 122] [Article Influence: 4.4] [Reference Citation Analysis]
519 Wroblewski LE, Peek RM Jr. Helicobacter pylori, Cancer, and the Gastric Microbiota. Adv Exp Med Biol. 2016;908:393-408. [PMID: 27573782 DOI: 10.1007/978-3-319-41388-4_19] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]
520 Nakagawa K, Koike T, Iijima K, Shinkai H, Hatta W, Endo H, Ara N, Uno K, Asano N, Imatani A, Shimosegawa T. Comparison of the long-term outcomes of endoscopic resection for superficial squamous cell carcinoma and adenocarcinoma of the esophagus in Japan. Am J Gastroenterol. 2014;109:348-356. [PMID: 24394751 DOI: 10.1038/ajg.2013.450] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
521 Li Y, Wo JM, Su RR, Ray MB, Martin RC. Alterations in manganese superoxide dismutase expression in the progression from reflux esophagitis to esophageal adenocarcinoma. Ann Surg Oncol. 2007;14:2045-2055. [PMID: 17473952 DOI: 10.1245/s10434-007-9387-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
522 Aurello P, D'angelo F, Nigri G, Bellagamba R, Cicchini C, Ruzzetti R, Ramacciato G. Comparison between Site N-Category and Number N-Category for Nodal Staging in Carcinoma of the Gastroesophageal Junction: Our Experience and Literature Review. The American Surgeon 2006;72:118-23. [DOI: 10.1177/000313480607200204] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
523 Wijnhoven BP, Siersema PD, Hop WC, van Dekken H, Tilanus HW. Adenocarcinomas of the distal oesophagus and gastric cardia are one clinical entity. Rotterdam Oesophageal Tumour Study Group. Br J Surg. 1999;86:529-535. [PMID: 10215831 DOI: 10.1046/j.1365-2168.1999.01082.x] [Cited by in Crossref: 128] [Cited by in F6Publishing: 119] [Article Influence: 5.6] [Reference Citation Analysis]
524 Barr H, Shepherd N, Dix A, Roberts D, Tan W, Krasner N. Eradication of high-grade dysplasia in columnar-lined (Barrett's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX. The Lancet 1996;348:584-5. [DOI: 10.1016/s0140-6736(96)03054-1] [Cited by in Crossref: 225] [Cited by in F6Publishing: 45] [Article Influence: 8.7] [Reference Citation Analysis]
525 Dietz J, Chaves-E-Silva S, Meurer L, Sekine S, de Souza AR, Meine GC. Short segment Barrett's esophagus and distal gastric intestinal metaplasia. Arq Gastroenterol 2006;43:117-20. [PMID: 17119666 DOI: 10.1590/s0004-28032006000200011] [Reference Citation Analysis]
526 Cooper GS, Yuan Z, Chak A, Rimm AA. Association of prediagnosis endoscopy with stage and survival in adenocarcinoma of the esophagus and gastric cardia. Cancer 2002;95:32-8. [PMID: 12115314 DOI: 10.1002/cncr.10646] [Cited by in Crossref: 57] [Cited by in F6Publishing: 51] [Article Influence: 2.9] [Reference Citation Analysis]
527 Muto M, Horimatsu T, Ezoe Y, Morita S, Miyamoto S. Improving visualization techniques by narrow band imaging and magnification endoscopy. J Gastroenterol Hepatol. 2009;24:1333-1346. [PMID: 19702901 DOI: 10.1111/j.1440-1746.2009.05925.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 3.6] [Reference Citation Analysis]
528 Kaklamanos IG, Walker GR, Ferry K, Franceschi D, Livingstone AS. Neoadjuvant treatment for resectable cancer of the esophagus and the gastroesophageal junction: a meta-analysis of randomized clinical trials. Ann Surg Oncol. 2003;10:754-761. [PMID: 12900366 DOI: 10.1245/aso.2003.03.078] [Cited by in Crossref: 175] [Cited by in F6Publishing: 53] [Article Influence: 9.2] [Reference Citation Analysis]
529 Robaszkiewicz M. Épidémiologie des adénocarcinomes de l’œsophage et de la jonction œsogastrique. Cancer/Radiothérapie 2001;5:78s-9s. [DOI: 10.1016/s1278-3218(01)80010-x] [Reference Citation Analysis]
530 Gulmann C, Hegarty H, Grace A, Leader M, Patchett S, Kay E. Differences in proximal (cardia) versus distal (antral) gastric carcinogenesis via retinoblastoma pathway. World J Gastroenterol 2004; 10(1): 17-21 [PMID: 14695761 DOI: 10.3748/wjg.v10.i1.17] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
531 Karapetis CS, Cheong KA, Yip D, Strickland AH, Steer C, Marx G, Yip S, Chrystal K, Harper PG. A phase I and II trial of epirubicin, cisplatin, 24-hour infusion 5 fluorouracil and sodium folinate in patients with advanced esophagogastric carcinomas. Asia Pac J Clin Oncol 2010;6:298-305. [PMID: 21114780 DOI: 10.1111/j.1743-7563.2010.01340.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
532 Wilkinson SP, Biddlestone L, Gore S, Shepherd NA. Regression of columnar-lined (Barrett's) oesophagus with omeprazole 40 mg daily: results of 5 years of continuous therapy. Aliment Pharmacol Ther. 1999;13:1205-1209. [PMID: 10468702 DOI: 10.1046/j.1365-2036.1999.00593.x] [Cited by in Crossref: 62] [Cited by in F6Publishing: 48] [Article Influence: 2.7] [Reference Citation Analysis]
533 Neshat K, Sanchez CA, Galipeau PC, Blount PL, Levine DS, Joslyn G, Reid BJ. p53 Mutations in Barrett's adenocarcinoma and high-grade dysplasia. Gastroenterology 1994;106:1589-95. [DOI: 10.1016/0016-5085(94)90415-4] [Cited by in Crossref: 95] [Cited by in F6Publishing: 97] [Article Influence: 3.4] [Reference Citation Analysis]
534 Créhange G, Bonnetain F, Chauffert B, Rat P, Bedenne L, Maingon P. [Resectable adenocarcinoma of the oesophagogastric junction care: which perioperative treatment?]. Cancer Radiother 2008;12:365-73. [PMID: 18420440 DOI: 10.1016/j.canrad.2008.02.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
535 Mountford C, Lean C, Malycha P, Russell P. Proton spectroscopy provides accurate pathology on biopsy and in vivo. J Magn Reson Imaging 2006;24:459-77. [DOI: 10.1002/jmri.20668] [Cited by in Crossref: 50] [Cited by in F6Publishing: 40] [Article Influence: 3.1] [Reference Citation Analysis]
536 Reynolds JV, Murphy TJ, Ravi N. Multimodality Therapy for Adenocarcinoma of the Esophagus, Gastric Cardia, and Upper Gastric Third. In: Schneider PM, editor. Adenocarcinoma of the Esophagogastric Junction. Berlin: Springer Berlin Heidelberg; 2010. pp. 155-66. [DOI: 10.1007/978-3-540-70579-6_13] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
537 Hirdes MM, Vleggaar FP, Siersema PD. Stent placement for esophageal strictures: an update. Expert Rev Med Devices. 2011;8:733-755. [PMID: 22029470 DOI: 10.1586/erd.11.44] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
538 Reed CE, Mishra G, Sahai AV, Hoffman BJ, Hawes RH. Esophageal cancer staging: improved accuracy by endoscopic ultrasound of celiac lymph nodes. Ann Thorac Surg. 1999;67:319-321; discussion 322. [PMID: 10197647 DOI: 10.1016/s0003-4975(99)00031-4] [Cited by in Crossref: 115] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
539 Beddow E, Wilcox D, Drake D, Pierro A, Kiely E, Spitz L. Surveillance of Barrett's esophagus in children. Journal of Pediatric Surgery 1999;34:88-91. [DOI: 10.1016/s0022-3468(99)90235-x] [Cited by in Crossref: 12] [Article Influence: 0.5] [Reference Citation Analysis]
540 Findlay M, Cunningham D, Norman A, Mansi J, Nicolson M, Hickish T, Nicolson V, Nash A, Sacks N, Ford H. A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF). Ann Oncol 1994;5:609-16. [PMID: 7993836 DOI: 10.1093/oxfordjournals.annonc.a058932] [Cited by in Crossref: 186] [Cited by in F6Publishing: 173] [Article Influence: 6.9] [Reference Citation Analysis]
541 Boger PC, Shutt JD, Neale JR, Wilson SJ, Bateman AC, Holloway JW, Patel P, Sampson AP. Increased expression of the 5-lipoxygenase pathway and its cellular localization in Barrett's adenocarcinoma. Histopathology 2012;61:509-17. [PMID: 22690932 DOI: 10.1111/j.1365-2559.2012.04258.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
542 Sharma P, Bhattacharyya A, Garewal HS, Sampliner RE. Durability of new squamous epithelium after endoscopic reversal of Barrett's esophagus. Gastrointest Endosc. 1999;50:159-164. [PMID: 10425406 DOI: 10.1016/S0016-5107(99)70218-X] [Cited by in Crossref: 60] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
543 Sampliner RE. Multipolar electrocoagulation. Gastrointestinal Endoscopy Clinics of North America 2003;13:449-55. [DOI: 10.1016/s1052-5157(03)00048-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
544 Chandrasoma P, Wickramasinghe K, Ma Y, DeMeester T. Is intestinal metaplasia a necessary precursor lesion for adenocarcinomas of the distal esophagus, gastroesophageal junction and gastric cardia? Dis Esophagus. 2007;20:36-41. [PMID: 17227308 DOI: 10.1111/j.1442-2050.2007.00638.x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 43] [Article Influence: 3.6] [Reference Citation Analysis]
545 Thomas P, Doddoli C, Lienne P, Morati N, Thirion X, Garbe L, Giudicelli R, Fuentes P. Changing patterns and surgical results in adenocarcinoma of the oesophagus: ADENOCARCINOMA OF THE OESOPHAGUS. Br J Surg 1997;84:119-25. [DOI: 10.1046/j.1365-2168.1997.02464.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
546 Raouf AA, Evoy DA, Carton E. Loss of bcl-2 expression in Barrett's dysplasia and adenocarcinoma is associated with tumor progression and wore survival but with response to neoaadjuvant chemradiation. Dis Esophagus. 2003;16:17-23. [PMID: 12581249 DOI: 10.1046/j.1442-2050.2003.00281.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 1.7] [Reference Citation Analysis]
547 Adelstein DJ, Rice TW, Becker M, Larto MA, Kirby TJ, Koka A, Tefft M, Zuccaro G. Use of concurrent chemotherapy, accelerated fractionation radiation, and surgery for patients with esophageal carcinoma. Cancer 1997;80:1011-20. [DOI: 10.1002/(sici)1097-0142(19970915)80:6<1011::aid-cncr2>3.0.co;2-c] [Cited by in Crossref: 87] [Article Influence: 3.5] [Reference Citation Analysis]
548 Luketich JD, Schauer P, Urso K, Kassis E, Ferson P, Keenan R, Landreneau R. Future directions in esophageal cancer. Chest 1998;113:120S-2S. [PMID: 9438701 DOI: 10.1378/chest.113.1_supplement.120s] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
549 Markar S, Gronnier C, Duhamel A, Pasquer A, Théreaux J, du Rieu MC, Lefevre JH, Turner K, Luc G, Mariette C. Salvage Surgery After Chemoradiotherapy in the Management of Esophageal Cancer: Is It a Viable Therapeutic Option? J Clin Oncol 2015;33:3866-73. [PMID: 26195702 DOI: 10.1200/JCO.2014.59.9092] [Cited by in Crossref: 100] [Cited by in F6Publishing: 42] [Article Influence: 14.3] [Reference Citation Analysis]
550 Buttar NS, Wang KK, Leontovich O, Westcott JY, Pacifico RJ, Anderson MA, Krishnadath KK, Lutzke LS, Burgart LJ. Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett’s esophagus. Gastroenterology. 2002;122:1101-1112. [PMID: 11910360 DOI: 10.1053/gast.2002.32371] [Cited by in Crossref: 264] [Cited by in F6Publishing: 233] [Article Influence: 13.2] [Reference Citation Analysis]
551 Qadeer MA, Colabianchi N, Strome M, Vaezi MF. Gastroesophageal reflux and laryngeal cancer: causation or association? A critical review. American Journal of Otolaryngology 2006;27:119-28. [DOI: 10.1016/j.amjoto.2005.07.010] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 2.3] [Reference Citation Analysis]
552 Casson AG. Role of molecular biology in the follow-up of patients who have Barrett's esophagus. Chest Surgery Clinics of North America 2002;12:93-111. [DOI: 10.1016/s1052-3359(03)00068-1] [Cited by in Crossref: 13] [Article Influence: 0.7] [Reference Citation Analysis]
553 Sampliner RE. Detecting, measuring, and managing Barrett's esophagus: the complete endoscopist's dilemma. Gastrointestinal Endoscopy 1997;45:533-5. [DOI: 10.1016/s0016-5107(97)70191-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
554 He YT, Hou J, Chen ZF, Qiao CY, Song GH, Meng FS, Jin HX, Chen C. Trends in incidence of esophageal and gastric cardia cancer in high-risk areas in China. Eur J Cancer Prev. 2008;17:71-76. [PMID: 18287862 DOI: 10.1097/cej.0b013e3282b6fd97] [Cited by in Crossref: 55] [Cited by in F6Publishing: 30] [Article Influence: 3.9] [Reference Citation Analysis]
555 Morgan RJ, Perry AC, Newcomb PV, Hardwick RH, Alderson D. Investigation of oesophageal adenocarcinoma for viral genomic sequences. European Journal of Surgical Oncology (EJSO) 1997;23:24-9. [DOI: 10.1016/s0748-7983(97)80138-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
556 Hirayama N, Arima M, Miyazaki S, Shimada H, Okazumi S, Matsubara H, Suzuki T, Ochiai T, Kouzu T. Endoscopic mucosal resection of adenocarcinoma arising in ectopic gastric mucosa in the cervical esophagus: case report. Gastrointestinal Endoscopy 2003;57:263-6. [DOI: 10.1067/mge.2003.84] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.3] [Reference Citation Analysis]
557 Rosemurgy A, Wilfong C, Craigg D, Co F, Sucandy I, Ross S. The Evolving Landscape of Esophageal Cancer: A Four-Decade Analysis. The American Surgeon 2019;85:944-8. [DOI: 10.1177/000313481908500933] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
558 Hirdes MM, Siersema P. Endoprosthetics for malignant esophageal disease. Techniques in Gastrointestinal Endoscopy 2014;16:64-70. [DOI: 10.1016/j.tgie.2014.07.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
559 Keller SM, Ryan LM, Coia LR, Dang P, Vaught DJ, Diggs C, Weiner LM, Benson AB. High dose chemoradiotherapy followed by esophagectomy for adenocarcinoma of the esophagus and gastroesophageal junction: Results of a Phase II study of the Eastern Cooperative Oncology Group. Cancer 1998;83:1908-16. [DOI: 10.1002/(sici)1097-0142(19981101)83:9<1908::aid-cncr5>3.0.co;2-6] [Cited by in Crossref: 54] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
560 Picton TD, Owen DA, Macdonald WC. Comparison of esophagocardiac and more distal gastric cancer in patients with prior ulcer surgery. Cancer 1993;71:5-8. [DOI: 10.1002/1097-0142(19930101)71:1<5::aid-cncr2820710103>3.0.co;2-c] [Cited by in Crossref: 6] [Article Influence: 0.2] [Reference Citation Analysis]
561 Clark CJ, Thirlby RC, Picozzi V, Schembre DB, Cummings FP, Lin E. Current problems in surgery: gastric cancer. Curr Probl Surg. 2006;43:566-670. [PMID: 17000267 DOI: 10.1067/j.cpsurg.2006.06.003] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 2.4] [Reference Citation Analysis]
562 Ward MH, Sinha R, Heineman EF, Rothman N, Markin R, Weisenburger DD, Correa P, Zahm SH. Risk of adenocarcinoma of the stomach and esophagus with meat cooking method and doneness preference. Int J Cancer 1997;71:14-9. [PMID: 9096659 DOI: 10.1002/(sici)1097-0215(19970328)71:1<14::aid-ijc4>3.0.co;2-6] [Cited by in Crossref: 94] [Cited by in F6Publishing: 34] [Article Influence: 3.8] [Reference Citation Analysis]
563 Lightdale CJ. Role of Photodynamic Therapy in the Management of Advanced Esophageal Cancer. Gastrointestinal Endoscopy Clinics of North America 2000;10:397-408. [DOI: 10.1016/s1052-5157(18)30112-0] [Cited by in Crossref: 28] [Article Influence: 1.3] [Reference Citation Analysis]
564 Nelson RL, Dollear T, Freels S, Persky V. The relation of age, race, and gender to the subsite location of colorectal carcinoma. Cancer 1997;80:193-7. [PMID: 9217029 DOI: 10.1002/(sici)1097-0142(19970715)80:2<193::aid-cncr4>3.0.co;2-v] [Cited by in Crossref: 93] [Cited by in F6Publishing: 40] [Article Influence: 3.7] [Reference Citation Analysis]
565 Shaikh T, Meyer JE, Horwitz EM. Optimal Use of Combined Modality Therapy in the Treatment of Esophageal Cancer. Surgical Oncology Clinics of North America 2017;26:405-29. [DOI: 10.1016/j.soc.2017.01.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
566 Bonde P, Gao D, Chen L, Miyashita T, Montgomery E, Harmon JW, Wei C. Duodenal Reflux Leads to Down Regulation of DNA Mismatch Repair Pathway in an Animal Model of Esophageal Cancer. The Annals of Thoracic Surgery 2007;83:433-40. [DOI: 10.1016/j.athoracsur.2006.06.090] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
567 Chak A, Canto MI, Cooper GS, Isenberg G, Willis J, Levitan N, Clayman J, Forastiere A, Heath E, Sivak MV. Endosonographic assessment of multimodality therapy predicts survival of esophageal carcinoma patients. Cancer 2000;88:1788-95. [DOI: 10.1002/(sici)1097-0142(20000415)88:8<1788::aid-cncr5>3.0.co;2-6] [Cited by in Crossref: 68] [Article Influence: 3.1] [Reference Citation Analysis]
568 Sujendran V, Wheeler J, Baron R, Warren BF, Maynard N. Effect of neoadjuvant chemotherapy on circumferential margin positivity and its impact on prognosis in patients with resectable oesophageal cancer. British Journal of Surgery 2008;95:191-4. [DOI: 10.1002/bjs.5983] [Cited by in Crossref: 50] [Cited by in F6Publishing: 42] [Article Influence: 3.3] [Reference Citation Analysis]
569 Su M, Chin SF, Li XY, Fitzgerald RC. Comparative genomic hybridization of esophageal adenocarcino-ma and squamous cell carcinoma cell lines. Dis Esophagus. 2006;19:10-14. [PMID: 16364037 DOI: 10.1111/j.1442-2050.2006.00530.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
570 Sharma P, Topalovski M, Mayo MS, Sampliner RE, Weston AP. Helicobacter pylori eradication dramatically improves inflammation in the gastric cardia. Am J Gastroenterol 2000;95:3107-11. [PMID: 11095325 DOI: 10.1111/j.1572-0241.2000.03257.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
571 Ryu SY, Joo JK, Lee JH, Kim DY. Prognosis of upper-third gastric carcinoma patients with invasion of the lower esophagus. Langenbecks Arch Surg 2008;393:957-62. [DOI: 10.1007/s00423-008-0344-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
572 Driessen A, Nafteux P, Lerut T, Van Raemdonck D, De Leyn P, Filez L, Penninckx F, Geboes K, Ectors N. Identical cytokeratin expression pattern CK7+/CK20− in esophageal and cardiac cancer: etiopathological and clinical implications. Mod Pathol 2004;17:49-55. [DOI: 10.1038/modpathol.3800011] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
573 Fitzsimmons D, Osmond C, George S, Johnson CD. Trends in stomach and pancreatic cancer incidence and mortality in England and Wales, 1951–2000. British Journal of Surgery 2007;94:1162-71. [DOI: 10.1002/bjs.5751] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
574 Conio M, Repici A, Cestari R, Blanchi S, Lapertosa G, Missale G, Casa DD, Villanacci V, Calandri PG, Filiberti R. Endoscopic mucosal resection for high-grade dysplasia and intramucosal carcinoma in Barrett’s esophagus: An Italian experience. World J Gastroenterol 2005; 11(42): 6650-6655 [PMID: 16425359 DOI: 10.3748/wjg.v11.i42.6650] [Cited by in CrossRef: 62] [Cited by in F6Publishing: 57] [Article Influence: 3.6] [Reference Citation Analysis]
575 Todd JA, Weston T, MacDonald TM, Johnston DA, Dillon JF. The prescribing of acid suppressants prior to the endoscopic diagnosis of Barrett's oesophagus and oesophagitis. Aliment Pharmacol Ther 2001;15:221-6. [PMID: 11148441 DOI: 10.1046/j.1365-2036.2001.00914.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
576 Markar SR, Karthikesalingam A, Jackson D, Hanna GB. Long-term survival after gastrectomy for cancer in randomized, controlled oncological trials: comparison between West and East. Ann Surg Oncol. 2013;20:2328-2338. [PMID: 23340695 DOI: 10.1245/s10434-012-2862-9] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 5.6] [Reference Citation Analysis]
577 Fass R, Garewal HS, Hayden CW, Ramsey L, Sampliner RE. Preferential repair by squamous epithelium of thermal induced injury to the proximal stomach in patients undergoing ablation of Barrett's esophagus. Gastrointestinal Endoscopy 2001;53:711-6. [DOI: 10.1067/mge.2001.114781] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
578 Stoner GD, Gupta A. Etiology and chemoprevention of esophageal squamous cell carcinoma. Carcinogenesis. 2001;22:1737-1746. [PMID: 11698334 DOI: 10.1093/carcin/22.11.1737] [Cited by in Crossref: 183] [Cited by in F6Publishing: 173] [Article Influence: 8.7] [Reference Citation Analysis]
579 Coppola D, Schreiber RH, Mora L, Dalton W, Karl RC. Significance of Fas and retinoblastoma protein expression during the progression of Barrett's metaplasia to adenocarcinoma. Ann Surg Oncol. 1999;6:298-304. [PMID: 10340890 DOI: 10.1007/s10434-999-0298-7] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 1.5] [Reference Citation Analysis]
580 Chr.-r. de Mas, M. Krämer, E. Seife. Short Barrett: Prevalence and Risk Factors. Scandinavian Journal of Gastroenterology 2009;34:1065-70. [DOI: 10.1080/003655299750024832] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
581 Samalin E, Ychou M. Neoadjuvant treatment in upper gastrointestinal adenocarcinomas: new paradigms from old concepts? Curr Opin Oncol 2007;19:384-9. [PMID: 17545805 DOI: 10.1097/CCO.0b013e3281a73674] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
582 Brown LM, Devesa SS. Epidemiologic trends in esophageal and gastric cancer in the United States. Surg Oncol Clin N Am. 2002;11:235-256. [PMID: 12424848 DOI: 10.1016/s1055-3207(02)00002-9] [Cited by in Crossref: 271] [Cited by in F6Publishing: 129] [Article Influence: 14.3] [Reference Citation Analysis]
583 Ormsby AH, Goldblum JR, Rice TW, Richter JE, Gramlich TL. The utility of cytokeratin subsets in distinguishing Barrett's-related oesophageal adenocarcinoma from gastric adenocarcinoma. Histopathology 2001;38:307-11. [PMID: 11318895 DOI: 10.1046/j.1365-2559.2001.01079.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 2.0] [Reference Citation Analysis]
584 Hosokawa Y, Kinoshita T, Konishi M, Takahashi S, Gotohda N, Kato Y, Daiko H, Nishimura M, Katsumata K, Sugiyama Y, Kinoshita T. Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan. Ann Surg Oncol. 2012;19:677-683. [PMID: 21822549 DOI: 10.1245/s10434-011-1983-x] [Cited by in Crossref: 62] [Cited by in F6Publishing: 65] [Article Influence: 5.6] [Reference Citation Analysis]
585 Carton E, Caldwell MT, McDonald G, Rama D, Tanner WA, Reynolds JV. Specialized intestinal metaplasia in patients with gastro-oesophageal reflux disease. Br J Surg 2000;87:116-21. [PMID: 10606922 DOI: 10.1046/j.1365-2168.2000.01322.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.6] [Reference Citation Analysis]
586 Triadafilopoulos G, Akiyama J. Emerging endoscopic techniques for the identification of esophageal disease. Expert Rev Gastroenterol Hepatol 2016;10:605-13. [PMID: 26753504 DOI: 10.1586/17474124.2016.1140037] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
587 Brand S, Wang TD, Schomacker KT, Poneros JM, Lauwers GY, Compton CC, Pedrosa MC, Nishioka NS. Detection of high-grade dysplasia in Barrett's esophagus by spectroscopy measurement of 5-aminolevulinic acid-induced protoporphyrin IX fluorescence. Gastrointest Endosc. 2002;56:479-487. [PMID: 12297761 DOI: 10.1016/s0016-5107(02)70430-6] [Cited by in Crossref: 51] [Cited by in F6Publishing: 1] [Article Influence: 2.6] [Reference Citation Analysis]
588 Si J, Behar J, Wands J, Beer DG, Lambeth D, Chin YE, Cao W. STAT5 mediates PAF-induced NADPH oxidase NOX5-S expression in Barrett's esophageal adenocarcinoma cells. Am J Physiol Gastrointest Liver Physiol 2008;294:G174-83. [PMID: 17947454 DOI: 10.1152/ajpgi.00291.2007] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
589 Gockel I, Kneist W, Junginger T. Incurable Esophageal Cancer: Patterns of Tumor Spread and Therapeutic Consequences. World J Surg 2006;30:183-90. [DOI: 10.1007/s00268-005-7861-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
590 Koch J, Halvorsen RA. Staging of esophageal cancer: Computed tomography, magnetic resonance imaging, and endoscopic ultrasound. Seminars in Roentgenology 1994;29:364-72. [DOI: 10.1016/s0037-198x(05)80050-1] [Cited by in Crossref: 30] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
591 Kleinberg L. Therapy for locally advanced adenocarcinoma of the gastroesophageal junction: optimizing outcome. Semin Radiat Oncol. 2013;23:38-50. [PMID: 23207046 DOI: 10.1016/j.semradonc.2012.10.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
592 Siewert JR, Stein HJ. Barrett's cancer: Indications, extent, and results of surgical resection. Semin Surg Oncol 1997;13:245-52. [DOI: 10.1002/(sici)1098-2388(199707/08)13:4<245::aid-ssu5>3.0.co;2-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
593 Segal I. The gastro-oesophageal reflux disease complex in sub-Saharan Africa: . European Journal of Cancer Prevention 2001;10:209-12. [DOI: 10.1097/00008469-200106000-00003] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
594 Collard JM, Romagnoli R, Hermans BP, Malaise J. Radical esophageal resection for adenocarcinoma arising in Barrett's esophagus. Am J Surg 1997;174:307-11. [PMID: 9324143 DOI: 10.1016/s0002-9610(97)00107-4] [Cited by in Crossref: 25] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
595 Gleeson CM, Sloan JM, Mcguigan JA, Ritchie AJ, Weber JL, Russell SH. Barrett's oesophagus: Microsatellite analysis provides evidence to support the proposed metaplasia-dysplasia-carcinoma sequence. Genes Chromosom Cancer 1998;21:49-60. [DOI: 10.1002/(sici)1098-2264(199801)21:1<49::aid-gcc7>3.0.co;2-8] [Cited by in Crossref: 35] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
596 Wolfsen HC, Wallace MB. Reconsidering Barrett’s Esophagus: Practical Applications of Biophotonics. Gastroenterology 2008;134:382-5. [DOI: 10.1053/j.gastro.2007.12.018] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
597 Altorki N, Schwartz GK, Blundell M, Davis BM, Kelsen DP, Albino AP. Characterization of cell lines established from human gastric-esophageal adenocarcinomas. Biologic phenotype and invasion potential. Cancer 1993;72:649-57. [PMID: 8334620 DOI: 10.1002/1097-0142(19930801)72:3<649::aid-cncr2820720305>3.0.co;2-l] [Cited by in Crossref: 38] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
598 Martínez-Galindo MG, Zamarripa-Dorsey F, Carmona-Castañeda A, Angeles-Labra A, Peñavera-Hernández R, Ugarte-Briones C, Blanco-Vela CI. Histopathologic characteristics of gastric adenocarcinoma in Mexican patients: a 10-year experience at the Hospital Juárez of Mexico. Rev Gastroenterol Mex 2015;80:21-6. [PMID: 25747884 DOI: 10.1016/j.rgmx.2014.11.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
599 Mariette C, Finzi L, Piessen G, Van Seuningen I, Triboulet JP. Esophageal Carcinoma: Prognostic Differences between Squamous Cell Carcinoma And Adenocarcinoma. World J Surg 2005;29:39-45. [DOI: 10.1007/s00268-004-7542-x] [Cited by in Crossref: 66] [Cited by in F6Publishing: 64] [Article Influence: 3.7] [Reference Citation Analysis]
600 J. Nilsson, V. Skobe, J. Johansson,. Screening for Oesophageal Adenocarcinoma: An Evaluation of a Surveillance Program for Columnar Metaplasia of the Oesophagus. Scandinavian Journal of Gastroenterology 2009;35:10-6. [DOI: 10.1080/003655200750024461] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
601 Lin D, Khan U, Goetze TO, Reizine N, Goodman KA, Shah MA, Catenacci DV, Al-Batran SE, Posey JA. Gastroesophageal Junction Adenocarcinoma: Is There an Optimal Management? Am Soc Clin Oncol Educ Book 2019;39:e88-95. [PMID: 31099690 DOI: 10.1200/EDBK_236827] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
602 Wang XJ, Yuan SL, Xiao L, Wang XH, Wang CJ. Expression of c-src gene in the carcinogenesis process of human cardia adenocarcinoma. World J Gastroenterol 1999; 5(6): 488-491 [PMID: 11819497 DOI: 10.3748/wjg.v5.i6.488] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
603 Mehta SP, Boddy AP, Cook J, Sams V, Lund EK, Johnson IT, Rhodes M. Effect of n-3 polyunsaturated fatty acids on Barrett's epithelium in the human lower esophagus. Am J Clin Nutr 2008;87:949-56. [PMID: 18400718 DOI: 10.1093/ajcn/87.4.949] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
604 Munítiz V, Ortiz-escandell Á, Martínez de Haro LF, Antonio García-marcilla J, Molina J, Ruiz de Angulo D, Carlos Navalón J, Parrilla P. Resultados del cáncer de esófago resecado. Estudio comparativo entre el adenocarcinoma y el carcinoma epidermoide. Cirugía Española 2004;76:94-100. [DOI: 10.1016/s0009-739x(04)72367-2] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
605 Demeester SR, Peters JH, Demeester TR. Barrett’s esophagus. Curr Probl Surg. 2001;38:558-640. [PMID: 11468640 DOI: 10.1067/msg.2001.115514] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 1.2] [Reference Citation Analysis]
606 Dresner S, Lamb P, Bennett M, Hayes N, Griffin S. The pattern of metastatic lymph node dissemination from adenocarcinoma of the esophagogastric junction. Surgery 2001;129:103-9. [DOI: 10.1067/msy.2001.110024] [Cited by in Crossref: 117] [Cited by in F6Publishing: 108] [Article Influence: 5.6] [Reference Citation Analysis]
607 Fontham ETH. Prevention of Upper Gastrointestinal Tract Cancers. In: Bendich A, Deckelbaum RJ, editors. Preventive Nutrition. Totowa: Humana Press; 1997. pp. 33-55. [DOI: 10.1007/978-1-4757-6242-6_3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
608 Fagerberg J, Stockeld D, Lewensohn R. Combined Treatment Modalities in Esophageal Cancer: Should chemotherapy be included? Acta Oncologica 2011;33:439-50. [DOI: 10.3109/02841869409098441] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
609 Zhu M, Cao B, Li X, Li P, Wen Z, Ji J, Min L, Zhang S. Risk factors and a predictive nomogram for lymph node metastasis of superficial esophagogastric junction cancer. J Gastroenterol Hepatol 2020;35:1524-31. [PMID: 32023349 DOI: 10.1111/jgh.15004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
610 Alberts SR, Cervantes A, van de Velde CJ. Gastric cancer: epidemiology, pathology and treatment. Ann Oncol. 2003;14 Suppl 2:ii31-ii36. [PMID: 12810455 DOI: 10.1093/annonc/mdg726] [Cited by in Crossref: 217] [Cited by in F6Publishing: 231] [Article Influence: 11.4] [Reference Citation Analysis]
611 Wakatsuki K, Takayama T, Ueno M, Matsumoto S, Enomoto K, Tanaka T, Nakajima Y. Characteristics of Gastric Cancer with Esophageal Invasion and Aspects of Surgical Treatment. World J Surg 2009;33:1446-53. [DOI: 10.1007/s00268-009-0053-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
612 Fujiwara Y, Higuchi K, Takashima T, Hamaguchi M, Watanabe T, Tominaga K, Oshitani N, Matsumoto T, Arakawa T. Increased expression of epidermal growth factor receptors in basal cell hyperplasia of the oesophagus after acid reflux oesophagitis in rats: EGF RECEPTORS AND HEALING AFTER ACID REFLUX OESOPHAGITIS. Alimentary Pharmacology & Therapeutics 2002;16:52-8. [DOI: 10.1046/j.1365-2036.16.s2.29.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
613 Scheuten L, Kiemeney L. Remarkable age-dependent sex differences in the incidence of adenocarcinoma of the gastric cardia and oesophagus in The Netherlands. European Journal of Cancer 1997;33:1519. [DOI: 10.1016/s0959-8049(97)00045-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
614 Chow WH, Blot WJ, Vaughan TL, Risch HA, Gammon MD, Stanford JL, Dubrow R, Schoenberg JB, Mayne ST, Farrow DC. Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst. 1998;90:150-155. [PMID: 9450576 DOI: 10.1093/jnci/90.2.150] [Cited by in Crossref: 405] [Cited by in F6Publishing: 360] [Article Influence: 16.9] [Reference Citation Analysis]
615 Zafirellis K, Dolan K, Fountoulakis A, Dexter SP, Martin IG, Sue-Ling HM. Multivariate analysis of clinical, operative and pathologic features of esophageal cancer: who needs adjuvant therapy? Dis Esophagus. 2002;15:155-159. [PMID: 12220424 DOI: 10.1046/j.1442-2050.2002.00230.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 1.6] [Reference Citation Analysis]
616 Barthel JS, Kucera S, Harris C, Canchi D, Hoffe S, Meredith K. Cryoablation of persistent Barrett’s epithelium after definitive chemoradiation therapy for esophageal adenocarcinoma. Gastrointest Endosc. 2011;74:51-57. [PMID: 21549371 DOI: 10.1016/j.gie.2011.03.1121] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
617 Bhattacharyya R, Longcroft-Wheaton G, Bhandari P. The role of acetic acid in the management of Barrett's oesophagus. Clin Res Hepatol Gastroenterol 2015;39:282-91. [PMID: 25660984 DOI: 10.1016/j.clinre.2014.07.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
618 Tanomkiat W, Chongchitnan P. Transabdominal sonography of gastroesophageal junctions. J Clin Ultrasound 1999;27:505-12. [DOI: 10.1002/(sici)1097-0096(199911/12)27:9<505::aid-jcu4>3.0.co;2-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
619 Blum Murphy MA, Qiao W, Mewada N, Wadhwa R, Elimova E, Takashi T, Ho L, Phan A, Baker J, Ajani J. A Phase I/II Study of Docetaxel, Oxaliplatin, and Fluorouracil (D-FOX) Chemotherapy in Patients With Untreated Locally Unresectable or Metastatic Adenocarcinoma of the Stomach and Gastroesophageal Junction. American Journal of Clinical Oncology 2018;41:321-5. [DOI: 10.1097/coc.0000000000000271] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
620 Griffiths EA, Brummell Z, Gorthi G, Pritchard SA, Welch IM. Tumor length as a prognostic factor in esophageal malignancy: univariate and multivariate survival analyses. J Surg Oncol. 2006;93:258-267. [PMID: 16496364 DOI: 10.1002/jso.20449] [Cited by in Crossref: 51] [Cited by in F6Publishing: 54] [Article Influence: 3.2] [Reference Citation Analysis]
621 Bamias A, Pavlidis N. Systemic Chemotherapy in Gastric Cancer: Where Do We Stand Today? The Oncologist 1998;3:171-7. [DOI: 10.1634/theoncologist.3-3-171] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
622 Inamdar NV, Levin B. The Epidemiology and Causes of Gastric Cancer. Surgical Oncology Clinics of North America 1993;2:333-45. [DOI: 10.1016/s1055-3207(18)30560-x] [Cited by in Crossref: 4] [Article Influence: 0.1] [Reference Citation Analysis]
623 Guelrud M, Ehrlich EE. Enhanced magnification endoscopy in the upper gastrointestinal tract. Gastrointest Endosc Clin N Am. 2004;14:461-473, viii. [PMID: 15261196 DOI: 10.1016/j.giec.2004.03.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
624 Visbal AL, Allen MS, Miller DL, Deschamps C, Trastek VF, Pairolero PC. Ivor Lewis esophagogastrectomy for esophageal cancer. Ann Thorac Surg. 2001;71:1803-1808. [PMID: 11426751 DOI: 10.1016/s0003-4975(01)02601-7] [Cited by in Crossref: 119] [Cited by in F6Publishing: 32] [Article Influence: 5.7] [Reference Citation Analysis]
625 Pedrazzani C, Catalano F, Festini M, Zerman G, Tomezzoli A, Ruzzenente A, Guglielmi A, de Manzoni G. Endoscopic ablation of Barrett’s esophagus using high power setting argon plasma coagulation: A prospective study. World J Gastroenterol 2005; 11(12): 1872-1875 [PMID: 15793884 DOI: 10.3748/wjg.v11.i12.1872] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
626 Cameron AJ. Epidemiology of Barrett’s esophagus and adenocarcinoma*. Diseases of the Esophagus 2002;15:106-8. [DOI: 10.1046/j.1442-2050.2002.00216.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 2.0] [Reference Citation Analysis]
627 Wallace MB, Perelman LT, Backman V, Crawford JM, Fitzmaurice M, Seiler M, Badizadegan K, Shields SJ, Itzkan I, Dasari RR, Van Dam J, Feld MS. Endoscopic detection of dysplasia in patients with Barrett's esophagus using light-scattering spectroscopy. Gastroenterology 2000;119:677-82. [DOI: 10.1053/gast.2000.16511] [Cited by in Crossref: 188] [Cited by in F6Publishing: 149] [Article Influence: 8.5] [Reference Citation Analysis]
628 Yagi K, Nakamura A, Sekine A, Oyamatsu M, Tamiya Y, Watanabe H. An early cancer of the gastric cardia arising from carditis after long-term gastroesophageal reflux disease in the absence of Helicobacter pylori infection. J Gastroenterol Hepatol 2002;17:1236-8. [PMID: 12453287 DOI: 10.1046/j.1440-1746.2002.02749.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
629 Ekström AM, Signorello LB, Hansson LE, Bergström R, Lindgren A, Nyrén O. Evaluating gastric cancer misclassification: a potential explanation for the rise in cardia cancer incidence. J Natl Cancer Inst. 1999;91:786-790. [PMID: 10328109 DOI: 10.1093/jnci/91.9.786] [Cited by in Crossref: 132] [Cited by in F6Publishing: 129] [Article Influence: 5.7] [Reference Citation Analysis]
630 Mueller J, Werner M, Stolte M. Barrett's esophagus: histopathologic definitions and diagnostic criteria. World J Surg. 2004;28:148-154. [PMID: 14727064 DOI: 10.1007/s00268-003-7050-4] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 1.9] [Reference Citation Analysis]
631 Bouvier A, Esteve J, Mitry E, Clinard F, Bonithon-kopp C, Faivre J. Trends in gastric cancer incidence in a well-defined French population by time period and birth cohort: . European Journal of Cancer Prevention 2002;11:221-7. [DOI: 10.1097/00008469-200206000-00005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
632 Garces CA, McAuliffe PF, Hochwald SN, Cance WG. Neoadjuvant therapy in the treatment of solid tumors. Curr Probl Surg 2006;43:457-551. [PMID: 16860653 DOI: 10.1067/j.cpsurg.2006.04.003] [Reference Citation Analysis]
633 Cen P, Hofstetter WL, Lee JH, Ross WA, Wu TT, Swisher SG, Davila M, Rashid A, Correa AM, Ajani JA. Value of endoscopic ultrasound staging in conjunction with the evaluation of lymphovascular invasion in identifying low-risk esophageal carcinoma. Cancer 2008;112:503-10. [PMID: 18072264 DOI: 10.1002/cncr.23217] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
634 Nasr AO, Dillon MF, Conlon S, Downey P, Chen G, Ireland A, Leen E, Bouchier-hayes D, Walsh TN. Acid suppression increases rates of Barrett’s esophagus and esophageal injury in the presence of duodenal reflux. Surgery 2012;151:382-90. [DOI: 10.1016/j.surg.2011.08.021] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
635 Hölscher AH, Bollschweiler E, Schneider PM, Siewert JR. Early adenocarcinoma in Barrett's oesophagus: EARLY ADENOCARCINOMA IN BARRETT'S OESOPHAGUS. Br J Surg 1997;84:1470-3. [DOI: 10.1111/j.1365-2168.1997.02800.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
636 Chung JW, Lee GH, Choi KS, Kim DH, Jung KW, Song HJ, Choi KD, Jung HY, Kim JH, Yook JH. Unchanging trend of esophagogastric junction adenocarcinoma in Korea: experience at a single institution based on Siewert’s classification. Dis Esophagus. 2009;22:676-681. [PMID: 19222529 DOI: 10.1111/j.1442-2050.2009.00946.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 2.7] [Reference Citation Analysis]
637 Shikata K, Kiyohara Y, Kubo M, Yonemoto K, Ninomiya T, Shirota T, Tanizaki Y, Doi Y, Tanaka K, Oishi Y, Matsumoto T, Iida M. A prospective study of dietary salt intake and gastric cancer incidence in a defined Japanese population: the Hisayama study. Int J Cancer. 2006;119:196-201. [PMID: 16450397 DOI: 10.1002/ijc.21822] [Cited by in Crossref: 150] [Cited by in F6Publishing: 130] [Article Influence: 9.4] [Reference Citation Analysis]
638 Flucke U, Steinborn E, Dries V, Mönig SP, Schneider PM, Thiele J, Hölscher AH, Dienes HP, Baldus SE. Immunoreactivity of cytokeratins (CK7, CK20) and mucin peptide core antigens (MUC1, MUC2, MUC5AC) in adenocarcinomas, normal and metaplastic tissues of the distal oesophagus, oesophago-gastric junction and proximal stomach. Histopathology. 2003;43:127-134. [PMID: 12877727 DOI: 10.1046/j.1365-2559.2003.01680.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 2.0] [Reference Citation Analysis]
639 Lagergren J, Wang Z, Bergström R, Dillner J, Nyrén O. Human papillomavirus infection and esophageal cancer: a nationwide seroepidemiologic case-control study in Sweden. J Natl Cancer Inst. 1999;91:156-162. [PMID: 9923857 DOI: 10.1093/jnci/91.2.156] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 2.0] [Reference Citation Analysis]
640 Boys JA, Oh DS, Lewis JS, Demeester SR, Hagen JA. Esophageal Adenocarcinoma in Patients Younger than 40 Years: A Two-Decade Experience at a Public and Private Hospital. The American Surgeon 2015;81:974-8. [DOI: 10.1177/000313481508101013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
641 Fan X, Snyder N. Prevalence of Barrett’s Esophagus in Patients with or without GERD Symptoms: Role of Race, Age, and Gender. Dig Dis Sci 2009;54:572-7. [DOI: 10.1007/s10620-008-0395-7] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 2.9] [Reference Citation Analysis]
642 Menke V, Pot RG, Moons LM, van Zoest KP, Hansen B, van Dekken H, Siersema PD, Kusters JG, Kuipers EJ. Functional single-nucleotide polymorphism of epidermal growth factor is associated with the development of Barrett’s esophagus and esophageal adenocarcinoma. J Hum Genet. 2012;57:26-32. [PMID: 22129558 DOI: 10.1038/jhg.2011.124] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
643 Lardenoye JWH, Kappetein AP, Lagaay MB, Allema JH, Breslau PJ. Survival of proximal third gastric carcinoma. J Surg Oncol 1998;68:183-6. [DOI: 10.1002/(sici)1096-9098(199807)68:3<183::aid-jso10>3.0.co;2-2] [Cited by in Crossref: 5] [Article Influence: 0.2] [Reference Citation Analysis]
644 Pye JK, Crumplin MK, Charles J, Kerwat R, Foster ME, Biffin A; Hospital clinicians in Wales. One-year survey of carcinoma of the oesophagus and stomach in Wales. Br J Surg 2001;88:278-85. [PMID: 11167881 DOI: 10.1046/j.1365-2168.2001.01655.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 48] [Article Influence: 2.3] [Reference Citation Analysis]
645 Sharma P. An update on strategies for eradication of Barrett’s mucosa. The American Journal of Medicine 2001;111:147-52. [DOI: 10.1016/s0002-9343(01)00825-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
646 Strong VE. Defining the role of laparoscopic gastrectomy for gastric cancer. J Clin Oncol. 2014;32:613-614. [PMID: 24470013 DOI: 10.1200/jco.2013.52.9479] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
647 Maclennan AJ, Orringer MB, Beer DG. Identification of intestinal-type Barrett's metaplasia by using the intestine-specific protein villin and esophageal brush cytology. Mol Carcinog 1999;24:137-43. [DOI: 10.1002/(sici)1098-2744(199902)24:2<137::aid-mc8>3.0.co;2-a] [Cited by in Crossref: 21] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
648 Ilson DH, Bains M, Ginsberg RJ, Kelsen DP. Neoadjuvant Therapy of Esophageal Cancer. Surgical Oncology Clinics of North America 1997;6:723-40. [DOI: 10.1016/s1055-3207(18)30300-4] [Cited by in Crossref: 21] [Article Influence: 0.8] [Reference Citation Analysis]
649 Solomon N, Zhuge Y, Cheung M, Franceschi D, Koniaris LG. The Roles of Neoadjuvant Radiotherapy and Lymphadenectomy in the Treatment of Esophageal Adenocarcinoma. Ann Surg Oncol 2010;17:791-803. [DOI: 10.1245/s10434-009-0819-4] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 3.4] [Reference Citation Analysis]
650 Alcedo J, Ferrández A, Arenas J, Sopeña F, Ortego J, Sainz R, Lanas A. Trends in Barrett's esophagus diagnosis in Southern Europe: implications for surveillance. Dis Esophagus 2009;22:239-48. [PMID: 19425201 DOI: 10.1111/j.1442-2050.2008.00908.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 2.8] [Reference Citation Analysis]
651 Zhou Z, Xie X, Hao N, Diao D, Song Y, Xia P, Dang C, Zhang H. Different lymph node staging systems for patients with adenocarcinoma of esophagogastric junction. Curr Med Res Opin 2018;34:963-70. [PMID: 29338535 DOI: 10.1080/03007995.2018.1429390] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
652 Chaves P, Pereira AD, Cruz C, Suspiro A, Mendes de Almeida JC, Leitão CN, Soares J. Recurrent columnar-lined esophageal segments - study of the phenotypic characteristics using intestinal markers. Diseases of the Esophagus 2002;15:282-6. [DOI: 10.1046/j.1442-2050.2002.00264.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.0] [Reference Citation Analysis]
653 Barritt AS 4th, Shaheen NJ. Should patients with Barrett's oesophagus be kept under surveillance? The case against. Best Pract Res Clin Gastroenterol 2008;22:741-50. [PMID: 18656827 DOI: 10.1016/j.bpg.2007.12.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
654 Dhillon PK, Farrow DC, Vaughan TL, Chow WH, Risch HA, Gammon MD, Mayne ST, Stanford JL, Schoenberg JB, Ahsan H. Family history of cancer and risk of esophageal and gastric cancers in the United States. Int J Cancer. 2001;93:148-152. [PMID: 11391635 DOI: 10.1002/ijc.1294] [Cited by in Crossref: 86] [Cited by in F6Publishing: 91] [Article Influence: 4.1] [Reference Citation Analysis]
655 Sikkema M, Looman CW, Steyerberg EW, Kerkhof M, Kastelein F, van Dekken H, van Vuuren AJ, Bode WA, van der Valk H, Ouwendijk RJ. Predictors for neoplastic progression in patients with Barrett’s Esophagus: a prospective cohort study. Am J Gastroenterol. 2011;106:1231-1238. [PMID: 21577245 DOI: 10.1038/ajg.2011.153] [Cited by in Crossref: 129] [Cited by in F6Publishing: 102] [Article Influence: 11.7] [Reference Citation Analysis]
656 Gill KRS, Ghabril MS, Jamil LH, Al-haddad M, Gross SA, Achem SR, Woodward TA, Wallace MB, Raimondo M, Hemminger LL, Wolfsen HC. Variation in Barrett's Esophageal Wall Thickness: Is It Associated With Histology or Segment Length? Journal of Clinical Gastroenterology 2010;44:411-5. [DOI: 10.1097/mcg.0b013e3181dd8cd7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
657 Cavazzola LT, Rosa AR, Schirmer CC, Gurski RR, Telles JP, Mielke F, Meurer L, Edelweiss MI, Kruel CD. Immunohistochemical evaluation for P53 and VEGF (Vascular Endothelial Growth Factor) is not prognostic for long term survival in end stage esophageal adenocarcinoma. Rev Col Bras Cir. 2009;36:24-34. [PMID: 20076865 DOI: 10.1590/S0100-69912009000100007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
658 Bani-Hani KE, Bani-Hani BK, Martin IG. Characteristics of patients with columnar-lined Barrett’s esophagus and risk factors for progression to esophageal adenocarcinoma. World J Gastroenterol 2005; 11(43): 6807-6814 [PMID: 16425388 DOI: 10.3748/wjg.v11.i43.6807] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
659 Schnell TG, Sontag SJ, Chejfec G, Aranha G, Metz A, O'Connell S, Seidel UJ, Sonnenberg A. Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. Gastroenterology. 2001;120:1607-1619. [PMID: 11375943 DOI: 10.1053/gast.2001.25065] [Cited by in Crossref: 409] [Cited by in F6Publishing: 359] [Article Influence: 19.5] [Reference Citation Analysis]
660 Greenstein AJ, Wisnivesky JP, Litle VR. Effect of local therapy for the treatment of superficial esophageal cancer in non-operative candidates. Dis Esophagus 2008;21:673-8. [PMID: 18459986 DOI: 10.1111/j.1442-2050.2008.00832.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
661 Huang Q, Fan X, Agoston AT, Feng A, Yu H, Lauwers G, Zhang L, Odze RD. Comparison of gastro-oesophageal junction carcinomas in Chinese versus American patients. Histopathology. 2011;59:188-197. [PMID: 21884197 DOI: 10.1111/j.1365-2559.2011.03924.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 3.8] [Reference Citation Analysis]
662 Salminen JT, Rämö OJ, Ahotupa MO, Färkkilä MA, Salo JA. Increased DNA adducts in Barrett's esophagus and reflux-related esophageal malignancies. Ann Med 2002;34:565-70. [PMID: 12553496 DOI: 10.1080/078538902321117779] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
663 Zhang J, Chen XL, Wang KM, Guo XD, Zuo AL, Gong J. Barrett’s esophagus and its correlation with gastroesophageal reflux in Chinese. World J Gastroenterol 2004; 10(7): 1065-1068 [PMID: 15052695 DOI: 10.3748/wjg.v10.i7.1065] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 15] [Article Influence: 0.7] [Reference Citation Analysis]
664 Souza RC, Lima JH. Helicobacter pylori and gastroesophageal reflux disease: a review of this intriguing relationship. Dis Esophagus. 2009;22:256-263. [PMID: 19425207 DOI: 10.1111/j.1442-2050.2008.00911.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
665 Gono K, Obi T, Yamaguchi M, Ohyama N, Machida H, Sano Y, Yoshida S, Hamamoto Y, Endo T. Appearance of enhanced tissue features in narrow-band endoscopic imaging. J Biomed Opt. 2004;9:568-577. [PMID: 15189095 DOI: 10.1117/1.1695563] [Cited by in Crossref: 578] [Cited by in F6Publishing: 506] [Article Influence: 32.1] [Reference Citation Analysis]
666 Wallace MB, Sullivan D, Rustgi AK. Advanced imaging and technology in gastrointestinal neoplasia: summary of the AGA-NCI Symposium October 4-5, 2004. Gastroenterology. 2006;130:1333-1342. [PMID: 16618424 DOI: 10.1053/j.gastro.2006.01.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
667 Soslow RA, Nabeya Y, Ying L, Blundell M, Altorki NK. Acidic fibroblast growth factor is progressively increased in the development of oesophageal glandular dysplasia and adenocarcinoma. Histopathology. 1999;35:31-37. [PMID: 10383711 DOI: 10.1046/j.1365-2559.1999.00657.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 0.7] [Reference Citation Analysis]
668 Farinella E, Safar A, Nasser HA, Bouazza F, Liberale G, Paesmans M, Marechal R, Van Laethem JL, Hendlisz A, VanHoutte P, El Nakadi I. Salvage esophagectomy after failure of definitive radiochemotherapy for esophageal cancer. J Surg Oncol 2016;114:833-7. [PMID: 27778349 DOI: 10.1002/jso.24429] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
669 Jin LX, Sanford DE, Squires MH 3rd, Moses LE, Yan Y, Poultsides GA, Votanopoulos KI, Weber SM, Bloomston M, Pawlik TM, Hawkins WG, Linehan DC, Schmidt C, Worhunsky DJ, Acher AW, Cardona K, Cho CS, Kooby DA, Levine EA, Winslow E, Saunders N, Spolverato G, Colditz GA, Maithel SK, Fields RC. Interaction of Postoperative Morbidity and Receipt of Adjuvant Therapy on Long-Term Survival After Resection for Gastric Adenocarcinoma: Results From the U.S. Gastric Cancer Collaborative. Ann Surg Oncol 2016;23:2398-408. [PMID: 27006126 DOI: 10.1245/s10434-016-5121-7] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 7.3] [Reference Citation Analysis]
670 Abdi E, Latifi-Navid S, Zahri S, Yazdanbod A, Safaralizadeh R. Helicobacter pylori genotypes determine risk of non-cardia gastric cancer and intestinal- or diffuse-type GC in Ardabil: A very high-risk area in Northwestern Iran. Microb Pathog. 2017;107:287-292. [PMID: 28390977 DOI: 10.1016/j.micpath.2017.04.007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
671 Trudgill N. Familial factors in the etiology of gastroesophageal reflux disease, Barrett's esophagus, and esophageal adenocarcinoma. Chest Surgery Clinics of North America 2002;12:15-24. [DOI: 10.1016/s1052-3359(03)00062-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
672 Noguchi Y, Yoshikawa T, Tsuburaya A, Motohashi H, Karpeh MS, Brennan MF. Is gastric carcinoma different between Japan and the United States?: A comparison of patient survival among three institutions. Cancer 2000;89:2237-46. [DOI: 10.1002/1097-0142(20001201)89:11<2237::aid-cncr12>3.0.co;2-9] [Cited by in Crossref: 120] [Article Influence: 5.5] [Reference Citation Analysis]
673 Kumble S, Omary MB, Fajardo LF, Triadafilopoulos G. Multifocal heterogeneity in villin and Ep-CAM expression in Barrett's esophagus. Int J Cancer 1996;66:48-54. [DOI: 10.1002/(sici)1097-0215(19960328)66:1<48::aid-ijc9>3.0.co;2-z] [Cited by in Crossref: 28] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
674 Chow W, Mclaughlin JK, Malker HSR, Weiner JA, Ericsson JLE, Stone BJ, Blot WJ. Occupation and stomach cancer in a cohort of Swedish men. Am J Ind Med 1994;26:511-20. [DOI: 10.1002/ajim.4700260408] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 0.5] [Reference Citation Analysis]
675 Cooper SC, Croft S, Day R, Thomson CS, Trudgill NJ. Patients with prostate cancer are less likely to develop oesophageal adenocarcinoma: could androgens have a role in the aetiology of oesophageal adenocarcinoma? Cancer Causes Control 2009;20:1363-8. [PMID: 19455396 DOI: 10.1007/s10552-009-9359-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
676 Ghotli ZA, Serra S, Chetty R. Clear cell (glycogen rich) gastric adenocarcinoma: a distinct tubulo-papillary variant with a predilection for the cardia/gastro-oesophageal region. Pathology 2007;39:466-9. [PMID: 17886094 DOI: 10.1080/00313020701569972] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
677 Corley DA, Kubo A. Influence of site classification on cancer incidence rates: an analysis of gastric cardia carcinomas. J Natl Cancer Inst. 2004;96:1383-1387. [PMID: 15367571 DOI: 10.1093/jnci/djh265] [Cited by in Crossref: 57] [Cited by in F6Publishing: 56] [Article Influence: 3.2] [Reference Citation Analysis]
678 Graham AJ, Finley RJ, Clifton JC, Evans KG, Fradet G. Surgical management of adenocarcinoma of the cardia. Am J Surg. 1998;175:418-421. [PMID: 9600291 DOI: 10.1016/s0002-9610(98)00040-3] [Cited by in Crossref: 42] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
679 Crehange G, Bonnetain F, Peignaux K, Truc G, Blanchard N, Rat P, Chauffert B, Ghiringhelli F, Maingon P. Preoperative radiochemotherapy for resectable localised oesophageal cancer: a controversial strategy. Crit Rev Oncol Hematol. 2010;75:235-242. [PMID: 20044267 DOI: 10.1016/j.critrevonc.2009.11.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
680 Ekström AM, Serafini M, Nyrén O, Hansson LE, Ye W, Wolk A. Dietary antioxidant intake and the risk of cardia cancer and noncardia cancer of the intestinal and diffuse types: a population-based case-control study in Sweden. Int J Cancer. 2000;87:133-140. [PMID: 10861464 DOI: 10.1002/1097-0215(20000701)87:1%3C133::AID-IJC20%3E3.0.CO;2-E] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
681 Song Q, Hu P, Wang J, Jia Y, Zhang G, Lv L, Liu Y, Cheng Y. Association between gastric cardia adenocarcinoma risk and alcohol flushing response, but not alcohol consumption. Med Oncol 2014;31. [DOI: 10.1007/s12032-014-0858-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
682 Mallery S, Van Dam J. EUS in the evaluation of esophageal carcinoma. Gastrointestinal Endoscopy 2000;52:S6-S11. [DOI: 10.1067/mge.2000.110722] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 1.3] [Reference Citation Analysis]
683 Bintintan VV, Mehrabi A, Fonouni H, Esmaeilzadeh M, Müller-stich BP, Funariu G, Ciuce C, Gutt CN. Feasibility of a High Intrathoracic Esophagogastric Anastomosis Without Thoracic Access After Laparoscopic-Assisted Transhiatal Esophagectomy: A Pilot Experimental Study. Surg Innov 2009;16:228-36. [DOI: 10.1177/1553350609345852] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
684 Satoh S, Hasegawa S, Ozaki N, Okabe H, Watanabe G, Nagayama S, Fukushima M, Takabayashi A, Sakai Y. Retrospective analysis of 45 consecutive patients with advanced gastric cancer treated with neoadjuvant chemotherapy using an S-1/CDDP combination. Gastric Cancer 2006;9:129-35. [DOI: 10.1007/s10120-006-0369-4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
685 Imai K, Kakushima N, Tanaka M, Takizawa K, Matsubayashi H, Hotta K, Yamaguchi Y, Ono H. Validation of the application of the Japanese curative criteria for superficial adenocarcinoma at the esophagogastric junction treated by endoscopic submucosal dissection: a long-term analysis. Surg Endosc 2013;27:2436-45. [PMID: 23355156 DOI: 10.1007/s00464-012-2755-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
686 Costa F, Schwartz G, Kelsen D. Adjuvant chemotherapy in gastric adenocarcinomas. Cancer Treat Res 1998;98:41-63. [PMID: 10326664 DOI: 10.1007/978-1-4615-4977-2_2] [Reference Citation Analysis]
687 Pera M, Trastek VF, Carpenter HA, Allen MS, Deschamps C, Pairolero PC. Barrett's esophagus with high-grade dysplasia: an indication for esophagectomy? Ann Thorac Surg 1992;54:199-204. [PMID: 1637206 DOI: 10.1016/0003-4975(92)91